data_2m7p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m7p _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.336 . . . . 71.14 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -169.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 72.21 110.855 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.88 -63.86 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 73.41 110.92 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.54 47.07 3.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 61.44 112.493 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -138.49 154.23 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 74.22 110.914 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -144.18 153.14 56.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 75.14 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 172.59 12.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 71.34 112.327 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 m -109.83 -74.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.92 -119.25 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 75.33 112.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -51.82 -64.08 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 73.55 110.87 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.66 -21.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 71.33 111.169 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.13 21.7 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 74.13 111.117 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -52.61 121.05 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 65.11 110.901 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.4 m -77.59 130.8 37.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.12 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.2 pt -132.92 158.09 76.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.625 0.726 . . . . 65.53 111.096 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.73 137.35 35.35 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 64.14 112.343 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.81 -26.39 3.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 63.14 110.93 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -27.03 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.13 110.856 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.47 39.45 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -112.71 131.17 55.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.87 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.1 t 49.37 51.23 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 74.55 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.45 -53.48 2.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.76 41.78 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 55.34 112.487 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -133.21 147.39 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 73.21 110.941 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.48 12.71 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.097 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -38.58 -40.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.885 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 170.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.871 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -86.7 -29.23 22.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.83 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.83 19.15 11.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.891 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.91 28.81 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 63.45 112.443 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -70.95 -26.57 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.372 . . . . 73.11 110.85 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -65.64 -21.39 66.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 51.34 110.856 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -114.21 38.81 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.878 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 72.32 110.937 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.893 0.378 . . . . 62.42 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -169.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.831 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.42 -62.66 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 73.03 110.881 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.68 46.65 3.34 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.727 . . . . 70.52 112.511 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.36 153.9 48.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 73.55 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -142.51 152.78 61.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.603 0.716 . . . . 74.32 110.916 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 176.85 6.29 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.58 2.187 . . . . 75.41 112.383 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.97 -75.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 64.34 110.82 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.2 -114.9 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.793 -0.717 . . . . 63.52 112.531 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.91 -66.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 72.53 110.851 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mt -62.39 -21.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.21 111.141 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.83 25.65 15.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 62.22 111.142 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -51.63 120.05 4.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.873 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.7 m -75.69 126.42 30.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 71.11 110.892 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 pt -129.57 157.94 74.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.631 0.729 . . . . 75.14 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 138.08 36.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.711 2.274 . . . . 72.34 112.322 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.93 -26.31 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 72.54 110.869 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.73 -27.17 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 75.44 110.831 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -108.74 39.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 75.12 110.954 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.77 120.91 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.865 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.9 m 48.24 37.14 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.912 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -34.56 15.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.32 110.871 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.19 41.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.492 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -135.8 146.54 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 71.02 110.93 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -87.57 13.44 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 74.41 111.193 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -38.21 -41.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 64.01 110.842 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.8 169.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.913 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -88.71 -25.93 22.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.03 110.851 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -9.27 12.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.901 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.0 20.7 62.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 65.32 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -64.9 -28.54 69.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 64.55 110.833 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -61.89 -19.87 63.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 72.21 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -122.33 39.36 3.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.903 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.899 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.863 0.363 . . . . 71.43 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -169.8 1.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.11 110.809 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.85 -66.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 74.41 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.87 3.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 75.04 112.52 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -134.89 149.76 50.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.388 . . . . 65.14 110.922 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -137.52 153.25 74.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 73.4 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 177.62 5.38 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.636 2.224 . . . . 61.52 112.316 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 m -111.53 -73.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.35 110.811 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.26 -120.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 75.13 112.483 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -60.86 -42.13 97.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 74.4 110.937 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.79 -22.32 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.1 111.15 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.68 21.93 13.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 73.5 111.172 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -51.57 111.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 m -73.78 125.01 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.2 110.904 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.2 pt -127.94 157.74 72.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.658 0.742 . . . . 74.22 111.089 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.66 137.59 36.11 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.702 2.268 . . . . 62.34 112.352 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.17 -26.0 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -26.64 15.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.847 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -108.53 39.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.906 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -110.77 131.16 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 74.35 110.884 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.4 m 48.88 32.83 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.03 110.843 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.2 -33.51 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 70.31 110.812 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 46.79 0.83 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 61.43 112.498 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -137.2 144.59 42.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.35 110.931 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' ASP . 4.4 t -87.19 13.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.112 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' VAL . 30.3 m-20 -38.1 -42.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 65.13 110.845 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.68 141.18 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 75.1 110.859 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -56.02 -33.83 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 72.44 110.859 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.45 6.97 20.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.885 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.61 30.99 28.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 74.31 112.476 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.3 t -70.64 -23.9 62.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 73.43 110.845 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -62.03 -25.92 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -108.33 38.59 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.856 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 75.53 110.931 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.879 0.371 . . . . 72.23 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -168.47 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.03 110.886 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mt -67.32 -68.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.51 110.894 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.28 45.52 3.15 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.772 -0.728 . . . . 74.54 112.5 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -139.35 153.76 47.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.948 0.404 . . . . 74.12 110.858 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.69 153.09 67.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.743 . . . . 64.33 110.942 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.79 13.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 65.44 112.37 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -110.89 -75.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 64.34 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.97 -118.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.737 . . . . 62.51 112.505 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.48 -58.56 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 74.34 110.91 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.53 -22.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.203 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.49 21.0 12.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 74.32 111.119 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -51.69 115.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.927 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.56 122.76 27.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.876 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.431 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 pt -123.59 158.14 60.11 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.634 0.731 . . . . 71.31 111.111 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.73 137.25 35.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.286 . . . . 70.31 112.316 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.0 -26.74 2.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.22 -0.446 . . . . 74.25 110.939 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -28.96 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 70.34 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 4.7 m0 -109.91 55.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -122.44 129.02 51.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 72.05 110.826 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.7 t 45.85 36.36 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 71.41 110.836 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -101.54 -35.29 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.881 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.38 45.54 0.39 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -132.12 144.51 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 75.15 110.954 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.48 10.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.23 111.093 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.42 -37.63 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.53 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.29 133.42 55.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 61.34 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -57.69 -30.79 65.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.923 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -109.51 5.35 23.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.873 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.76 29.14 25.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 62.13 112.498 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -24.19 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 73.43 110.889 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -71.13 -21.02 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.909 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -113.17 38.03 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.918 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.945 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 72.44 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.04 -175.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 72.55 110.843 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 -53.97 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.926 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.05 35.47 4.08 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.676 -0.773 . . . . 73.02 112.442 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -137.88 158.01 45.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.89 0.376 . . . . 73.32 110.941 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -143.76 153.03 57.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.717 0.77 . . . . 73.21 110.828 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 173.56 10.78 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 62.22 112.33 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.95 -74.46 0.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.914 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.16 -120.01 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 70.12 112.481 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.83 -56.12 15.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 71.45 110.892 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 mm -65.8 -20.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.41 111.158 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.0 22.28 8.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -55.42 121.39 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.946 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 m -80.69 120.82 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.87 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.4 pt -121.52 158.72 53.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 74.24 111.097 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.8 Cg_endo -69.83 137.52 35.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.264 . . . . 75.03 112.294 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -49.47 -26.7 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.946 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.77 -26.87 10.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 73.54 110.904 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -108.87 52.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 75.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -123.83 132.15 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.5 m 48.18 48.41 18.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.857 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -59.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.868 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.14 42.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 72.11 112.509 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -125.34 140.06 53.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 72.31 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.55 11.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.34 111.131 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -39.98 -38.21 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.848 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.79 134.84 57.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.888 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -53.07 -42.02 65.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.868 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.03 12.83 31.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.909 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.67 27.74 20.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 64.34 112.509 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -63.03 -22.0 66.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 74.24 110.859 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -72.5 -20.44 61.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 61.21 110.868 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -113.4 37.77 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.946 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.83 0.348 . . . . 75.4 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.25 -175.32 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -54.12 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.952 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.79 35.54 4.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.25 112.461 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -141.1 151.49 44.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 73.13 110.941 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.8 149.06 63.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.612 0.72 . . . . 73.21 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 171.23 14.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 71.23 112.375 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.4 m -106.66 -76.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 61.41 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.8 -115.58 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 63.44 112.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -53.89 -58.29 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 70.54 110.939 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.6 mm -61.78 -19.5 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 75.42 111.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.73 21.68 9.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 70.15 111.195 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.04 122.41 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.9 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.41 126.72 34.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.898 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.9 pt -125.38 157.91 66.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 64.12 111.172 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.6 Cg_endo -69.7 138.46 38.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 75.31 112.358 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.11 -26.18 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 63.51 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.67 -27.62 18.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.82 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -109.44 42.23 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 74.54 110.898 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -105.51 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 75.03 110.902 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t 51.41 43.15 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -106.7 18.09 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.849 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.33 32.33 72.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 54.5 112.402 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -116.34 136.51 52.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 71.44 110.942 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 t -83.7 11.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.05 111.169 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -38.82 -41.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.807 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.66 140.78 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.894 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.62 -50.77 53.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.892 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.53 11.95 38.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 52.43 110.861 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.43 37.14 39.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.771 -0.728 . . . . 33.34 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 t -74.74 -7.25 52.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 73.41 110.817 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.1 -21.05 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.872 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -119.19 38.87 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.909 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.985 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.905 0.384 . . . . 72.03 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -66.48 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.933 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.93 44.92 2.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 45.42 112.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.9 148.8 52.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 65.33 110.949 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -137.64 153.64 74.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.54 110.859 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.89 11.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.697 2.264 . . . . 71.21 112.328 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -105.71 -73.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 70.42 110.864 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.36 -118.51 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.697 -0.764 . . . . 33.45 112.465 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -51.31 -45.03 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 75.33 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mm -72.02 -23.31 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 75.53 111.148 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.91 21.52 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.12 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -66.36 131.29 45.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 73.12 110.89 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.9 m -84.51 130.63 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.22 110.8 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.2 pt -128.56 157.48 74.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 74.41 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.79 138.0 36.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 2.236 . . . . 72.23 112.373 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.67 -25.82 4.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.9 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -28.45 13.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 64.35 110.901 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -106.24 44.2 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.955 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -121.43 134.71 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.4 110.939 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t 56.97 23.74 8.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 65.32 110.874 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -32.53 15.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.88 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.91 43.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.684 -0.769 . . . . 53.42 112.481 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -127.49 143.07 51.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 73.12 110.876 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 32' ' ' ASP . 4.1 t -86.0 13.07 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 64.31 111.153 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 31' ' ' VAL . 35.1 m-20 -37.91 -42.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.51 110.898 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.25 137.22 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.882 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.92 -31.47 40.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 53.04 110.903 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -11.26 15.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.41 110.837 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.74 18.06 67.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 73.24 112.482 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -20.85 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 65.34 110.843 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -63.39 -24.53 67.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 75.53 110.865 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.63 38.53 2.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 62.2 110.893 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.21 110.908 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.836 0.351 . . . . 71.34 110.873 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.33 -164.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 71.23 110.863 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -61.34 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 65.21 110.879 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.69 46.76 3.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 71.55 112.477 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -138.79 158.2 44.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 74.32 110.863 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -146.05 152.76 48.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.609 0.719 . . . . 75.54 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 174.12 9.99 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.665 2.243 . . . . 74.05 112.325 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 m -113.79 -73.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.92 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.7 -116.32 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 70.42 112.444 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -51.37 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.15 110.931 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.26 -21.46 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.13 111.161 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.64 27.03 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.167 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -51.43 114.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 73.23 110.946 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.05 125.05 25.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 75.35 110.876 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 pt -128.92 158.7 71.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 71.14 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 137.17 34.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.33 112.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -49.0 -27.01 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -27.63 12.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.894 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -108.63 52.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.907 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -121.57 129.21 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.1 t 45.83 53.92 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -66.44 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.52 41.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.668 -0.777 . . . . 65.44 112.405 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -126.78 138.05 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.335 . . . . 74.53 110.912 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.53 12.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.125 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -40.02 -39.2 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.3 110.849 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.03 140.49 52.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.846 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -64.48 -32.22 73.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 71.52 110.854 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.03 11.25 22.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 72.04 110.859 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.75 25.56 22.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 72.31 112.41 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.7 t -67.31 -13.27 61.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 61.43 110.952 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -82.54 -19.15 39.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 74.04 110.867 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -120.97 39.18 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.94 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.839 0.352 . . . . 61.33 110.822 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.76 -171.06 1.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 73.13 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.61 -29.97 41.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 75.44 110.944 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.85 28.84 11.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.74 . . . . 63.31 112.496 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -135.81 157.9 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 71.11 110.944 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -146.02 151.5 45.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 73.33 110.964 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.243 . . . . 75.1 112.346 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.6 m -104.66 -74.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 53.24 110.855 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.48 -104.66 0.3 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.72 . . . . 73.03 112.556 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.88 -61.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 71.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.2 -23.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.11 111.125 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.72 23.55 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 75.31 111.171 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -51.93 116.32 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 72.23 110.859 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.25 114.78 15.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 73.12 110.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 pt -117.03 158.4 44.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.709 0.766 . . . . 74.44 111.05 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 136.71 33.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.621 2.214 . . . . 75.53 112.366 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.7 -26.2 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.97 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.01 13.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.916 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -108.38 46.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 72.42 110.88 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -121.26 133.08 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 73.25 110.816 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t 53.35 27.49 6.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.921 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -93.27 -41.68 9.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.824 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.43 41.45 0.8 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 74.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 144.45 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 74.23 110.827 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.05 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 73.15 111.104 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -38.67 -41.62 0.72 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.836 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.76 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.04 110.911 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.76 -27.42 14.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.85 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.13 11.98 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 75.15 110.9 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.34 30.33 58.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 74.41 112.429 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -79.84 -3.9 49.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 64.14 110.88 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -88.7 -23.71 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.812 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.7 39.55 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.863 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.0 m . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.806 0.336 . . . . 72.21 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 -164.74 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 74.53 110.871 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.929 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.91 3.43 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.753 -0.737 . . . . 72.1 112.468 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.42 155.15 47.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 73.45 110.901 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.17 153.5 48.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.618 0.723 . . . . 74.33 110.889 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.39 24.57 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.638 2.225 . . . . 73.21 112.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.83 -75.2 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.34 110.903 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.34 -127.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 51.05 112.434 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -54.3 -42.36 70.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 75.3 110.845 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.08 -20.13 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.111 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.85 23.79 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 64.45 111.156 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -51.15 111.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.833 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -70.38 122.45 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 73.4 110.927 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.7 pt -129.22 158.56 72.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.635 0.731 . . . . 75.24 111.139 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.81 135.66 30.89 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.718 2.279 . . . . 73.22 112.313 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -48.76 -26.68 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.958 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -28.4 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 72.03 110.838 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -108.59 39.66 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.874 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -109.77 126.41 53.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 71.4 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m 46.72 64.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -125.5 -45.37 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 64.23 110.873 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.81 40.33 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.677 -0.773 . . . . 64.2 112.478 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -135.8 145.9 46.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 74.55 110.854 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.62 13.13 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.157 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -38.7 -39.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.71 171.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 54.51 110.919 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -30.17 22.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 50.15 110.882 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 20.42 10.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 75.14 110.796 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.64 29.55 25.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 73.53 112.437 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.4 t -71.99 -28.44 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 74.22 110.911 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -62.91 -22.13 66.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.54 110.876 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.87 38.28 2.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.823 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.14 110.959 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.835 0.35 . . . . 64.43 110.834 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.49 -169.27 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 75.32 110.843 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.78 -67.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.33 110.904 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.71 45.42 3.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 61.34 112.517 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -139.5 147.86 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 73.14 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -135.68 153.1 77.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 70.13 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 173.5 10.84 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.724 2.283 . . . . 65.04 112.378 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.7 m -107.93 -72.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 73.43 110.889 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.83 -122.85 0.89 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 63.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -56.12 -43.6 78.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 71.53 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -74.36 -19.11 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 71.41 111.146 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.6 24.14 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 72.42 111.126 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 112.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.937 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.9 m -75.65 120.51 21.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 71.01 110.91 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 pt -123.7 158.85 58.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 63.31 111.158 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 137.34 35.14 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 64.1 112.386 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -25.96 3.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -52.52 -26.45 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.21 110.824 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.53 39.82 2.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -108.35 127.83 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 73.35 110.928 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 m 49.28 33.2 4.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.962 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -33.88 15.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.937 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.23 40.93 1.0 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 72.41 112.409 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -132.41 145.03 50.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 74.24 110.897 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.76 13.27 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.42 111.112 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -38.42 -42.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.44 141.13 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.908 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -55.46 -32.18 62.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.25 110.86 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.87 2.7 17.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 73.2 110.916 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.25 32.9 37.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 75.45 112.534 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -70.97 -23.7 62.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 74.12 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.3 -28.89 69.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 74.11 110.872 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.79 38.9 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.855 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 75.31 110.952 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.857 0.36 . . . . 74.4 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.92 -171.71 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 74.41 110.909 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mt -63.81 -68.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 62.35 110.954 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.16 46.56 3.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 74.25 112.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.81 141.38 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 73.23 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -130.19 151.22 78.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.705 0.764 . . . . 72.44 110.818 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.59 14.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.267 . . . . 74.1 112.305 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 m -106.26 -74.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.888 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.58 -119.6 0.7 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -52.97 -63.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.784 0.326 . . . . 75.34 110.907 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.31 -22.99 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 70.41 111.152 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 64.45 22.19 12.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.42 111.169 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -52.41 111.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.972 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.3 m -74.99 128.12 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 pt -129.62 158.28 73.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.633 0.73 . . . . 73.21 111.091 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.67 137.25 35.29 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 72.11 112.397 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.67 -25.6 4.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.913 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -26.2 18.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -107.11 39.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.903 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -111.14 134.53 52.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.833 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t 50.94 30.12 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 70.03 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -93.17 -42.7 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.862 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.38 43.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 71.31 112.477 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.92 144.6 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 75.34 110.919 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.11 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 73.24 111.115 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -38.68 -41.54 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 61.51 110.844 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.42 170.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.45 110.825 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.46 -27.82 16.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.905 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.26 0.51 14.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.802 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.77 28.79 72.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.525 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -78.88 -2.66 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 74.13 110.852 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -88.41 -23.6 23.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -120.97 39.41 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.2 110.883 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.919 -179.927 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.883 0.373 . . . . 75.24 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -171.95 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 63.42 110.85 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.62 -67.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.857 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 46.32 3.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.767 -0.73 . . . . 71.34 112.514 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -144.56 141.16 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 73.32 110.895 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -129.28 150.01 74.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 72.35 110.836 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 179.01 3.99 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.668 2.246 . . . . 72.52 112.364 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.0 m -113.83 -74.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.865 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.76 -113.11 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.752 . . . . 75.51 112.502 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -51.58 -65.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 74.54 110.86 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.4 mt -65.79 -18.78 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.25 111.12 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.11 26.29 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.33 111.138 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -51.49 109.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 75.41 110.842 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.0 m -68.7 123.67 21.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.54 110.874 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 pt -125.42 158.26 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.647 0.737 . . . . 74.12 111.12 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.6 Cg_endo -69.76 138.05 36.91 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 74.42 112.322 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -26.1 4.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.906 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.35 -27.43 15.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.32 110.818 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -109.59 39.91 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.865 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.09 122.66 45.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.877 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 m 49.3 35.88 8.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 54.42 110.868 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.69 -31.81 16.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.84 34.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 71.11 112.479 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.19 143.28 50.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 74.24 110.848 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 32' ' ' ASP . 5.0 t -86.6 13.46 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.181 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 31' ' ' VAL . 28.1 m-20 -38.53 -41.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.15 110.803 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.88 173.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 73.21 110.836 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.63 -24.05 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.57 -7.37 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.862 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 22.82 61.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 74.24 112.446 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -69.25 -13.47 62.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 72.42 110.824 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -80.11 -24.16 40.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 70.15 110.875 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -123.03 39.88 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.977 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 75.14 110.879 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.859 0.361 . . . . 75.32 110.873 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -169.59 1.71 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.792 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -63.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 73.14 110.926 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.78 46.33 3.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 54.15 112.5 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -138.61 158.75 43.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 73.1 110.942 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -143.8 148.18 41.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 74.21 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 163.59 37.67 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.256 . . . . 75.33 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 m -103.75 -65.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.858 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.21 -127.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 61.43 112.462 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -52.23 -52.43 52.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.42 110.875 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.61 -18.13 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.41 111.101 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.43 22.27 9.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.143 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -62.12 113.73 3.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.45 110.941 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.0 m -82.56 130.94 35.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.911 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 pt -131.59 159.39 72.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 71.13 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.79 138.31 37.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 75.42 112.393 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -48.47 -27.6 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.17 -29.21 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.812 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.401 ' N ' ' CD1' ' A' ' 25' ' ' TRP . 4.9 m0 -109.5 52.91 0.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 73.03 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.31 122.78 45.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 75.23 110.897 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.2 m 49.02 32.32 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.0 -31.26 16.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.829 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 34.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.492 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 143.14 47.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 75.54 110.94 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 t -88.73 13.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.181 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.6 -37.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 72.33 110.893 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.1 m -70.91 125.05 25.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 75.54 110.871 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -31.93 63.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.814 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.96 7.15 46.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 75.32 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.82 27.25 19.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.734 . . . . 61.22 112.485 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t -66.57 -18.0 65.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 72.2 110.87 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -80.21 -21.21 43.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.916 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -119.19 39.31 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 73.33 110.923 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.832 0.349 . . . . 73.43 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.2 -170.83 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.53 110.876 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -64.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 74.01 110.957 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 46.63 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 53.22 112.458 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -139.77 156.6 46.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.386 . . . . 74.23 110.913 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.56 153.41 65.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.743 . . . . 75.34 110.873 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 165.76 29.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.709 2.273 . . . . 70.22 112.376 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 m -103.98 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 63.25 110.859 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.23 -121.96 0.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.715 -0.755 . . . . 70.14 112.48 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -57.61 -54.19 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 74.44 110.91 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp -63.55 -19.29 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 72.14 111.134 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.96 23.79 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.35 111.111 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.3 116.35 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 75.2 110.924 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.9 m -83.31 124.03 30.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 65.52 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -127.29 157.64 71.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.653 0.74 . . . . 71.41 111.054 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.4 Cg_endo -69.81 137.97 36.57 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.711 2.274 . . . . 72.41 112.29 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -49.28 -26.1 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.909 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -28.51 24.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 70.34 110.933 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -108.47 42.52 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 73.23 110.919 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -107.63 131.16 54.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.851 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 m 51.21 37.77 19.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 55.53 110.853 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -101.25 11.67 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 75.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.62 29.31 74.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 73.31 112.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -110.92 138.69 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 75.31 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.07 12.11 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 71.24 111.166 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -38.36 -42.03 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 74.32 110.848 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.28 136.14 57.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 73.53 110.852 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -55.04 -26.38 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -10.57 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 51.1 110.911 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.26 16.12 70.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.692 -0.766 . . . . 64.33 112.483 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -18.65 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 72.32 110.79 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.26 -22.75 65.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.868 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -115.69 39.82 2.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 63.25 110.901 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.928 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.873 0.368 . . . . 73.32 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.0 -174.23 2.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 63.33 110.886 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -54.82 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.32 110.945 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.91 38.58 3.17 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.697 -0.763 . . . . 62.53 112.472 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -141.53 158.36 43.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 74.5 110.926 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -142.76 152.22 58.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.628 0.727 . . . . 73.24 110.842 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 164.15 35.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.277 . . . . 74.31 112.347 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.1 m -104.17 -69.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.877 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.46 -120.52 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 64.43 112.478 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -59.23 -53.18 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 75.33 110.798 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.9 mm -61.17 -17.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 73.51 111.154 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.04 22.17 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.97 121.78 12.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.874 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.6 m -90.06 123.99 34.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.915 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -124.31 157.59 64.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.45 111.192 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.9 Cg_endo -69.85 138.37 37.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 74.33 112.347 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -48.4 -27.08 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.54 110.904 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -29.73 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.969 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 3.6 m0 -110.41 58.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 73.21 110.904 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -125.58 126.53 44.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.54 110.883 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t 48.25 47.47 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 75.4 110.859 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -116.93 -25.15 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 75.23 110.823 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.87 42.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 73.22 112.498 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -125.93 134.9 51.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.863 0.363 . . . . 71.53 110.922 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.17 11.82 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 75.41 111.191 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.97 -38.77 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.815 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.1 131.68 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.417 . . . . 74.35 110.816 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.4 -35.99 68.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.43 110.852 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.33 2.52 39.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 74.44 110.913 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 50.89 33.72 28.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 70.1 112.469 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -77.12 -3.25 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.895 0.378 . . . . 72.45 110.858 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.14 -20.56 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.31 110.846 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -120.5 38.49 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.11 110.946 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 75.15 110.936 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.856 0.36 . . . . 64.44 110.872 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.08 -169.59 2.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.855 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.42 -67.68 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 74.12 110.917 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.01 47.51 3.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.773 -0.727 . . . . 74.52 112.555 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -143.99 155.1 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 63.2 110.903 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.16 153.39 69.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 74.1 110.91 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 165.34 31.28 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.723 2.282 . . . . 71.53 112.321 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -107.52 -71.25 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 71.44 110.864 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.22 -128.58 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 54.23 112.507 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.31 -48.34 68.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.744 0.307 . . . . 73.1 110.895 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 mm -66.24 -14.97 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 54.23 111.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.99 24.59 7.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.164 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -60.86 120.01 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.903 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.4 m -86.63 124.42 32.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.309 -0.405 . . . . 74.32 110.908 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 12.4 pt -125.34 157.45 67.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 75.31 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.0 Cg_endo -69.84 138.43 37.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 72.23 112.327 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -48.74 -27.03 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.84 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.9 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -109.78 57.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.53 110.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -126.14 127.74 46.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.54 110.882 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t 51.84 29.76 6.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.15 110.895 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.71 -34.71 11.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.779 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.99 44.92 0.52 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 75.31 112.422 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -128.12 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 74.01 110.962 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.26 12.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.18 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.6 -39.14 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.875 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.11 123.96 19.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 72.43 110.883 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.49 -26.74 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.848 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -14.46 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.875 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.22 26.57 72.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 44.23 112.492 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 t -74.0 -7.13 51.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 74.15 110.887 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.89 -20.13 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.888 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -122.44 38.98 4.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 54.13 110.888 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 72.42 110.878 -179.919 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.832 0.348 . . . . 73.32 110.888 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -169.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.822 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.52 -67.51 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 74.41 110.96 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.53 46.02 3.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 62.54 112.439 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -140.19 150.33 44.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 70.45 110.921 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -140.8 152.78 66.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.718 0.771 . . . . 74.45 110.82 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 164.48 34.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 74.42 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -98.69 -75.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.853 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.21 -132.52 2.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 73.43 112.475 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -52.35 -49.69 63.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 71.02 110.874 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.8 mt -58.99 -21.69 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.25 111.154 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.59 21.09 11.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 74.33 111.127 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 117.07 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 63.54 110.888 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.9 m -81.96 138.79 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.853 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 1.8 pt -140.16 159.52 63.7 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.606 0.717 . . . . 75.04 111.118 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.74 136.17 32.38 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.752 2.302 . . . . 73.31 112.334 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -26.15 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.9 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.99 -26.96 11.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.904 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -110.15 40.21 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -109.24 131.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 74.14 110.823 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.0 m 48.8 32.99 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.845 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -92.66 -27.4 17.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 75.04 110.909 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.79 31.53 5.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 52.51 112.445 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -118.24 142.08 47.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 73.43 110.96 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.66 12.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 75.13 111.151 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -38.46 -42.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.915 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.98 173.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.916 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -106.4 -11.97 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.868 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.09 9.15 10.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.868 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.29 37.46 38.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.747 . . . . 74.01 112.487 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -94.96 -6.79 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 74.3 110.842 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -83.24 -22.96 32.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 62.52 110.893 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.06 39.95 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.15 110.89 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.32 110.874 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.873 0.368 . . . . 73.52 110.895 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 -164.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.871 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -62.94 1.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 74.44 110.909 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.58 46.13 3.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 64.54 112.51 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.5 151.21 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 72.54 110.913 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -139.8 152.96 69.4 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.642 0.734 . . . . 75.24 110.9 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 175.11 8.53 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.695 2.264 . . . . 74.43 112.392 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 m -108.03 -75.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.909 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.86 -105.73 0.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.508 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' ND2' HD21 ' A' ' 35' ' ' ASN . 6.8 p30 -74.25 -46.45 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.324 . . . . 75.12 110.861 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -70.81 -12.0 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.097 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 55.84 26.16 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.12 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.12 116.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.41 110.916 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.0 m -80.53 120.68 24.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.53 110.918 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 10.7 pt -126.9 157.71 70.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 75.0 111.162 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.81 136.85 33.88 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.728 2.286 . . . . 63.31 112.29 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -26.36 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.24 110.943 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.53 -27.7 17.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.846 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -108.88 42.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.92 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -108.29 128.17 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 74.23 110.851 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m 54.08 37.07 26.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.45 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.79 14.3 32.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 65.22 112.474 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -108.12 137.49 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 75.33 110.887 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.59 11.61 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 74.34 111.17 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -38.9 -41.16 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 73.3 110.811 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.56 141.76 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.894 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -54.57 -35.73 63.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 61.4 110.892 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.442 HD21 ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -111.95 8.45 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.04 110.907 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.2 31.8 27.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.772 . . . . 75.25 112.475 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -71.81 -16.14 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.349 . . . . 74.1 110.875 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.69 -16.2 61.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 72.12 110.849 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.51 38.89 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.32 110.873 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.973 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.851 0.358 . . . . 63.24 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -167.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 73.21 110.883 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -11.07 51.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.908 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.98 25.37 6.43 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.498 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.97 162.26 32.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.01 110.886 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.52 152.98 46.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.643 0.735 . . . . 75.2 110.843 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 162.45 42.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 74.23 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -102.48 -75.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 72.2 110.922 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.76 -115.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.765 -0.731 . . . . 64.23 112.466 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -52.6 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 74.25 110.915 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.33 -21.96 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 75.24 111.139 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m 59.42 22.18 10.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 64.32 111.194 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -54.09 121.36 7.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.929 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 m -75.47 116.51 16.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 73.02 110.914 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 pt -114.51 158.06 41.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 75.32 111.134 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.1 Cg_endo -69.73 136.67 33.67 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.71 2.273 . . . . 74.41 112.339 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.3 -26.62 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.934 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.52 -27.7 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -106.31 44.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.903 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -116.28 128.49 55.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.04 110.878 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t 50.02 31.68 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 75.52 110.795 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -33.2 14.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.462 . . . . 72.42 110.914 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.69 47.44 0.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.742 . . . . 71.25 112.502 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -138.03 146.24 42.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.31 110.905 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASP . 5.1 t -89.2 13.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.123 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' VAL . 13.9 m-20 -36.98 -44.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 72.1 110.874 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.42 135.28 33.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 64.24 110.925 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.43 -30.19 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 13.4 20.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.87 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.66 30.51 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 52.24 112.459 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 m -72.4 -31.06 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 74.22 110.809 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.95 -28.47 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 75.04 110.892 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -107.82 38.66 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.821 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 75.44 110.934 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.245 . . . . 45.03 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.81 91.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 71.34 110.888 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -161.58 161.57 29.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.31 110.882 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 -60.51 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.91 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 m -59.75 141.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 75.33 111.094 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.16 143.64 23.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 73.43 111.103 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.2 m -134.2 -169.81 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 71.14 110.894 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -169.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 72.21 110.855 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.88 -63.86 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 73.41 110.92 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.54 47.07 3.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 61.44 112.493 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -138.49 154.23 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 74.22 110.914 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -144.18 153.14 56.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 75.14 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 172.59 12.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 71.34 112.327 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 m -109.83 -74.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.92 -119.25 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 75.33 112.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -51.82 -64.08 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 73.55 110.87 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.66 -21.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 71.33 111.169 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.13 21.7 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 74.13 111.117 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -52.61 121.05 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 65.11 110.901 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.4 m -77.59 130.8 37.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.12 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.2 pt -132.92 158.09 76.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.625 0.726 . . . . 65.53 111.096 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.73 137.35 35.35 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 64.14 112.343 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.81 -26.39 3.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 63.14 110.93 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -27.03 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.13 110.856 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.47 39.45 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -112.71 131.17 55.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.87 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.1 t 49.37 51.23 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 74.55 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.45 -53.48 2.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.76 41.78 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 55.34 112.487 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -133.21 147.39 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 73.21 110.941 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.48 12.71 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.097 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -38.58 -40.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.885 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 170.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.871 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -86.7 -29.23 22.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.83 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.83 19.15 11.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.891 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.91 28.81 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 63.45 112.443 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -70.95 -26.57 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.372 . . . . 73.11 110.85 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -65.64 -21.39 66.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 51.34 110.856 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -114.21 38.81 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.878 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -118.5 64.58 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 72.32 110.937 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.41 -13.07 6.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 41.15 112.501 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 119.281 -0.39 . . . . 64.14 110.881 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.464 -0.254 . . . . 64.22 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -79.24 -68.15 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 74.42 110.868 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 54.46 53.17 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 74.44 110.9 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 52.18 68.12 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 64.22 110.886 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 m -59.31 137.27 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 72.33 111.156 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.36 144.69 51.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 71.33 111.116 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -134.59 -169.85 2.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 62.42 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -169.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.831 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.42 -62.66 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 73.03 110.881 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.68 46.65 3.34 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.727 . . . . 70.52 112.511 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.36 153.9 48.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 73.55 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -142.51 152.78 61.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.603 0.716 . . . . 74.32 110.916 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 176.85 6.29 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.58 2.187 . . . . 75.41 112.383 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.97 -75.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 64.34 110.82 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.2 -114.9 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.793 -0.717 . . . . 63.52 112.531 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.91 -66.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 72.53 110.851 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.2 mt -62.39 -21.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.21 111.141 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.83 25.65 15.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 62.22 111.142 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -51.63 120.05 4.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.873 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.7 m -75.69 126.42 30.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 71.11 110.892 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 pt -129.57 157.94 74.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.631 0.729 . . . . 75.14 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 138.08 36.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.711 2.274 . . . . 72.34 112.322 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.93 -26.31 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 72.54 110.869 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.73 -27.17 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 75.44 110.831 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -108.74 39.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 75.12 110.954 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.77 120.91 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.865 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.9 m 48.24 37.14 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.912 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -34.56 15.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.32 110.871 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.19 41.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.492 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -135.8 146.54 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 71.02 110.93 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -87.57 13.44 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 74.41 111.193 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -38.21 -41.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 64.01 110.842 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.8 169.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.913 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -88.71 -25.93 22.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.03 110.851 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -9.27 12.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.901 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.0 20.7 62.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 65.32 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -64.9 -28.54 69.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 64.55 110.833 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -61.89 -19.87 63.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 72.21 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -122.33 39.36 3.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.903 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -100.26 70.41 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.899 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.22 -21.73 23.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 72.42 112.483 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 119.291 -0.385 . . . . 53.21 110.877 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.517 -0.233 . . . . 72.11 112.517 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -42.93 91.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 74.44 110.907 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.98 176.49 5.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.883 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -151.95 84.61 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 64.14 110.86 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 m -58.52 139.75 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.04 111.137 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.62 52.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 73.04 111.161 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.8 m -131.66 -169.99 2.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.43 . . . . 71.43 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -169.8 1.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.11 110.809 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.85 -66.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 74.41 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.87 3.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 75.04 112.52 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -134.89 149.76 50.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.388 . . . . 65.14 110.922 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -137.52 153.25 74.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 73.4 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 177.62 5.38 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.636 2.224 . . . . 61.52 112.316 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 m -111.53 -73.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.35 110.811 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.26 -120.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 75.13 112.483 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -60.86 -42.13 97.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 74.4 110.937 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.79 -22.32 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.1 111.15 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.68 21.93 13.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 73.5 111.172 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -51.57 111.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 m -73.78 125.01 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.2 110.904 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.2 pt -127.94 157.74 72.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.658 0.742 . . . . 74.22 111.089 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.66 137.59 36.11 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.702 2.268 . . . . 62.34 112.352 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.17 -26.0 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -26.64 15.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.847 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -108.53 39.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.906 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -110.77 131.16 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 74.35 110.884 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.4 m 48.88 32.83 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.03 110.843 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.2 -33.51 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 70.31 110.812 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 46.79 0.83 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 61.43 112.498 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -137.2 144.59 42.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.35 110.931 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' ASP . 4.4 t -87.19 13.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.112 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' VAL . 30.3 m-20 -38.1 -42.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 65.13 110.845 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.68 141.18 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 75.1 110.859 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -56.02 -33.83 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 72.44 110.859 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.45 6.97 20.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.885 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.61 30.99 28.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 74.31 112.476 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.3 t -70.64 -23.9 62.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 73.43 110.845 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -62.03 -25.92 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -108.33 38.59 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.856 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -121.57 63.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 75.53 110.931 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.29 -11.84 6.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 60.41 112.505 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 119.31 -0.376 . . . . 72.24 110.9 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.473 -0.251 . . . . 72.33 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.65 26.6 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.944 0.402 . . . . 73.24 110.973 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.51 -172.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 63.12 110.937 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -174.4 36.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.479 . . . . 75.41 110.83 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 m -58.64 133.12 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 72.01 111.124 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.28 167.17 23.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 75.11 111.113 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -130.81 -172.21 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.906 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -168.47 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.03 110.886 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mt -67.32 -68.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.51 110.894 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.28 45.52 3.15 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.772 -0.728 . . . . 74.54 112.5 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -139.35 153.76 47.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.948 0.404 . . . . 74.12 110.858 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.69 153.09 67.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.743 . . . . 64.33 110.942 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.79 13.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 65.44 112.37 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -110.89 -75.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 64.34 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.97 -118.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.737 . . . . 62.51 112.505 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.48 -58.56 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 74.34 110.91 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.53 -22.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.203 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.49 21.0 12.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 74.32 111.119 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -51.69 115.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.927 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.56 122.76 27.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.876 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.431 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 pt -123.59 158.14 60.11 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.634 0.731 . . . . 71.31 111.111 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.73 137.25 35.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.286 . . . . 70.31 112.316 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.0 -26.74 2.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.22 -0.446 . . . . 74.25 110.939 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -28.96 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 70.34 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 4.7 m0 -109.91 55.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -122.44 129.02 51.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 72.05 110.826 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.7 t 45.85 36.36 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 71.41 110.836 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -101.54 -35.29 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.881 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.38 45.54 0.39 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -132.12 144.51 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 75.15 110.954 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.48 10.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.23 111.093 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.42 -37.63 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.53 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.29 133.42 55.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 61.34 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -57.69 -30.79 65.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.923 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -109.51 5.35 23.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.873 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.76 29.14 25.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 62.13 112.498 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -24.19 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 73.43 110.889 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -71.13 -21.02 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.909 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -113.17 38.03 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.918 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -125.11 63.23 1.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.945 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.49 -11.54 6.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 74.13 112.43 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 119.333 -0.365 . . . . 64.45 110.831 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.489 -0.244 . . . . 70.24 112.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m -109.05 -171.17 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 74.21 110.86 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -49.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.889 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.9 68.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 71.32 110.889 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.86 134.38 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 61.0 111.132 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 154.36 41.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 74.4 111.14 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m -131.12 -170.29 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.84 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.04 -175.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 72.55 110.843 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 -53.97 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.926 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.05 35.47 4.08 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.676 -0.773 . . . . 73.02 112.442 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -137.88 158.01 45.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.89 0.376 . . . . 73.32 110.941 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -143.76 153.03 57.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.717 0.77 . . . . 73.21 110.828 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 173.56 10.78 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 62.22 112.33 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.95 -74.46 0.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.914 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.16 -120.01 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 70.12 112.481 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.83 -56.12 15.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 71.45 110.892 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 mm -65.8 -20.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.41 111.158 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.0 22.28 8.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -55.42 121.39 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.946 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 m -80.69 120.82 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.87 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.4 pt -121.52 158.72 53.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 74.24 111.097 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.8 Cg_endo -69.83 137.52 35.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.264 . . . . 75.03 112.294 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -49.47 -26.7 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.946 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.77 -26.87 10.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 73.54 110.904 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -108.87 52.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 75.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -123.83 132.15 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.5 m 48.18 48.41 18.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.857 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -59.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.868 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.14 42.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 72.11 112.509 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -125.34 140.06 53.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 72.31 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.55 11.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.34 111.131 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -39.98 -38.21 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.848 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.79 134.84 57.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.888 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -53.07 -42.02 65.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.868 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.03 12.83 31.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.909 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.67 27.74 20.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 64.34 112.509 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -63.03 -22.0 66.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 74.24 110.859 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -72.5 -20.44 61.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 61.21 110.868 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -113.4 37.77 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -119.47 -16.07 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.946 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.14 10.78 5.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.774 . . . . 73.34 112.476 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 119.313 -0.375 . . . . 75.24 110.905 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.461 -0.256 . . . . 74.12 112.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.48 -51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 72.01 110.867 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -126.12 99.43 5.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.951 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.48 144.19 44.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.23 110.918 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 135.44 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 75.44 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.61 168.44 27.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.43 111.174 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -127.99 -169.62 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 75.4 110.898 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.25 -175.32 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -54.12 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.952 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.79 35.54 4.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.25 112.461 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -141.1 151.49 44.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 73.13 110.941 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.8 149.06 63.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.612 0.72 . . . . 73.21 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 171.23 14.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 71.23 112.375 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.4 m -106.66 -76.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 61.41 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.8 -115.58 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 63.44 112.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -53.89 -58.29 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 70.54 110.939 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.6 mm -61.78 -19.5 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 75.42 111.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.73 21.68 9.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 70.15 111.195 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.04 122.41 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.9 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.41 126.72 34.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.898 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.9 pt -125.38 157.91 66.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 64.12 111.172 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.6 Cg_endo -69.7 138.46 38.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 75.31 112.358 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.11 -26.18 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 63.51 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.67 -27.62 18.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.82 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -109.44 42.23 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 74.54 110.898 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -105.51 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 75.03 110.902 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t 51.41 43.15 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -106.7 18.09 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.849 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.33 32.33 72.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 54.5 112.402 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -116.34 136.51 52.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 71.44 110.942 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 t -83.7 11.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.05 111.169 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -38.82 -41.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.807 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.66 140.78 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.894 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.62 -50.77 53.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.892 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.53 11.95 38.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 52.43 110.861 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.43 37.14 39.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.771 -0.728 . . . . 33.34 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 t -74.74 -7.25 52.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 73.41 110.817 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.1 -21.05 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.872 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -119.19 38.87 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.909 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.89 66.85 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.985 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.83 -17.63 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.694 -0.765 . . . . 62.24 112.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 119.341 -0.361 . . . . 75.11 110.836 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.394 -0.282 . . . . 65.34 112.394 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -75.77 -45.09 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 73.42 110.847 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 52.23 63.59 2.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.941 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -99.62 25.28 7.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.892 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t 64.93 150.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 71.44 111.122 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.94 142.79 36.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 63.34 111.116 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.8 m -134.31 -169.85 2.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 72.03 110.835 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -66.48 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.933 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.93 44.92 2.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 45.42 112.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.9 148.8 52.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 65.33 110.949 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -137.64 153.64 74.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.54 110.859 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.89 11.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.697 2.264 . . . . 71.21 112.328 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -105.71 -73.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 70.42 110.864 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.36 -118.51 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.697 -0.764 . . . . 33.45 112.465 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -51.31 -45.03 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 75.33 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mm -72.02 -23.31 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 75.53 111.148 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.91 21.52 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.12 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -66.36 131.29 45.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 73.12 110.89 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.9 m -84.51 130.63 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.22 110.8 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.2 pt -128.56 157.48 74.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 74.41 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.79 138.0 36.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 2.236 . . . . 72.23 112.373 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.67 -25.82 4.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.9 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -28.45 13.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 64.35 110.901 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -106.24 44.2 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.955 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -121.43 134.71 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.4 110.939 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t 56.97 23.74 8.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 65.32 110.874 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -32.53 15.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.88 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.91 43.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.684 -0.769 . . . . 53.42 112.481 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -127.49 143.07 51.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 73.12 110.876 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 32' ' ' ASP . 4.1 t -86.0 13.07 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 64.31 111.153 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 31' ' ' VAL . 35.1 m-20 -37.91 -42.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.51 110.898 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.25 137.22 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.882 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.92 -31.47 40.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 53.04 110.903 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -11.26 15.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.41 110.837 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.74 18.06 67.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 73.24 112.482 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -20.85 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 65.34 110.843 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -63.39 -24.53 67.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 75.53 110.865 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.63 38.53 2.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 62.2 110.893 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -117.94 -15.81 9.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.21 110.908 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.64 5.8 7.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 71.45 112.446 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 119.357 -0.354 . . . . 74.41 110.919 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.456 -0.258 . . . . 71.23 112.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -61.78 144.95 53.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.87 0.367 . . . . 73.41 110.945 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.28 -28.46 8.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.908 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.11 117.82 12.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.847 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -54.47 136.79 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 73.54 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.15 51.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 71.51 111.099 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 m -134.3 -169.87 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.34 110.873 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.33 -164.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 71.23 110.863 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -61.34 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 65.21 110.879 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.69 46.76 3.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 71.55 112.477 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -138.79 158.2 44.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 74.32 110.863 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -146.05 152.76 48.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.609 0.719 . . . . 75.54 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 174.12 9.99 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.665 2.243 . . . . 74.05 112.325 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 m -113.79 -73.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.92 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.7 -116.32 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 70.42 112.444 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -51.37 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.15 110.931 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.26 -21.46 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.13 111.161 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.64 27.03 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.167 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -51.43 114.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 73.23 110.946 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.05 125.05 25.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 75.35 110.876 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 pt -128.92 158.7 71.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 71.14 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 137.17 34.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.33 112.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -49.0 -27.01 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -27.63 12.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.894 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -108.63 52.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.907 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -121.57 129.21 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.1 t 45.83 53.92 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -66.44 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.52 41.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.668 -0.777 . . . . 65.44 112.405 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -126.78 138.05 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.335 . . . . 74.53 110.912 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.53 12.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.125 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -40.02 -39.2 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.3 110.849 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.03 140.49 52.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.846 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -64.48 -32.22 73.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 71.52 110.854 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.03 11.25 22.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 72.04 110.859 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.75 25.56 22.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 72.31 112.41 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.7 t -67.31 -13.27 61.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 61.43 110.952 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -82.54 -19.15 39.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 74.04 110.867 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -120.97 39.18 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -108.41 63.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.94 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.38 -14.71 10.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 65.41 112.444 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 119.296 -0.383 . . . . 75.51 110.934 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.432 -0.267 . . . . 73.25 112.432 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 61.68 84.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 54.53 110.874 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -91.97 -36.17 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.4 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.18 98.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 55.12 110.86 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.35 142.4 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 74.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.68 149.19 40.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.138 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 m -131.47 -169.93 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.33 110.822 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.76 -171.06 1.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 73.13 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.61 -29.97 41.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 75.44 110.944 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.85 28.84 11.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.74 . . . . 63.31 112.496 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -135.81 157.9 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 71.11 110.944 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -146.02 151.5 45.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 73.33 110.964 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.243 . . . . 75.1 112.346 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.6 m -104.66 -74.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 53.24 110.855 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.48 -104.66 0.3 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.72 . . . . 73.03 112.556 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.88 -61.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 71.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.2 -23.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.11 111.125 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.72 23.55 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 75.31 111.171 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -51.93 116.32 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 72.23 110.859 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.25 114.78 15.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 73.12 110.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 pt -117.03 158.4 44.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.709 0.766 . . . . 74.44 111.05 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 136.71 33.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.621 2.214 . . . . 75.53 112.366 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.7 -26.2 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.97 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.01 13.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.916 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -108.38 46.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 72.42 110.88 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -121.26 133.08 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 73.25 110.816 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t 53.35 27.49 6.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.921 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -93.27 -41.68 9.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.824 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.43 41.45 0.8 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 74.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 144.45 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 74.23 110.827 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.05 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 73.15 111.104 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -38.67 -41.62 0.72 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.836 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.76 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.04 110.911 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.76 -27.42 14.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.85 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.13 11.98 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 75.15 110.9 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.34 30.33 58.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 74.41 112.429 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -79.84 -3.9 49.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 64.14 110.88 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -88.7 -23.71 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.812 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.7 39.55 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -116.48 -29.4 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.863 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.47 15.01 9.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.535 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 119.286 -0.388 . . . . 75.13 110.919 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.522 -0.231 . . . . 70.42 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -108.74 82.77 1.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 73.4 110.862 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -27.03 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 61.23 110.939 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.74 154.64 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.84 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.42 136.78 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.23 111.106 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.13 146.71 50.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.15 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.0 m -131.93 -169.67 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 72.21 110.879 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 -164.74 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 74.53 110.871 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.929 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.91 3.43 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.753 -0.737 . . . . 72.1 112.468 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.42 155.15 47.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 73.45 110.901 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.17 153.5 48.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.618 0.723 . . . . 74.33 110.889 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.39 24.57 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.638 2.225 . . . . 73.21 112.349 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.83 -75.2 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.34 110.903 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.34 -127.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 51.05 112.434 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -54.3 -42.36 70.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 75.3 110.845 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.08 -20.13 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.111 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.85 23.79 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 64.45 111.156 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -51.15 111.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.833 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -70.38 122.45 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 73.4 110.927 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.7 pt -129.22 158.56 72.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.635 0.731 . . . . 75.24 111.139 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.81 135.66 30.89 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.718 2.279 . . . . 73.22 112.313 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -48.76 -26.68 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.958 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -28.4 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 72.03 110.838 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -108.59 39.66 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.874 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -109.77 126.41 53.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 71.4 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m 46.72 64.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -125.5 -45.37 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 64.23 110.873 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.81 40.33 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.677 -0.773 . . . . 64.2 112.478 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -135.8 145.9 46.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 74.55 110.854 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.62 13.13 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.157 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -38.7 -39.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.71 171.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 54.51 110.919 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -30.17 22.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 50.15 110.882 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 20.42 10.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 75.14 110.796 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.64 29.55 25.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 73.53 112.437 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.4 t -71.99 -28.44 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 74.22 110.911 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -62.91 -22.13 66.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.54 110.876 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.87 38.28 2.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.823 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -113.32 68.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.14 110.959 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.96 -21.68 8.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 71.31 112.511 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 17.5 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 119.295 -0.383 . . . . 73.43 110.827 -179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.531 -0.228 . . . . 75.44 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -102.39 35.79 2.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 75.43 110.889 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.79 -31.22 5.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 62.22 110.993 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.84 177.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 74.33 110.81 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 m -59.18 125.35 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 74.51 111.164 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 152.68 37.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.42 111.117 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m -131.77 -170.53 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 64.43 110.834 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.49 -169.27 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 75.32 110.843 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.78 -67.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.33 110.904 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.71 45.42 3.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 61.34 112.517 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -139.5 147.86 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 73.14 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -135.68 153.1 77.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 70.13 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 173.5 10.84 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.724 2.283 . . . . 65.04 112.378 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.7 m -107.93 -72.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 73.43 110.889 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.83 -122.85 0.89 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 63.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -56.12 -43.6 78.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 71.53 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -74.36 -19.11 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 71.41 111.146 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.6 24.14 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 72.42 111.126 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 112.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.937 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.9 m -75.65 120.51 21.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 71.01 110.91 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 pt -123.7 158.85 58.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 63.31 111.158 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 137.34 35.14 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 64.1 112.386 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -25.96 3.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -52.52 -26.45 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.21 110.824 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.53 39.82 2.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -108.35 127.83 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 73.35 110.928 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 m 49.28 33.2 4.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.962 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -33.88 15.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.937 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.23 40.93 1.0 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 72.41 112.409 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -132.41 145.03 50.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 74.24 110.897 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.76 13.27 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.42 111.112 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -38.42 -42.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.44 141.13 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.908 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -55.46 -32.18 62.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.25 110.86 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.87 2.7 17.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 73.2 110.916 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.25 32.9 37.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 75.45 112.534 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -70.97 -23.7 62.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 74.12 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.3 -28.89 69.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 74.11 110.872 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.79 38.9 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.855 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -120.85 65.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 75.31 110.952 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.83 -11.19 12.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 72.15 112.493 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 119.222 -0.418 . . . . 74.14 110.91 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.437 -0.265 . . . . 63.14 112.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -116.45 81.8 1.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 73.35 110.854 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.61 152.38 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 75.4 110.941 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 55.85 42.64 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.02 110.915 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.97 150.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 74.53 111.102 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.47 163.95 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m -130.31 -169.65 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 74.4 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.92 -171.71 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 74.41 110.909 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mt -63.81 -68.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 62.35 110.954 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.16 46.56 3.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 74.25 112.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.81 141.38 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 73.23 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -130.19 151.22 78.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.705 0.764 . . . . 72.44 110.818 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.59 14.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.267 . . . . 74.1 112.305 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 m -106.26 -74.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.888 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.58 -119.6 0.7 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -52.97 -63.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.784 0.326 . . . . 75.34 110.907 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.31 -22.99 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 70.41 111.152 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 64.45 22.19 12.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.42 111.169 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -52.41 111.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.972 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.3 m -74.99 128.12 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 pt -129.62 158.28 73.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.633 0.73 . . . . 73.21 111.091 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.67 137.25 35.29 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 72.11 112.397 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.67 -25.6 4.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.913 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -26.2 18.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -107.11 39.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.903 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -111.14 134.53 52.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.833 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t 50.94 30.12 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 70.03 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -93.17 -42.7 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.862 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.38 43.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 71.31 112.477 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.92 144.6 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 75.34 110.919 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.11 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 73.24 111.115 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -38.68 -41.54 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 61.51 110.844 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.42 170.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.45 110.825 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.46 -27.82 16.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.905 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.26 0.51 14.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.802 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.77 28.79 72.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.525 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -78.88 -2.66 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 74.13 110.852 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -88.41 -23.6 23.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -120.97 39.41 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.2 110.883 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -116.6 -28.82 6.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.919 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.72 14.3 9.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 61.43 112.523 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 119.367 -0.349 . . . . 62.51 110.876 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.238 . . . . 64.01 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -127.68 115.87 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 54.44 110.869 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.11 92.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 73.44 110.861 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -122.6 104.48 9.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.841 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.33 140.87 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.3 111.13 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.84 147.45 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 71.44 111.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.7 m -133.54 -169.87 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.92 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -171.95 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 63.42 110.85 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.62 -67.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.857 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 46.32 3.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.767 -0.73 . . . . 71.34 112.514 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -144.56 141.16 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 73.32 110.895 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -129.28 150.01 74.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 72.35 110.836 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 179.01 3.99 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.668 2.246 . . . . 72.52 112.364 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.0 m -113.83 -74.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.865 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.76 -113.11 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.752 . . . . 75.51 112.502 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -51.58 -65.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 74.54 110.86 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.4 mt -65.79 -18.78 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.25 111.12 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.11 26.29 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.33 111.138 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -51.49 109.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 75.41 110.842 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.0 m -68.7 123.67 21.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.54 110.874 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 pt -125.42 158.26 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.647 0.737 . . . . 74.12 111.12 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.6 Cg_endo -69.76 138.05 36.91 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 74.42 112.322 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -26.1 4.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.906 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.35 -27.43 15.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.32 110.818 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -109.59 39.91 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.865 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.09 122.66 45.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.877 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 m 49.3 35.88 8.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 54.42 110.868 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.69 -31.81 16.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.84 34.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 71.11 112.479 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.19 143.28 50.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 74.24 110.848 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 32' ' ' ASP . 5.0 t -86.6 13.46 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.181 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 31' ' ' VAL . 28.1 m-20 -38.53 -41.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.15 110.803 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.88 173.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 73.21 110.836 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.63 -24.05 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.57 -7.37 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.862 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 22.82 61.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 74.24 112.446 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -69.25 -13.47 62.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 72.42 110.824 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -80.11 -24.16 40.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 70.15 110.875 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -123.03 39.88 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.977 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -90.39 50.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 75.14 110.879 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.0 -5.93 72.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.515 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 119.288 -0.387 . . . . 60.41 110.892 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.518 -0.233 . . . . 31.12 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m 52.03 31.41 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 73.35 110.909 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.15 -68.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.967 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 106.49 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.27 -0.423 . . . . 75.31 110.836 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.9 t -75.44 135.18 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 75.33 111.147 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.97 170.46 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 71.21 111.162 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.25 -169.87 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.873 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -169.59 1.71 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.792 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -63.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 73.14 110.926 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.78 46.33 3.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 54.15 112.5 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -138.61 158.75 43.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 73.1 110.942 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -143.8 148.18 41.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 74.21 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 163.59 37.67 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.256 . . . . 75.33 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 m -103.75 -65.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.858 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.21 -127.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 61.43 112.462 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -52.23 -52.43 52.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.42 110.875 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.61 -18.13 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.41 111.101 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.43 22.27 9.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.143 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -62.12 113.73 3.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.45 110.941 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.0 m -82.56 130.94 35.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.911 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 pt -131.59 159.39 72.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 71.13 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.79 138.31 37.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 75.42 112.393 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -48.47 -27.6 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.17 -29.21 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.812 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.401 ' N ' ' CD1' ' A' ' 25' ' ' TRP . 4.9 m0 -109.5 52.91 0.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 73.03 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.31 122.78 45.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 75.23 110.897 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.2 m 49.02 32.32 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.0 -31.26 16.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.829 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 34.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.492 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 143.14 47.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 75.54 110.94 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 t -88.73 13.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.181 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.6 -37.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 72.33 110.893 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.1 m -70.91 125.05 25.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 75.54 110.871 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -31.93 63.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.814 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.96 7.15 46.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 75.32 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.82 27.25 19.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.734 . . . . 61.22 112.485 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t -66.57 -18.0 65.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 72.2 110.87 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -80.21 -21.21 43.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.916 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -119.19 39.31 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -112.44 69.25 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 73.33 110.923 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.88 -21.35 10.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 73.32 112.486 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 119.282 -0.389 . . . . 74.23 110.846 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.45 -0.26 . . . . 60.55 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 140.5 29.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 63.42 110.865 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -171.34 132.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 74.13 110.955 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.48 137.11 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 71.4 110.836 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t 62.56 161.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 72.22 111.119 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.36 126.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.141 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.2 m -134.62 -169.25 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 73.43 110.928 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.2 -170.83 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.53 110.876 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -64.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 74.01 110.957 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 46.63 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 53.22 112.458 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -139.77 156.6 46.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.386 . . . . 74.23 110.913 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.56 153.41 65.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.743 . . . . 75.34 110.873 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 165.76 29.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.709 2.273 . . . . 70.22 112.376 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 m -103.98 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 63.25 110.859 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.23 -121.96 0.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.715 -0.755 . . . . 70.14 112.48 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -57.61 -54.19 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 74.44 110.91 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 mp -63.55 -19.29 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 72.14 111.134 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.96 23.79 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.35 111.111 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.3 116.35 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 75.2 110.924 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.9 m -83.31 124.03 30.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 65.52 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -127.29 157.64 71.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.653 0.74 . . . . 71.41 111.054 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.4 Cg_endo -69.81 137.97 36.57 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.711 2.274 . . . . 72.41 112.29 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -49.28 -26.1 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.909 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -28.51 24.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 70.34 110.933 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -108.47 42.52 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 73.23 110.919 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -107.63 131.16 54.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.851 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 m 51.21 37.77 19.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 55.53 110.853 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -101.25 11.67 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 75.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.62 29.31 74.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 73.31 112.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -110.92 138.69 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 75.31 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -85.07 12.11 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 71.24 111.166 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -38.36 -42.03 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 74.32 110.848 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.28 136.14 57.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 73.53 110.852 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -55.04 -26.38 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -10.57 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 51.1 110.911 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.26 16.12 70.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.692 -0.766 . . . . 64.33 112.483 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -18.65 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 72.32 110.79 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.26 -22.75 65.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.868 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -115.69 39.82 2.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 63.25 110.901 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -120.3 66.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.928 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.0 -13.54 9.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.716 -0.754 . . . . 30.44 112.454 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 119.345 -0.36 . . . . 73.21 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.461 -0.256 . . . . 74.41 112.461 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -61.66 124.1 19.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.805 0.336 . . . . 72.33 110.906 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.35 -73.81 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.892 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.91 -58.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 75.35 110.845 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.15 135.43 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 75.32 111.161 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.74 169.87 17.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 75.45 111.106 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.2 m -125.7 -169.78 2.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.892 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.0 -174.23 2.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 63.33 110.886 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -54.82 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.32 110.945 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.91 38.58 3.17 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.697 -0.763 . . . . 62.53 112.472 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -141.53 158.36 43.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 74.5 110.926 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -142.76 152.22 58.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.628 0.727 . . . . 73.24 110.842 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 164.15 35.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.277 . . . . 74.31 112.347 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.1 m -104.17 -69.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.877 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.46 -120.52 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 64.43 112.478 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -59.23 -53.18 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 75.33 110.798 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.9 mm -61.17 -17.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 73.51 111.154 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.04 22.17 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.97 121.78 12.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.874 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.6 m -90.06 123.99 34.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.915 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -124.31 157.59 64.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.45 111.192 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.9 Cg_endo -69.85 138.37 37.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 74.33 112.347 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -48.4 -27.08 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.54 110.904 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -29.73 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.969 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 3.6 m0 -110.41 58.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 73.21 110.904 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -125.58 126.53 44.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 74.54 110.883 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t 48.25 47.47 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 75.4 110.859 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -116.93 -25.15 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 75.23 110.823 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.87 42.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 73.22 112.498 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -125.93 134.9 51.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.863 0.363 . . . . 71.53 110.922 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.17 11.82 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 75.41 111.191 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.97 -38.77 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.815 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.1 131.68 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.417 . . . . 74.35 110.816 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.4 -35.99 68.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.43 110.852 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.33 2.52 39.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 74.44 110.913 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 50.89 33.72 28.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 70.1 112.469 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -77.12 -3.25 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.895 0.378 . . . . 72.45 110.858 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.14 -20.56 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.31 110.846 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -120.5 38.49 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.11 110.946 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -114.55 64.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 75.15 110.936 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.45 -16.85 7.03 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 44.55 112.47 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 119.353 -0.356 . . . . 61.02 110.903 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.447 -0.261 . . . . 63.42 112.447 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.3 m -153.37 34.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.372 . . . . 64.5 110.887 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.98 159.39 29.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 74.22 110.962 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.46 125.02 45.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.878 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 t -96.85 126.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.14 111.072 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 176.01 8.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 64.42 111.094 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.3 m -126.62 -171.95 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.872 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.08 -169.59 2.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.855 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.42 -67.68 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 74.12 110.917 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.01 47.51 3.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.773 -0.727 . . . . 74.52 112.555 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -143.99 155.1 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 63.2 110.903 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.16 153.39 69.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 74.1 110.91 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 165.34 31.28 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.723 2.282 . . . . 71.53 112.321 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -107.52 -71.25 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 71.44 110.864 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.22 -128.58 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 54.23 112.507 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.31 -48.34 68.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.744 0.307 . . . . 73.1 110.895 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 mm -66.24 -14.97 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 54.23 111.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.99 24.59 7.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.164 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -60.86 120.01 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.903 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.4 m -86.63 124.42 32.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.309 -0.405 . . . . 74.32 110.908 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 12.4 pt -125.34 157.45 67.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 75.31 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.0 Cg_endo -69.84 138.43 37.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 72.23 112.327 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -48.74 -27.03 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.84 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.9 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -109.78 57.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.53 110.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -126.14 127.74 46.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.54 110.882 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t 51.84 29.76 6.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.15 110.895 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.71 -34.71 11.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.779 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.99 44.92 0.52 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 75.31 112.422 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -128.12 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 74.01 110.962 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.26 12.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.18 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.6 -39.14 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.875 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.11 123.96 19.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 72.43 110.883 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.49 -26.74 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.848 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -14.46 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.875 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.22 26.57 72.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 44.23 112.492 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 t -74.0 -7.13 51.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 74.15 110.887 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.89 -20.13 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.888 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -122.44 38.98 4.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 54.13 110.888 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -119.54 -30.9 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 72.42 110.878 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.09 15.46 8.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.783 -0.723 . . . . 75.43 112.513 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 119.371 -0.347 . . . . 64.11 110.886 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.504 -0.238 . . . . 55.1 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -130.7 142.81 50.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.781 0.324 . . . . 70.2 110.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -160.43 160.06 31.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.873 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.5 138.0 44.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 75.55 110.89 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 175.26 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.54 111.17 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 141.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.33 111.079 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 m -129.49 -169.68 2.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.888 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -169.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.822 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.52 -67.51 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 74.41 110.96 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.53 46.02 3.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 62.54 112.439 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -140.19 150.33 44.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 70.45 110.921 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -140.8 152.78 66.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.718 0.771 . . . . 74.45 110.82 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 164.48 34.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 74.42 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -98.69 -75.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.853 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.21 -132.52 2.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 73.43 112.475 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -52.35 -49.69 63.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 71.02 110.874 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.8 mt -58.99 -21.69 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.25 111.154 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.59 21.09 11.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 74.33 111.127 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 117.07 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 63.54 110.888 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.9 m -81.96 138.79 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.853 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 1.8 pt -140.16 159.52 63.7 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.606 0.717 . . . . 75.04 111.118 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.74 136.17 32.38 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.752 2.302 . . . . 73.31 112.334 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -26.15 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.9 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.99 -26.96 11.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.904 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -110.15 40.21 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -109.24 131.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 74.14 110.823 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.0 m 48.8 32.99 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.845 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -92.66 -27.4 17.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 75.04 110.909 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.79 31.53 5.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 52.51 112.445 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -118.24 142.08 47.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 73.43 110.96 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.66 12.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 75.13 111.151 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -38.46 -42.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.915 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.98 173.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.916 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -106.4 -11.97 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.868 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -121.09 9.15 10.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.868 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.29 37.46 38.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.747 . . . . 74.01 112.487 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -94.96 -6.79 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 74.3 110.842 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -83.24 -22.96 32.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 62.52 110.893 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.06 39.95 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.15 110.89 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -104.08 65.84 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.32 110.874 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.55 -15.75 10.58 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.735 -0.745 . . . . 75.45 112.461 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 119.369 -0.348 . . . . 72.33 110.918 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.432 -0.267 . . . . 74.5 112.432 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -54.76 -60.61 3.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.32 110.843 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -66.54 154.77 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.951 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -158.72 29.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.45 110.822 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.33 168.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.124 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.46 13.36 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 72.25 111.189 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 m -64.5 -175.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 73.52 110.895 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 -164.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.871 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -62.94 1.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 74.44 110.909 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.58 46.13 3.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 64.54 112.51 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.5 151.21 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 72.54 110.913 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -139.8 152.96 69.4 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.642 0.734 . . . . 75.24 110.9 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 175.11 8.53 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.695 2.264 . . . . 74.43 112.392 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 m -108.03 -75.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.909 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.86 -105.73 0.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.508 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' ND2' HD21 ' A' ' 35' ' ' ASN . 6.8 p30 -74.25 -46.45 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.324 . . . . 75.12 110.861 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -70.81 -12.0 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.097 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 55.84 26.16 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.12 111.159 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.12 116.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.41 110.916 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.0 m -80.53 120.68 24.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.53 110.918 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 10.7 pt -126.9 157.71 70.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 75.0 111.162 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.81 136.85 33.88 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.728 2.286 . . . . 63.31 112.29 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -26.36 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.24 110.943 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.53 -27.7 17.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.846 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -108.88 42.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.92 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -108.29 128.17 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 74.23 110.851 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m 54.08 37.07 26.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.45 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.79 14.3 32.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 65.22 112.474 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -108.12 137.49 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 75.33 110.887 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.59 11.61 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 74.34 111.17 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -38.9 -41.16 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 73.3 110.811 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.56 141.76 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.894 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -54.57 -35.73 63.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 61.4 110.892 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.442 HD21 ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -111.95 8.45 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.04 110.907 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.2 31.8 27.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.772 . . . . 75.25 112.475 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -71.81 -16.14 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.349 . . . . 74.1 110.875 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.69 -16.2 61.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 72.12 110.849 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.51 38.89 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.32 110.873 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -28.47 7.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.973 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.72 11.76 18.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.775 -0.726 . . . . 70.52 112.541 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 119.281 -0.39 . . . . 70.43 110.892 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.494 -0.242 . . . . 64.2 112.494 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -128.39 63.19 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 74.41 110.86 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.82 26.46 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 63.3 110.921 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -154.47 26.04 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.812 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t 65.31 118.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 74.12 111.16 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.5 131.59 41.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 73.45 111.131 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 m -133.68 -169.5 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -167.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 73.21 110.883 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -11.07 51.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.908 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.98 25.37 6.43 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.498 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.97 162.26 32.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.01 110.886 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.52 152.98 46.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.643 0.735 . . . . 75.2 110.843 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 162.45 42.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 74.23 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -102.48 -75.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 72.2 110.922 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.76 -115.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.765 -0.731 . . . . 64.23 112.466 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -52.6 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 74.25 110.915 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.33 -21.96 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 75.24 111.139 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m 59.42 22.18 10.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 64.32 111.194 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -54.09 121.36 7.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.929 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 m -75.47 116.51 16.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 73.02 110.914 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 pt -114.51 158.06 41.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 75.32 111.134 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.1 Cg_endo -69.73 136.67 33.67 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.71 2.273 . . . . 74.41 112.339 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.3 -26.62 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.934 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.52 -27.7 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -106.31 44.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.903 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -116.28 128.49 55.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.04 110.878 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t 50.02 31.68 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 75.52 110.795 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -33.2 14.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.462 . . . . 72.42 110.914 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.69 47.44 0.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.742 . . . . 71.25 112.502 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -138.03 146.24 42.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.31 110.905 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASP . 5.1 t -89.2 13.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.123 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' VAL . 13.9 m-20 -36.98 -44.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 72.1 110.874 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.42 135.28 33.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 64.24 110.925 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.43 -30.19 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 13.4 20.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.87 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.66 30.51 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 52.24 112.459 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 m -72.4 -31.06 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 74.22 110.809 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.95 -28.47 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 75.04 110.892 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -107.82 38.66 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.821 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.36 57.95 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 75.44 110.934 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.71 9.23 21.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 34.23 112.487 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.3 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 119.311 -0.376 . . . . 70.33 110.907 -179.903 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.336 . . . . 71.140000000000001 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -169.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 72.109999999999999 110.855 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -68.88 -63.86 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 72.329999999999998 110.92 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.54 47.07 3.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 61.439999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -138.49 154.23 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 51.530000000000001 110.914 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -144.18 153.14 56.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 72.319999999999993 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.81 172.59 12.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 62.219999999999999 112.327 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 m -109.83 -74.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 61.329999999999998 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.92 -119.25 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 75.329999999999998 112.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -51.82 -64.08 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 73.549999999999997 110.87 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.4 mp -58.66 -21.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 111.169 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 61.13 21.7 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 64.349999999999994 111.117 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -52.61 121.05 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 65.109999999999999 110.901 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.4 m -77.59 130.8 37.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 53.030000000000001 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.2 pt -132.92 158.09 76.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.625 0.726 . . . . 64.25 111.096 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.73 137.35 35.35 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 53.149999999999999 112.343 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.81 -26.39 3.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 63.140000000000001 110.93 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -27.03 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 54.020000000000003 110.856 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.47 39.45 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -112.71 131.17 55.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.439999999999998 110.87 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.1 t 49.37 51.23 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 74.549999999999997 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.45 -53.48 2.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.209999999999994 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.76 41.78 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 55.340000000000003 112.487 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -133.21 147.39 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 71.230000000000004 110.941 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.2 t -86.48 12.71 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.349999999999994 111.097 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -38.58 -40.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.885 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 170.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 71.120000000000005 110.871 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 17' ' ' ILE . 7.9 t0 -86.7 -29.23 22.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.83 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.83 19.15 11.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.349999999999994 110.891 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.91 28.81 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 61.109999999999999 112.443 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -70.95 -26.57 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.372 . . . . 73.109999999999999 110.85 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -65.64 -21.39 66.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 51.340000000000003 110.856 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -114.21 38.81 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 44.340000000000003 110.878 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 72.319999999999993 110.937 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.893 0.378 . . . . 60.140000000000001 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -169.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 65.450000000000003 110.831 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -70.42 -62.66 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.881 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.68 46.65 3.34 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.727 . . . . 70.519999999999996 112.511 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.36 153.9 48.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 73.239999999999995 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -142.51 152.78 61.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.603 0.716 . . . . 65.120000000000005 110.916 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.615 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.86 176.85 6.29 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.58 2.187 . . . . 71.329999999999998 112.383 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.97 -75.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 41.25 110.82 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.2 -114.9 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.793 -0.717 . . . . 52.140000000000001 112.531 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -51.91 -66.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 72.530000000000001 110.851 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.655 HD12 ' HB3' ' A' ' 34' ' ' ASP . 33.2 mt -62.39 -21.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 53.130000000000003 111.141 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.83 25.65 15.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 62.219999999999999 111.142 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -51.63 120.05 4.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.873 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.7 m -75.69 126.42 30.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.892 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 pt -129.57 157.94 74.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.631 0.729 . . . . 75.140000000000001 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 138.08 36.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.711 2.274 . . . . 62.109999999999999 112.322 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.93 -26.31 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 110.869 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.73 -27.17 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 52.310000000000002 110.831 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -108.74 39.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 75.120000000000005 110.954 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.77 120.91 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.865 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.9 m 48.24 37.14 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.510000000000005 110.912 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -34.56 15.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 62.240000000000002 110.871 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.19 41.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 71.310000000000002 112.492 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -135.8 146.54 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 71.019999999999996 110.93 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.2 t -87.57 13.44 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 64.129999999999995 111.193 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -38.21 -41.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 54.119999999999997 110.842 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.8 169.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.913 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' ILE . 18.7 m-20 -88.71 -25.93 22.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.030000000000001 110.851 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -9.27 12.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 42.119999999999997 110.901 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.0 20.7 62.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 65.319999999999993 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -64.9 -28.54 69.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 64.549999999999997 110.833 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -61.89 -19.87 63.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 72.209999999999994 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -122.33 39.36 3.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.903 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.899 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.863 0.363 . . . . 71.430000000000007 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -169.8 1.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.020000000000003 110.809 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.85 -66.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 51.100000000000001 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.87 3.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 73.349999999999994 112.52 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -134.89 149.76 50.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.388 . . . . 65.140000000000001 110.922 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -137.52 153.25 74.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 73.400000000000006 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.73 177.62 5.38 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.636 2.224 . . . . 54.229999999999997 112.316 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 m -111.53 -73.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.349999999999994 110.811 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.26 -120.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 75.129999999999995 112.483 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -60.86 -42.13 97.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 64.340000000000003 110.937 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' CB ' ' A' ' 34' ' ' ASP . 60.6 mt -72.79 -22.32 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 60.130000000000003 111.15 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.68 21.93 13.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 73.5 111.172 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -51.57 111.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 72.030000000000001 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 m -73.78 125.01 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 110.904 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.2 pt -127.94 157.74 72.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.658 0.742 . . . . 71.349999999999994 111.089 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.66 137.59 36.11 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.702 2.268 . . . . 62.340000000000003 112.352 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.17 -26.0 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -26.64 15.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.847 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -108.53 39.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 73.310000000000002 110.906 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -110.77 131.16 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 110.884 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.4 m 48.88 32.83 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.030000000000001 110.843 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.2 -33.51 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 51.310000000000002 110.812 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 46.79 0.83 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 13.23 112.498 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -137.2 144.59 42.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.349999999999994 110.931 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.4 t -87.19 13.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.112 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' VAL . 30.3 m-20 -38.1 -42.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.210000000000001 110.845 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.68 141.18 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 110.859 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.713 ' CB ' HD12 ' A' ' 17' ' ' ILE . 38.3 m-20 -56.02 -33.83 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 72.439999999999998 110.859 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.45 6.97 20.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.209999999999994 110.885 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.61 30.99 28.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.219999999999999 112.476 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.3 t -70.64 -23.9 62.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 72.120000000000005 110.845 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -62.03 -25.92 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -108.33 38.59 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 71.540000000000006 110.856 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.931 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.879 0.371 . . . . 63.409999999999997 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -168.47 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.886 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.1 mt -67.32 -68.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.894 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.28 45.52 3.15 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.772 -0.728 . . . . 74.540000000000006 112.5 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -139.35 153.76 47.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 110.858 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.69 153.09 67.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.743 . . . . 60.5 110.942 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.79 13.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 65.340000000000003 112.37 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -110.89 -75.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 52.049999999999997 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.97 -118.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.737 . . . . 62.509999999999998 112.505 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.8 m-80 -61.48 -58.56 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 72.049999999999997 110.91 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.773 HD13 ' HB3' ' A' ' 34' ' ' ASP . 2.7 mp -56.53 -22.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 111.203 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.49 21.0 12.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 65.019999999999996 111.119 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 21' ' ' ILE . 5.1 tttp -51.69 115.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.56 122.76 27.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 64.209999999999994 110.876 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 pt -123.59 158.14 60.11 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.634 0.731 . . . . 71.310000000000002 111.111 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.73 137.25 35.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.286 . . . . 70.310000000000002 112.316 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.0 -26.74 2.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.22 -0.446 . . . . 72.030000000000001 110.939 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -28.96 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 65.420000000000002 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 4.7 m0 -109.91 55.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 70.450000000000003 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -122.44 129.02 51.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 72.049999999999997 110.826 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.7 t 45.85 36.36 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 71.409999999999997 110.836 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -101.54 -35.29 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.881 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.38 45.54 0.39 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 74.219999999999999 112.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -132.12 144.51 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 52.340000000000003 110.954 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 31' ' ' VAL . 3.9 t -93.48 10.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.230000000000004 111.093 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.42 -37.63 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.530000000000001 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.29 133.42 55.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 61.340000000000003 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 17' ' ' ILE . 37.1 m-20 -57.69 -30.79 65.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.450000000000003 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.622 ' OD1' HD12 ' A' ' 17' ' ' ILE . 15.5 m-80 -109.51 5.35 23.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 70.450000000000003 110.873 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.76 29.14 25.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 53.229999999999997 112.498 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -24.19 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 73.430000000000007 110.889 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -71.13 -21.02 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 71.329999999999998 110.909 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -113.17 38.03 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 110.918 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 74.239999999999995 110.945 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 72.439999999999998 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.04 -175.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 70.150000000000006 110.843 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 -53.97 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.926 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.05 35.47 4.08 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.676 -0.773 . . . . 72.310000000000002 112.442 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -137.88 158.01 45.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.89 0.376 . . . . 73.319999999999993 110.941 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -143.76 153.03 57.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.717 0.77 . . . . 73.209999999999994 110.828 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 173.56 10.78 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 54.409999999999997 112.33 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.95 -74.46 0.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.914 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.16 -120.01 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 70.120000000000005 112.481 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.83 -56.12 15.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 71.219999999999999 110.892 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.558 HG21 ' OD2' ' A' ' 34' ' ' ASP . 16.5 mm -65.8 -20.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 111.158 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.0 22.28 8.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -55.42 121.39 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.946 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 m -80.69 120.82 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.87 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.4 pt -121.52 158.72 53.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 62.399999999999999 111.097 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.8 Cg_endo -69.83 137.52 35.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.264 . . . . 75.030000000000001 112.294 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -49.47 -26.7 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 70.299999999999997 110.946 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.77 -26.87 10.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 72.530000000000001 110.904 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -108.87 52.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 75.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -123.83 132.15 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 70.099999999999994 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.5 m 48.18 48.41 18.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 110.857 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -59.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.868 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.14 42.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 72.109999999999999 112.509 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -125.34 140.06 53.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 52.109999999999999 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.3 t -88.55 11.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 64.209999999999994 111.131 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -39.98 -38.21 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.030000000000001 110.848 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.79 134.84 57.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 110.888 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD2' HG21 ' A' ' 17' ' ' ILE . 5.0 m-20 -53.07 -42.02 65.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.868 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.03 12.83 31.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 72.209999999999994 110.909 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.67 27.74 20.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 64.340000000000003 112.509 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -63.03 -22.0 66.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 74.239999999999995 110.859 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -72.5 -20.44 61.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 61.210000000000001 110.868 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -113.4 37.77 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.946 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.83 0.348 . . . . 75.400000000000006 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.25 -175.32 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 70.239999999999995 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -54.12 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 53.420000000000002 110.952 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.79 35.54 4.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.25 112.461 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -141.1 151.49 44.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 61.030000000000001 110.941 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.8 149.06 63.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.612 0.72 . . . . 73.209999999999994 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 171.23 14.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 65.049999999999997 112.375 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.4 m -106.66 -76.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 61.409999999999997 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.8 -115.58 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 63.409999999999997 112.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -53.89 -58.29 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 70.540000000000006 110.939 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.6 mm -61.78 -19.5 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 75.420000000000002 111.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.73 21.68 9.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 70.150000000000006 111.195 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.04 122.41 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 110.9 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.41 126.72 34.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.898 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.9 pt -125.38 157.91 66.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 64.120000000000005 111.172 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.6 Cg_endo -69.7 138.46 38.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 73.510000000000005 112.358 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.11 -26.18 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 63.509999999999998 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.67 -27.62 18.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.82 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -109.44 42.23 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.898 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -105.51 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 60.310000000000002 110.902 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t 51.41 43.15 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -106.7 18.09 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.849 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.33 32.33 72.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 54.5 112.402 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -116.34 136.51 52.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 65.230000000000004 110.942 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.8 t -83.7 11.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.049999999999997 111.169 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -38.82 -41.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 62.530000000000001 110.807 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.66 140.78 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.310000000000002 110.894 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.62 -50.77 53.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 110.892 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.53 11.95 38.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 45.119999999999997 110.861 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.43 37.14 39.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.771 -0.728 . . . . 33.219999999999999 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 t -74.74 -7.25 52.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 73.409999999999997 110.817 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.1 -21.05 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 75.340000000000003 110.872 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -119.19 38.87 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 62.409999999999997 110.909 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 53.520000000000003 110.985 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.905 0.384 . . . . 72.030000000000001 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 71.120000000000005 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -66.48 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 110.933 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.93 44.92 2.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 45.420000000000002 112.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.9 148.8 52.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 65.329999999999998 110.949 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -137.64 153.64 74.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 72.340000000000003 110.859 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.89 11.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.697 2.264 . . . . 71.209999999999994 112.328 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -105.71 -73.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 52.229999999999997 110.864 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.36 -118.51 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.697 -0.764 . . . . 31.210000000000001 112.465 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -51.31 -45.03 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 75.329999999999998 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mm -72.02 -23.31 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 111.148 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.91 21.52 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 73.230000000000004 111.12 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -66.36 131.29 45.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 60.030000000000001 110.89 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.9 m -84.51 130.63 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 110.8 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.4 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.2 pt -128.56 157.48 74.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 62.420000000000002 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.79 138.0 36.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 2.236 . . . . 65.120000000000005 112.373 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.67 -25.82 4.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.9 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -28.45 13.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 63.539999999999999 110.901 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -106.24 44.2 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.955 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -121.43 134.71 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.939 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t 56.97 23.74 8.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 65.319999999999993 110.874 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -32.53 15.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 62.350000000000001 110.88 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.91 43.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.684 -0.769 . . . . 31.23 112.481 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -127.49 143.07 51.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 72.409999999999997 110.876 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.1 t -86.0 13.07 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 51.329999999999998 111.153 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 31' ' ' VAL . 35.1 m-20 -37.91 -42.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.509999999999998 110.898 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.25 137.22 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 61.530000000000001 110.882 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.92 -31.47 40.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 53.009999999999998 110.903 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -11.26 15.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 51.100000000000001 110.837 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.74 18.06 67.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 73.239999999999995 112.482 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -20.85 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 62.439999999999998 110.843 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -63.39 -24.53 67.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 51.219999999999999 110.865 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.63 38.53 2.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 110.893 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.209999999999994 110.908 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.836 0.351 . . . . 71.209999999999994 110.873 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.33 -164.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.409999999999997 110.863 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -61.34 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 52.240000000000002 110.879 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.69 46.76 3.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 55.030000000000001 112.477 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -138.79 158.2 44.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 74.319999999999993 110.863 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -146.05 152.76 48.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.609 0.719 . . . . 73.510000000000005 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.1 Cg_endo -69.78 174.12 9.99 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.665 2.243 . . . . 61.020000000000003 112.325 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 m -113.79 -73.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.92 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.7 -116.32 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 70.420000000000002 112.444 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -51.37 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.150000000000006 110.931 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 34' ' ' ASP . 27.8 mt -62.26 -21.46 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 64.540000000000006 111.161 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.64 27.03 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.450000000000003 111.167 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -51.43 114.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 71.329999999999998 110.946 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.05 125.05 25.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.876 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 pt -128.92 158.7 71.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 70.329999999999998 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 137.17 34.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.0 112.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -49.0 -27.01 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -27.63 12.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.510000000000005 110.894 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -108.63 52.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.907 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -121.57 129.21 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 52.140000000000001 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.1 t 45.83 53.92 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 54.130000000000003 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -66.44 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.52 41.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.668 -0.777 . . . . 63.539999999999999 112.405 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -126.78 138.05 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.335 . . . . 71.319999999999993 110.912 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.0 t -87.53 12.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.125 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -40.02 -39.2 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 62.399999999999999 110.849 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.03 140.49 52.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.846 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.661 ' CB ' HD12 ' A' ' 17' ' ' ILE . 53.0 m-20 -64.48 -32.22 73.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 71.519999999999996 110.854 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.03 11.25 22.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 72.040000000000006 110.859 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.75 25.56 22.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 52.329999999999998 112.41 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.7 t -67.31 -13.27 61.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 61.43 110.952 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -82.54 -19.15 39.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 74.040000000000006 110.867 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -120.97 39.18 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.340000000000003 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 110.94 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.839 0.352 . . . . 61.329999999999998 110.822 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.76 -171.06 1.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 73.129999999999995 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 10' ' ' GLY . 4.1 pp -79.61 -29.97 41.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 75.439999999999998 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -107.85 28.84 11.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.74 . . . . 63.310000000000002 112.496 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -135.81 157.9 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 71.109999999999999 110.944 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -146.02 151.5 45.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 65.239999999999995 110.964 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.9 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.243 . . . . 75.099999999999994 112.346 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.6 m -104.66 -74.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 52.340000000000003 110.855 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.48 -104.66 0.3 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.72 . . . . 73.030000000000001 112.556 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.88 -61.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 71.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.735 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.5 mp -57.2 -23.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.030000000000001 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.72 23.55 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 75.310000000000002 111.171 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -51.93 116.32 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 110.859 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.25 114.78 15.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 53.210000000000001 110.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -117.03 158.4 44.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.709 0.766 . . . . 74.439999999999998 111.05 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 136.71 33.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.621 2.214 . . . . 75.519999999999996 112.366 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.7 -26.2 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.509999999999998 110.97 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.01 13.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 70.530000000000001 110.916 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -108.38 46.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 72.420000000000002 110.88 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -121.26 133.08 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 73.25 110.816 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t 53.35 27.49 6.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 74.510000000000005 110.921 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -93.27 -41.68 9.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 110.824 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.43 41.45 0.8 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 74.340000000000003 112.512 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 144.45 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 62.43 110.827 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.7 t -86.05 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 73.150000000000006 111.104 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -38.67 -41.62 0.72 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.836 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.76 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.039999999999999 110.911 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 17' ' ' ILE . 3.7 t0 -97.76 -27.42 14.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.85 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.13 11.98 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 75.150000000000006 110.9 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.34 30.33 58.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 74.409999999999997 112.429 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -79.84 -3.9 49.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 62.219999999999999 110.88 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -88.7 -23.71 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 72.340000000000003 110.812 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.7 39.55 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.239999999999995 110.863 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.0 m . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.806 0.336 . . . . 72.209999999999994 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 -164.74 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 72.420000000000002 110.871 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 60.450000000000003 110.929 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.91 3.43 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.753 -0.737 . . . . 71.019999999999996 112.468 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.42 155.15 47.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 72.230000000000004 110.901 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.17 153.5 48.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.618 0.723 . . . . 74.230000000000004 110.889 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.76 167.39 24.57 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.638 2.225 . . . . 64.140000000000001 112.349 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.83 -75.2 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.340000000000003 110.903 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.34 -127.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 51.049999999999997 112.434 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' ND2' HG13 ' A' ' 17' ' ' ILE . 5.7 p-10 -54.3 -42.36 70.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 75.299999999999997 110.845 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 34' ' ' ASP . 72.1 mt -73.08 -20.13 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 42.219999999999999 111.111 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.789 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 58.85 23.79 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 52.409999999999997 111.156 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -51.15 111.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.040000000000006 110.833 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -70.38 122.45 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 73.400000000000006 110.927 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.7 pt -129.22 158.56 72.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.635 0.731 . . . . 75.239999999999995 111.139 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.81 135.66 30.89 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.718 2.279 . . . . 63.229999999999997 112.313 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -48.76 -26.68 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.958 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -28.4 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 72.030000000000001 110.838 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 m0 -108.59 39.66 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.16 -0.473 . . . . 71.239999999999995 110.874 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -109.77 126.41 53.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m 46.72 64.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.540000000000006 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -125.5 -45.37 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 64.230000000000004 110.873 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.81 40.33 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.677 -0.773 . . . . 64.200000000000003 112.478 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -135.8 145.9 46.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 61.329999999999998 110.854 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.7 t -86.62 13.13 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 111.157 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -38.7 -39.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.239999999999995 110.877 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.71 171.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 54.100000000000001 110.919 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.791 ' HB3' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -86.31 -30.17 22.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 44.119999999999997 110.882 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 20.42 10.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 75.140000000000001 110.796 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.64 29.55 25.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 73.530000000000001 112.437 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.4 t -71.99 -28.44 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 74.219999999999999 110.911 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -62.91 -22.13 66.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.540000000000006 110.876 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.87 38.28 2.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 53.149999999999999 110.823 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.140000000000001 110.959 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.835 0.35 . . . . 64.430000000000007 110.834 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.49 -169.27 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 110.843 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 9' ' ' LEU . 4.3 mt -67.78 -67.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 35.039999999999999 110.904 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.71 45.42 3.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 42.310000000000002 112.517 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -139.5 147.86 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 73.140000000000001 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -135.68 153.1 77.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 62.399999999999999 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.666 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.4 Cg_endo -69.72 173.5 10.84 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.724 2.283 . . . . 52.409999999999997 112.378 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.7 m -107.93 -72.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 55.420000000000002 110.889 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.83 -122.85 0.89 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 63.009999999999998 112.502 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -56.12 -43.6 78.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 71.530000000000001 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' CB ' ' A' ' 34' ' ' ASP . 20.8 mt -74.36 -19.11 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 51.509999999999998 111.146 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 59.6 24.14 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.126 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 112.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.937 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.9 m -75.65 120.51 21.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 63.32 110.91 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 pt -123.7 158.85 58.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 63.310000000000002 111.158 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 137.34 35.14 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 64.099999999999994 112.386 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -25.96 3.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -52.52 -26.45 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.824 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.53 39.82 2.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 75.150000000000006 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -108.35 127.83 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 73.349999999999994 110.928 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 m 49.28 33.2 4.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.962 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -33.88 15.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 61.229999999999997 110.937 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.23 40.93 1.0 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 22.140000000000001 112.409 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -132.41 145.03 50.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 55.409999999999997 110.897 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 31' ' ' VAL . 3.5 t -87.76 13.27 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.420000000000002 111.112 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -38.42 -42.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.109999999999999 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.44 141.13 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 71.219999999999999 110.908 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.733 ' CB ' HD12 ' A' ' 17' ' ' ILE . 72.0 m-20 -55.46 -32.18 62.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.86 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.87 2.7 17.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 110.916 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.25 32.9 37.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 75.450000000000003 112.534 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -70.97 -23.7 62.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 71.299999999999997 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.3 -28.89 69.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 74.109999999999999 110.872 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.79 38.9 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 110.855 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 75.310000000000002 110.952 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.857 0.36 . . . . 65.239999999999995 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.92 -171.71 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 73.019999999999996 110.909 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 5.2 mt -63.81 -68.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 61.340000000000003 110.954 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.16 46.56 3.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 74.25 112.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.81 141.38 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 72.299999999999997 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -130.19 151.22 78.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.705 0.764 . . . . 72.120000000000005 110.818 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.59 14.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.267 . . . . 74.099999999999994 112.305 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 m -106.26 -74.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.340000000000003 110.888 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.58 -119.6 0.7 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 71.439999999999998 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.97 -63.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.784 0.326 . . . . 75.340000000000003 110.907 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.77 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.6 mp -57.31 -22.99 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 111.152 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 64.45 22.19 12.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.169 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -52.41 111.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 110.972 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.3 m -74.99 128.12 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 53.399999999999999 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -129.62 158.28 73.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.633 0.73 . . . . 60.130000000000003 111.091 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 137.25 35.29 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 41.039999999999999 112.397 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.67 -25.6 4.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.913 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -26.2 18.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -107.11 39.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.903 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -111.14 134.53 52.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 110.833 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t 50.94 30.12 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 65.209999999999994 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -93.17 -42.7 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 64.400000000000006 110.862 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.38 43.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 71.310000000000002 112.477 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.92 144.6 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 110.919 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.8 t -86.11 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 54.310000000000002 111.115 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -38.68 -41.54 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 53.25 110.844 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.42 170.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.825 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.77 ' HB3' HD13 ' A' ' 17' ' ' ILE . 5.7 t0 -93.46 -27.82 16.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.140000000000001 110.905 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.26 0.51 14.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.109999999999999 110.802 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.77 28.79 72.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 52.140000000000001 112.525 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -78.88 -2.66 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 74.129999999999995 110.852 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -88.41 -23.6 23.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 63.140000000000001 110.877 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -120.97 39.41 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.200000000000003 110.883 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 110.919 -179.927 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.883 0.373 . . . . 45.049999999999997 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -171.95 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 44.32 110.85 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.8 mt -65.62 -67.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.857 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 46.32 3.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.767 -0.73 . . . . 71.340000000000003 112.514 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -144.56 141.16 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 73.319999999999993 110.895 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -129.28 150.01 74.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 55.049999999999997 110.836 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.603 ' CB ' HG22 ' A' ' 18' ' ' THR . 54.1 Cg_endo -69.75 179.01 3.99 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.668 2.246 . . . . 72.519999999999996 112.364 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.0 m -113.83 -74.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 110.865 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.76 -113.11 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.752 . . . . 75.510000000000005 112.502 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -51.58 -65.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 73.530000000000001 110.86 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.71 HD12 ' CG ' ' A' ' 34' ' ' ASP . 26.4 mt -65.79 -18.78 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.25 111.12 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 57.11 26.29 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.329999999999998 111.138 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -51.49 109.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 75.409999999999997 110.842 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.0 m -68.7 123.67 21.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.874 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 pt -125.42 158.26 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.647 0.737 . . . . 63.140000000000001 111.12 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.6 Cg_endo -69.76 138.05 36.91 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 74.420000000000002 112.322 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -26.1 4.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.906 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.35 -27.43 15.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 72.030000000000001 110.818 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -109.59 39.91 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.865 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.09 122.66 45.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.877 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 m 49.3 35.88 8.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 54.420000000000002 110.868 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.69 -31.81 16.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 75.450000000000003 110.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.84 34.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 71.109999999999999 112.479 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.19 143.28 50.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 74.239999999999995 110.848 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.0 t -86.6 13.46 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 111.181 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 31' ' ' VAL . 28.1 m-20 -38.53 -41.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 64.200000000000003 110.803 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.88 173.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 73.209999999999994 110.836 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.71 ' CG ' HD12 ' A' ' 17' ' ' ILE . 9.4 m-20 -97.63 -24.05 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.919 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.57 -7.37 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.862 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 22.82 61.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 60.25 112.446 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -69.25 -13.47 62.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 65.430000000000007 110.824 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -80.11 -24.16 40.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.240000000000002 110.875 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -123.03 39.88 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.977 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 73.439999999999998 110.879 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.859 0.361 . . . . 75.319999999999993 110.873 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -169.59 1.71 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.519999999999996 110.792 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.5 -63.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 73.140000000000001 110.926 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.78 46.33 3.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 54.149999999999999 112.5 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -138.61 158.75 43.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.329999999999998 110.942 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -143.8 148.18 41.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 71.129999999999995 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 163.59 37.67 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.256 . . . . 74.019999999999996 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 m -103.75 -65.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 52.409999999999997 110.858 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.21 -127.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 53.5 112.462 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -52.23 -52.43 52.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.420000000000002 110.875 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.61 -18.13 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 111.101 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.43 22.27 9.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 61.140000000000001 111.143 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -62.12 113.73 3.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.941 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.0 m -82.56 130.94 35.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 64.109999999999999 110.911 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' OD1' ' A' ' 32' ' ' ASP . 7.1 pt -131.59 159.39 72.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 71.129999999999995 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.79 138.31 37.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 61.5 112.393 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -48.47 -27.6 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.17 -29.21 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.812 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.401 ' N ' ' CD1' ' A' ' 25' ' ' TRP . 4.9 m0 -109.5 52.91 0.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 70.450000000000003 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.31 122.78 45.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 75.230000000000004 110.897 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.2 m 49.02 32.32 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.0 -31.26 16.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 63.219999999999999 110.829 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 34.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 73.109999999999999 112.492 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -119.78 143.14 47.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 75.540000000000006 110.94 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.4 t -88.73 13.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 72.319999999999993 111.181 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.741 ' OD1' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -39.6 -37.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 72.329999999999998 110.893 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.1 m -70.91 125.05 25.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 75.519999999999996 110.871 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -31.93 63.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.814 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.96 7.15 46.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.82 27.25 19.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.734 . . . . 43.210000000000001 112.485 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t -66.57 -18.0 65.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 51.130000000000003 110.87 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -80.21 -21.21 43.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 70.319999999999993 110.916 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -119.19 39.31 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 73.329999999999998 110.923 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.832 0.349 . . . . 73.430000000000007 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.2 -170.83 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 52.530000000000001 110.876 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.95 -64.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 71.329999999999998 110.957 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 46.63 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 53.219999999999999 112.458 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -139.77 156.6 46.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.386 . . . . 74.230000000000004 110.913 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.56 153.41 65.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.743 . . . . 74.319999999999993 110.873 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 165.76 29.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.709 2.273 . . . . 64.150000000000006 112.376 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 m -103.98 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 63.25 110.859 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.23 -121.96 0.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.715 -0.755 . . . . 70.140000000000001 112.48 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 2.0 p30 -57.61 -54.19 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 74.439999999999998 110.91 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.59 HD13 ' CB ' ' A' ' 34' ' ' ASP . 2.8 mp -63.55 -19.29 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 64.150000000000006 111.134 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.96 23.79 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 111.111 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.3 116.35 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 72.230000000000004 110.924 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.9 m -83.31 124.03 30.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 65.519999999999996 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -127.29 157.64 71.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.653 0.74 . . . . 71.409999999999997 111.054 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.4 Cg_endo -69.81 137.97 36.57 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.711 2.274 . . . . 55.340000000000003 112.29 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -49.28 -26.1 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 110.909 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -28.51 24.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 70.340000000000003 110.933 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -108.47 42.52 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 73.230000000000004 110.919 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -107.63 131.16 54.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.851 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 m 51.21 37.77 19.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 54.450000000000003 110.853 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -101.25 11.67 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 75.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.62 29.31 74.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 73.310000000000002 112.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -110.92 138.69 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 65.439999999999998 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.1 t -85.07 12.11 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 51.539999999999999 111.166 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -38.36 -42.03 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 74.319999999999993 110.848 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.28 136.14 57.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 110.852 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.59 ' CB ' HD13 ' A' ' 17' ' ' ILE . 32.9 m-20 -55.04 -26.38 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -10.57 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 40.219999999999999 110.911 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.26 16.12 70.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.692 -0.766 . . . . 64.329999999999998 112.483 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -18.65 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 72.319999999999993 110.79 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.26 -22.75 65.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.868 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -115.69 39.82 2.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 51.439999999999998 110.901 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.510000000000005 110.928 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.873 0.368 . . . . 71.109999999999999 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.0 -174.23 2.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 63.329999999999998 110.886 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -54.82 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 43.229999999999997 110.945 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.91 38.58 3.17 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.697 -0.763 . . . . 22.25 112.472 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -141.53 158.36 43.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 71.450000000000003 110.926 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -142.76 152.22 58.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.628 0.727 . . . . 73.239999999999995 110.842 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 164.15 35.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.277 . . . . 74.310000000000002 112.347 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.1 m -104.17 -69.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 65.219999999999999 110.877 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.46 -120.52 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 64.430000000000007 112.478 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -59.23 -53.18 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 75.329999999999998 110.798 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.9 mm -61.17 -17.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 73.510000000000005 111.154 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.04 22.17 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.439999999999998 111.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.97 121.78 12.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 71.519999999999996 110.874 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.6 m -90.06 123.99 34.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.340000000000003 110.915 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -124.31 157.59 64.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 72.430000000000007 111.192 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.9 Cg_endo -69.85 138.37 37.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.040000000000006 112.347 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -48.4 -27.08 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 110.904 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -29.73 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 110.969 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 3.6 m0 -110.41 58.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 63.140000000000001 110.904 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -125.58 126.53 44.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 110.883 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t 48.25 47.47 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 75.400000000000006 110.859 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -116.93 -25.15 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 75.230000000000004 110.823 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.87 42.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 54.240000000000002 112.498 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -125.93 134.9 51.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.863 0.363 . . . . 71.530000000000001 110.922 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.5 t -87.17 11.82 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 70.299999999999997 111.191 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.97 -38.77 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.815 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.1 131.68 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.417 . . . . 63.329999999999998 110.816 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.4 -35.99 68.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.230000000000004 110.852 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.33 2.52 39.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 72.319999999999993 110.913 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 50.89 33.72 28.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 62.030000000000001 112.469 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -77.12 -3.25 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.895 0.378 . . . . 62.329999999999998 110.858 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.14 -20.56 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.310000000000002 110.846 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -120.5 38.49 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.099999999999994 110.946 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 73.299999999999997 110.936 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.856 0.36 . . . . 64.439999999999998 110.872 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.08 -169.59 2.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.049999999999997 110.855 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.7 mt -65.42 -67.68 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 110.917 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.01 47.51 3.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.773 -0.727 . . . . 64.219999999999999 112.555 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -143.99 155.1 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 53.409999999999997 110.903 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.16 153.39 69.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 74.099999999999994 110.91 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 165.34 31.28 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.723 2.282 . . . . 71.530000000000001 112.321 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -107.52 -71.25 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 52.009999999999998 110.864 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.22 -128.58 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 54.229999999999997 112.507 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.31 -48.34 68.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.744 0.307 . . . . 73.099999999999994 110.895 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 mm -66.24 -14.97 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 53.020000000000003 111.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.99 24.59 7.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 111.164 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -60.86 120.01 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.903 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.4 m -86.63 124.42 32.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.309 -0.405 . . . . 62.299999999999997 110.908 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 12.4 pt -125.34 157.45 67.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 75.310000000000002 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.0 Cg_endo -69.84 138.43 37.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 61.32 112.327 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -48.74 -27.03 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.84 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.140000000000001 110.9 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -109.78 57.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -126.14 127.74 46.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.882 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t 51.84 29.76 6.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.150000000000006 110.895 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.71 -34.71 11.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 110.779 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.99 44.92 0.52 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 75.310000000000002 112.422 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -128.12 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 72.420000000000002 110.962 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.6 t -87.26 12.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 111.18 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.6 -39.14 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.875 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.11 123.96 19.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 72.430000000000007 110.883 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.49 -26.74 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 110.848 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -14.46 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 62.219999999999999 110.875 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.22 26.57 72.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 44.229999999999997 112.492 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 t -74.0 -7.13 51.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 74.150000000000006 110.887 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.89 -20.13 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.888 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -122.44 38.98 4.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 52.219999999999999 110.888 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 70.340000000000003 110.878 -179.919 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 110.888 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -169.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 63.450000000000003 110.822 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.52 -67.51 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 62.299999999999997 110.96 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.53 46.02 3.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 62.539999999999999 112.439 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -140.19 150.33 44.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 63.020000000000003 110.921 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -140.8 152.78 66.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.718 0.771 . . . . 73.329999999999998 110.82 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 164.48 34.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 33.310000000000002 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -98.69 -75.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.230000000000004 110.853 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.21 -132.52 2.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 73.430000000000007 112.475 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.1 p30 -52.35 -49.69 63.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 71.019999999999996 110.874 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.547 HD12 ' OD1' ' A' ' 35' ' ' ASN . 11.8 mt -58.99 -21.69 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.25 111.154 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.59 21.09 11.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 71.340000000000003 111.127 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -58.8 117.07 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 63.329999999999998 110.888 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.9 m -81.96 138.79 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.853 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.455 HG23 ' HD3' ' A' ' 19' ' ' LYS . 1.8 pt -140.16 159.52 63.7 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 111.118 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.74 136.17 32.38 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.752 2.302 . . . . 73.310000000000002 112.334 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -26.15 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.9 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.99 -26.96 11.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 71.150000000000006 110.904 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -110.15 40.21 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 75.129999999999995 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -109.24 131.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 74.140000000000001 110.823 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.0 m 48.8 32.99 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.310000000000002 110.845 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -92.66 -27.4 17.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 75.040000000000006 110.909 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.79 31.53 5.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 52.509999999999998 112.445 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -118.24 142.08 47.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 73.430000000000007 110.96 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.9 t -85.66 12.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 62.210000000000001 111.151 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -38.46 -42.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.915 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.98 173.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 53.030000000000001 110.916 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -106.4 -11.97 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 71.109999999999999 110.868 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.547 ' OD1' HD12 ' A' ' 17' ' ' ILE . 4.7 m-80 -121.09 9.15 10.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 73.140000000000001 110.868 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.29 37.46 38.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.747 . . . . 62.240000000000002 112.487 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -94.96 -6.79 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 74.109999999999999 110.842 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -83.24 -22.96 32.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 62.520000000000003 110.893 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.06 39.95 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.89 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.319999999999993 110.874 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.873 0.368 . . . . 51.229999999999997 110.895 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 -164.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.209999999999994 110.871 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -62.94 1.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 74.439999999999998 110.909 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.58 46.13 3.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 12.539999999999999 112.51 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.5 151.21 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 72.530000000000001 110.913 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -139.8 152.96 69.4 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.642 0.734 . . . . 71.329999999999998 110.9 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.74 175.11 8.53 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.695 2.264 . . . . 55.219999999999999 112.392 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 m -108.03 -75.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 71.430000000000007 110.909 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.86 -105.73 0.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.724 -0.75 . . . . 75.120000000000005 112.508 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' ND2' HG13 ' A' ' 17' ' ' ILE . 5.2 p-10 -74.25 -46.45 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.324 . . . . 74.319999999999993 110.861 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 34' ' ' ASP . 19.9 mt -70.81 -12.0 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.456 . . . . 74.230000000000004 111.097 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 55.84 26.16 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.120000000000005 111.159 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.12 116.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.019999999999996 110.916 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.0 m -80.53 120.68 24.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.439999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 10.7 pt -126.9 157.71 70.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 75.0 111.162 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.81 136.85 33.88 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.728 2.286 . . . . 63.310000000000002 112.29 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -26.36 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.239999999999995 110.943 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.53 -27.7 17.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 63.420000000000002 110.846 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -108.88 42.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 74.099999999999994 110.92 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -108.29 128.17 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 72.209999999999994 110.851 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m 54.08 37.07 26.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.450000000000003 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.79 14.3 32.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.430000000000007 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 65.219999999999999 112.474 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -108.12 137.49 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 75.329999999999998 110.887 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.1 t -83.59 11.61 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 61.340000000000003 111.17 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -38.9 -41.16 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 71.299999999999997 110.811 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.56 141.76 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 50.43 110.894 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.596 ' CG ' HD12 ' A' ' 17' ' ' ILE . 1.1 p30 -54.57 -35.73 63.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 61.399999999999999 110.892 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.95 8.45 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 61.229999999999997 110.907 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.2 31.8 27.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.772 . . . . 62.340000000000003 112.475 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -71.81 -16.14 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.349 . . . . 74.099999999999994 110.875 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.69 -16.2 61.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 72.120000000000005 110.849 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.51 38.89 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.030000000000001 110.873 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.120000000000005 110.973 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.851 0.358 . . . . 24.34 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -167.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 73.209999999999994 110.883 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -86.84 -11.07 51.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 70.200000000000003 110.908 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -122.98 25.37 6.43 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.721 -0.752 . . . . 73.019999999999996 112.498 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.97 162.26 32.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.010000000000005 110.886 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.52 152.98 46.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.643 0.735 . . . . 75.200000000000003 110.843 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 162.45 42.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 63.009999999999998 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -102.48 -75.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 72.200000000000003 110.922 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.76 -115.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.765 -0.731 . . . . 55.539999999999999 112.466 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -52.6 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 74.25 110.915 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' CB ' ' A' ' 34' ' ' ASP . 46.5 mt -58.33 -21.96 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 111.139 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m 59.42 22.18 10.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 64.319999999999993 111.194 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -54.09 121.36 7.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.019999999999996 110.929 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 m -75.47 116.51 16.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 73.019999999999996 110.914 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 pt -114.51 158.06 41.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 74.430000000000007 111.134 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.1 Cg_endo -69.73 136.67 33.67 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.71 2.273 . . . . 74.409999999999997 112.339 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.3 -26.62 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 110.934 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.52 -27.7 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -106.31 44.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 73.049999999999997 110.903 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -116.28 128.49 55.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.040000000000006 110.878 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t 50.02 31.68 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.795 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -33.2 14.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.462 . . . . 61.450000000000003 110.914 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.69 47.44 0.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.742 . . . . 60.340000000000003 112.502 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -138.03 146.24 42.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.310000000000002 110.905 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.1 t -89.2 13.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 111.123 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' VAL . 13.9 m-20 -36.98 -44.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 71.420000000000002 110.874 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.42 135.28 33.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 64.239999999999995 110.925 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.698 ' CB ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -55.43 -30.19 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.872 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 13.4 20.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 65.230000000000004 110.87 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.66 30.51 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 52.240000000000002 112.459 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 m -72.4 -31.06 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 74.219999999999999 110.809 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.95 -28.47 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 75.040000000000006 110.892 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -107.82 38.66 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 70.420000000000002 110.821 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 75.439999999999998 110.934 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.245 . . . . 45.030000000000001 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.81 91.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 71.340000000000003 110.888 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -161.58 161.57 29.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 53.049999999999997 110.882 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 -60.51 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 110.91 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 m -59.75 141.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 75.329999999999998 111.094 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.16 143.64 23.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 60.329999999999998 111.103 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.2 m -134.2 -169.81 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 71.140000000000001 110.894 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -169.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 72.109999999999999 110.855 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -68.88 -63.86 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 72.329999999999998 110.92 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.54 47.07 3.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 61.439999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -138.49 154.23 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 51.530000000000001 110.914 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -144.18 153.14 56.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 72.319999999999993 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.81 172.59 12.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 62.219999999999999 112.327 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 m -109.83 -74.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 61.329999999999998 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.92 -119.25 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 75.329999999999998 112.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -51.82 -64.08 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 73.549999999999997 110.87 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.4 mp -58.66 -21.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 111.169 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 61.13 21.7 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 64.349999999999994 111.117 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -52.61 121.05 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 65.109999999999999 110.901 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.4 m -77.59 130.8 37.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 53.030000000000001 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.2 pt -132.92 158.09 76.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.625 0.726 . . . . 64.25 111.096 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.73 137.35 35.35 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 53.149999999999999 112.343 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.81 -26.39 3.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 63.140000000000001 110.93 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -27.03 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 54.020000000000003 110.856 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.47 39.45 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -112.71 131.17 55.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.439999999999998 110.87 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.1 t 49.37 51.23 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 74.549999999999997 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.45 -53.48 2.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.209999999999994 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.76 41.78 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 55.340000000000003 112.487 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -133.21 147.39 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 71.230000000000004 110.941 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.2 t -86.48 12.71 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.349999999999994 111.097 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -38.58 -40.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.885 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 170.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 71.120000000000005 110.871 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 17' ' ' ILE . 7.9 t0 -86.7 -29.23 22.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.83 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.83 19.15 11.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.349999999999994 110.891 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.91 28.81 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 61.109999999999999 112.443 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -70.95 -26.57 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.372 . . . . 73.109999999999999 110.85 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -65.64 -21.39 66.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 51.340000000000003 110.856 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -114.21 38.81 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 44.340000000000003 110.878 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -118.5 64.58 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 72.319999999999993 110.937 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.41 -13.07 6.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 41.149999999999999 112.501 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 119.281 -0.39 . . . . 64.140000000000001 110.881 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.464 -0.254 . . . . 34.310000000000002 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -79.24 -68.15 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 71.150000000000006 110.868 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 54.46 53.17 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 71.040000000000006 110.9 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 52.18 68.12 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 43.200000000000003 110.886 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.445 HG21 HG21 ' A' ' 18' ' ' THR . 7.8 m -59.31 137.27 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 62.240000000000002 111.156 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.36 144.69 51.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 63.350000000000001 111.116 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -134.59 -169.85 2.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 60.140000000000001 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -169.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 65.450000000000003 110.831 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -70.42 -62.66 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.881 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.68 46.65 3.34 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.727 . . . . 70.519999999999996 112.511 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.36 153.9 48.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 73.239999999999995 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -142.51 152.78 61.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.603 0.716 . . . . 65.120000000000005 110.916 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.615 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.86 176.85 6.29 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.58 2.187 . . . . 71.329999999999998 112.383 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.97 -75.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 41.25 110.82 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.2 -114.9 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.793 -0.717 . . . . 52.140000000000001 112.531 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -51.91 -66.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 72.530000000000001 110.851 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.655 HD12 ' HB3' ' A' ' 34' ' ' ASP . 33.2 mt -62.39 -21.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 53.130000000000003 111.141 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.83 25.65 15.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 62.219999999999999 111.142 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -51.63 120.05 4.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.873 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.7 m -75.69 126.42 30.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.892 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 pt -129.57 157.94 74.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.631 0.729 . . . . 75.140000000000001 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 138.08 36.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.711 2.274 . . . . 62.109999999999999 112.322 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.93 -26.31 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 110.869 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.73 -27.17 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 52.310000000000002 110.831 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -108.74 39.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 75.120000000000005 110.954 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.77 120.91 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.865 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.9 m 48.24 37.14 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.510000000000005 110.912 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -34.56 15.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 62.240000000000002 110.871 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.19 41.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 71.310000000000002 112.492 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -135.8 146.54 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 71.019999999999996 110.93 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.2 t -87.57 13.44 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 64.129999999999995 111.193 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -38.21 -41.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 54.119999999999997 110.842 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.8 169.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.913 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' ILE . 18.7 m-20 -88.71 -25.93 22.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.030000000000001 110.851 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -9.27 12.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 42.119999999999997 110.901 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.0 20.7 62.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 65.319999999999993 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -64.9 -28.54 69.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 64.549999999999997 110.833 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -61.89 -19.87 63.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 72.209999999999994 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -122.33 39.36 3.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.903 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -100.26 70.41 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.899 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.22 -21.73 23.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 72.420000000000002 112.483 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 119.291 -0.385 . . . . 44.350000000000001 110.877 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.517 -0.233 . . . . 72.109999999999999 112.517 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -42.93 91.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 74.439999999999998 110.907 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.98 176.49 5.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.883 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -151.95 84.61 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 64.140000000000001 110.86 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG21 HG21 ' A' ' 18' ' ' THR . 6.8 m -58.52 139.75 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 111.137 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.62 52.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.230000000000004 111.161 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.8 m -131.66 -169.99 2.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.43 . . . . 71.430000000000007 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -169.8 1.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.020000000000003 110.809 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.85 -66.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 51.100000000000001 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.87 3.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 73.349999999999994 112.52 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -134.89 149.76 50.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.388 . . . . 65.140000000000001 110.922 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -137.52 153.25 74.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 73.400000000000006 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.73 177.62 5.38 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.636 2.224 . . . . 54.229999999999997 112.316 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 m -111.53 -73.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.349999999999994 110.811 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.26 -120.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 75.129999999999995 112.483 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -60.86 -42.13 97.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 64.340000000000003 110.937 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' CB ' ' A' ' 34' ' ' ASP . 60.6 mt -72.79 -22.32 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 60.130000000000003 111.15 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.591 HG21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 62.68 21.93 13.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 73.5 111.172 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -51.57 111.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 72.030000000000001 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 m -73.78 125.01 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 110.904 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.2 pt -127.94 157.74 72.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.658 0.742 . . . . 71.349999999999994 111.089 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.66 137.59 36.11 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.702 2.268 . . . . 62.340000000000003 112.352 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.17 -26.0 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -26.64 15.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.847 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -108.53 39.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 73.310000000000002 110.906 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -110.77 131.16 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 110.884 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.4 m 48.88 32.83 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.030000000000001 110.843 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.2 -33.51 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 51.310000000000002 110.812 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 46.79 0.83 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 13.23 112.498 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -137.2 144.59 42.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.349999999999994 110.931 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.4 t -87.19 13.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.112 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' VAL . 30.3 m-20 -38.1 -42.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.210000000000001 110.845 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.68 141.18 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 110.859 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.713 ' CB ' HD12 ' A' ' 17' ' ' ILE . 38.3 m-20 -56.02 -33.83 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 72.439999999999998 110.859 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.45 6.97 20.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.209999999999994 110.885 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.61 30.99 28.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.219999999999999 112.476 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.3 t -70.64 -23.9 62.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 72.120000000000005 110.845 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -62.03 -25.92 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -108.33 38.59 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 71.540000000000006 110.856 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -121.57 63.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.931 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.29 -11.84 6.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 60.409999999999997 112.505 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 119.31 -0.376 . . . . 72.239999999999995 110.9 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.473 -0.251 . . . . 72.329999999999998 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.65 26.6 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.973 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.51 -172.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 63.119999999999997 110.937 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -174.4 36.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.479 . . . . 75.409999999999997 110.83 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 m -58.64 133.12 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 111.124 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.28 167.17 23.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.310000000000002 111.113 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -130.81 -172.21 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.906 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -168.47 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.886 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.1 mt -67.32 -68.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.894 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.28 45.52 3.15 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.772 -0.728 . . . . 74.540000000000006 112.5 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -139.35 153.76 47.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 110.858 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.69 153.09 67.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.743 . . . . 60.5 110.942 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.79 13.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 65.340000000000003 112.37 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -110.89 -75.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 52.049999999999997 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.97 -118.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.737 . . . . 62.509999999999998 112.505 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.8 m-80 -61.48 -58.56 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 72.049999999999997 110.91 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.773 HD13 ' HB3' ' A' ' 34' ' ' ASP . 2.7 mp -56.53 -22.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 111.203 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.49 21.0 12.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 65.019999999999996 111.119 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 21' ' ' ILE . 5.1 tttp -51.69 115.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.56 122.76 27.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 64.209999999999994 110.876 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 pt -123.59 158.14 60.11 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.634 0.731 . . . . 71.310000000000002 111.111 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.73 137.25 35.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.286 . . . . 70.310000000000002 112.316 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.0 -26.74 2.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.22 -0.446 . . . . 72.030000000000001 110.939 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -28.96 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 65.420000000000002 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 4.7 m0 -109.91 55.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 70.450000000000003 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -122.44 129.02 51.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 72.049999999999997 110.826 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.7 t 45.85 36.36 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 71.409999999999997 110.836 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -101.54 -35.29 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.881 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.38 45.54 0.39 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 74.219999999999999 112.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -132.12 144.51 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 52.340000000000003 110.954 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 31' ' ' VAL . 3.9 t -93.48 10.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.230000000000004 111.093 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.42 -37.63 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.530000000000001 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.29 133.42 55.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 61.340000000000003 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 17' ' ' ILE . 37.1 m-20 -57.69 -30.79 65.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.450000000000003 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.622 ' OD1' HD12 ' A' ' 17' ' ' ILE . 15.5 m-80 -109.51 5.35 23.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 70.450000000000003 110.873 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.76 29.14 25.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 53.229999999999997 112.498 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -24.19 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 73.430000000000007 110.889 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -71.13 -21.02 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 71.329999999999998 110.909 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -113.17 38.03 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 110.918 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -125.11 63.23 1.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 74.239999999999995 110.945 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.49 -11.54 6.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 74.129999999999995 112.43 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 119.333 -0.365 . . . . 61.530000000000001 110.831 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.489 -0.244 . . . . 60.130000000000003 112.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m -109.05 -171.17 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 74.209999999999994 110.86 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -49.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 110.889 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.9 68.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 64.530000000000001 110.889 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.86 134.38 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 55.109999999999999 111.132 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 154.36 41.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 64.109999999999999 111.14 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m -131.12 -170.29 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.84 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.04 -175.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 70.150000000000006 110.843 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 -53.97 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.926 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.05 35.47 4.08 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.676 -0.773 . . . . 72.310000000000002 112.442 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -137.88 158.01 45.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.89 0.376 . . . . 73.319999999999993 110.941 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -143.76 153.03 57.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.717 0.77 . . . . 73.209999999999994 110.828 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 173.56 10.78 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 54.409999999999997 112.33 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.95 -74.46 0.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.914 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.16 -120.01 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 70.120000000000005 112.481 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.83 -56.12 15.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 71.219999999999999 110.892 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.558 HG21 ' OD2' ' A' ' 34' ' ' ASP . 16.5 mm -65.8 -20.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 111.158 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.0 22.28 8.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -55.42 121.39 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.946 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 m -80.69 120.82 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.87 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.4 pt -121.52 158.72 53.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 62.399999999999999 111.097 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.8 Cg_endo -69.83 137.52 35.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.264 . . . . 75.030000000000001 112.294 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -49.47 -26.7 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 70.299999999999997 110.946 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.77 -26.87 10.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 72.530000000000001 110.904 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -108.87 52.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 75.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -123.83 132.15 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 70.099999999999994 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.5 m 48.18 48.41 18.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 110.857 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -59.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.868 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.14 42.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 72.109999999999999 112.509 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -125.34 140.06 53.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 52.109999999999999 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.3 t -88.55 11.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 64.209999999999994 111.131 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -39.98 -38.21 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.030000000000001 110.848 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.79 134.84 57.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 110.888 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD2' HG21 ' A' ' 17' ' ' ILE . 5.0 m-20 -53.07 -42.02 65.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.868 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.03 12.83 31.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 72.209999999999994 110.909 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.67 27.74 20.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 64.340000000000003 112.509 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -63.03 -22.0 66.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 74.239999999999995 110.859 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -72.5 -20.44 61.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 61.210000000000001 110.868 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -113.4 37.77 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -119.47 -16.07 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.946 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.14 10.78 5.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.774 . . . . 61.219999999999999 112.476 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 119.313 -0.375 . . . . 75.239999999999995 110.905 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.461 -0.256 . . . . 74.120000000000005 112.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.48 -51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 61.140000000000001 110.867 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -126.12 99.43 5.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 110.951 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.48 144.19 44.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.230000000000004 110.918 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 18' ' ' THR . 45.4 t -88.15 135.44 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 64.540000000000006 111.157 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.61 168.44 27.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 111.174 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -127.99 -169.62 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 75.400000000000006 110.898 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.25 -175.32 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 70.239999999999995 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -54.12 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 53.420000000000002 110.952 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.79 35.54 4.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.25 112.461 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -141.1 151.49 44.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 61.030000000000001 110.941 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.8 149.06 63.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.612 0.72 . . . . 73.209999999999994 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 171.23 14.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 65.049999999999997 112.375 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.4 m -106.66 -76.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 61.409999999999997 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.8 -115.58 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 63.409999999999997 112.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -53.89 -58.29 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 70.540000000000006 110.939 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.6 mm -61.78 -19.5 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 75.420000000000002 111.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.53 ' CG2' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 58.73 21.68 9.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 70.150000000000006 111.195 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.04 122.41 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 110.9 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.41 126.72 34.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.898 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.9 pt -125.38 157.91 66.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 64.120000000000005 111.172 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.6 Cg_endo -69.7 138.46 38.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 73.510000000000005 112.358 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.11 -26.18 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 63.509999999999998 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.67 -27.62 18.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.82 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -109.44 42.23 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.898 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -105.51 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 60.310000000000002 110.902 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t 51.41 43.15 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -106.7 18.09 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.849 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.33 32.33 72.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 54.5 112.402 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -116.34 136.51 52.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 65.230000000000004 110.942 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.8 t -83.7 11.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.049999999999997 111.169 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -38.82 -41.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 62.530000000000001 110.807 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.66 140.78 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.310000000000002 110.894 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.62 -50.77 53.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 110.892 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.53 11.95 38.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 45.119999999999997 110.861 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.43 37.14 39.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.771 -0.728 . . . . 33.219999999999999 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 t -74.74 -7.25 52.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 73.409999999999997 110.817 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.1 -21.05 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 75.340000000000003 110.872 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -119.19 38.87 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 62.409999999999997 110.909 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.89 66.85 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 53.520000000000003 110.985 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.83 -17.63 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.694 -0.765 . . . . 62.240000000000002 112.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 119.341 -0.361 . . . . 75.109999999999999 110.836 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.394 -0.282 . . . . 44.219999999999999 112.394 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -75.77 -45.09 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 54.119999999999997 110.847 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 52.23 63.59 2.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 110.941 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -99.62 25.28 7.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 71.430000000000007 110.892 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.753 HG21 HG21 ' A' ' 18' ' ' THR . 23.3 t 64.93 150.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 71.439999999999998 111.122 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.94 142.79 36.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 111.116 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.8 m -134.31 -169.85 2.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 72.030000000000001 110.835 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 71.120000000000005 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -66.48 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 110.933 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.93 44.92 2.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 45.420000000000002 112.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.9 148.8 52.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 65.329999999999998 110.949 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -137.64 153.64 74.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 72.340000000000003 110.859 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.89 11.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.697 2.264 . . . . 71.209999999999994 112.328 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -105.71 -73.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 52.229999999999997 110.864 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.36 -118.51 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.697 -0.764 . . . . 31.210000000000001 112.465 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -51.31 -45.03 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 75.329999999999998 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mm -72.02 -23.31 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 111.148 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.753 HG21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 58.91 21.52 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 73.230000000000004 111.12 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -66.36 131.29 45.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 60.030000000000001 110.89 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.9 m -84.51 130.63 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 110.8 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.4 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.2 pt -128.56 157.48 74.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 62.420000000000002 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.79 138.0 36.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 2.236 . . . . 65.120000000000005 112.373 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.67 -25.82 4.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.9 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -28.45 13.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 63.539999999999999 110.901 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -106.24 44.2 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.955 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -121.43 134.71 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.939 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t 56.97 23.74 8.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 65.319999999999993 110.874 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -32.53 15.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 62.350000000000001 110.88 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.91 43.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.684 -0.769 . . . . 31.23 112.481 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -127.49 143.07 51.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 72.409999999999997 110.876 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.1 t -86.0 13.07 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 51.329999999999998 111.153 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 31' ' ' VAL . 35.1 m-20 -37.91 -42.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.509999999999998 110.898 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.25 137.22 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 61.530000000000001 110.882 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.92 -31.47 40.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 53.009999999999998 110.903 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -11.26 15.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 51.100000000000001 110.837 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.74 18.06 67.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 73.239999999999995 112.482 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -20.85 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 62.439999999999998 110.843 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -63.39 -24.53 67.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 51.219999999999999 110.865 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.63 38.53 2.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 110.893 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -117.94 -15.81 9.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.209999999999994 110.908 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.64 5.8 7.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 63.100000000000001 112.446 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 119.357 -0.354 . . . . 61.020000000000003 110.919 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.456 -0.258 . . . . 71.230000000000004 112.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -61.78 144.95 53.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.87 0.367 . . . . 73.409999999999997 110.945 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.28 -28.46 8.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 73.200000000000003 110.908 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.11 117.82 12.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.847 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -54.47 136.79 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 73.019999999999996 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.15 51.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 71.409999999999997 111.099 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 m -134.3 -169.87 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.873 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.33 -164.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.409999999999997 110.863 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -61.34 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 52.240000000000002 110.879 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.69 46.76 3.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 55.030000000000001 112.477 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -138.79 158.2 44.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 74.319999999999993 110.863 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -146.05 152.76 48.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.609 0.719 . . . . 73.510000000000005 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.1 Cg_endo -69.78 174.12 9.99 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.665 2.243 . . . . 61.020000000000003 112.325 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 m -113.79 -73.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.92 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.7 -116.32 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 70.420000000000002 112.444 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -51.37 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.150000000000006 110.931 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 34' ' ' ASP . 27.8 mt -62.26 -21.46 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 64.540000000000006 111.161 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.64 27.03 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.450000000000003 111.167 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -51.43 114.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 71.329999999999998 110.946 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.05 125.05 25.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.876 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 pt -128.92 158.7 71.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 70.329999999999998 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 137.17 34.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.0 112.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -49.0 -27.01 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -27.63 12.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.510000000000005 110.894 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -108.63 52.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.907 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -121.57 129.21 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 52.140000000000001 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.1 t 45.83 53.92 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 54.130000000000003 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -66.44 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.52 41.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.668 -0.777 . . . . 63.539999999999999 112.405 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -126.78 138.05 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.335 . . . . 71.319999999999993 110.912 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.0 t -87.53 12.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.125 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -40.02 -39.2 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 62.399999999999999 110.849 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.03 140.49 52.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.846 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.661 ' CB ' HD12 ' A' ' 17' ' ' ILE . 53.0 m-20 -64.48 -32.22 73.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 71.519999999999996 110.854 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.03 11.25 22.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 72.040000000000006 110.859 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.75 25.56 22.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 52.329999999999998 112.41 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.7 t -67.31 -13.27 61.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 61.43 110.952 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -82.54 -19.15 39.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 74.040000000000006 110.867 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -120.97 39.18 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.340000000000003 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -108.41 63.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 110.94 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.38 -14.71 10.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 65.409999999999997 112.444 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 119.296 -0.383 . . . . 75.510000000000005 110.934 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.432 -0.267 . . . . 73.25 112.432 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 61.68 84.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 54.530000000000001 110.874 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.424 ' O ' HG23 ' A' ' 5' ' ' VAL . 20.6 pt20 -91.97 -36.17 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.400000000000006 110.948 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.18 98.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 55.119999999999997 110.86 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 3' ' ' GLN . 61.8 t -113.35 142.4 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 74.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.68 149.19 40.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.138 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 m -131.47 -169.93 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.329999999999998 110.822 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.76 -171.06 1.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 73.129999999999995 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 10' ' ' GLY . 4.1 pp -79.61 -29.97 41.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 75.439999999999998 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -107.85 28.84 11.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.74 . . . . 63.310000000000002 112.496 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -135.81 157.9 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 71.109999999999999 110.944 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -146.02 151.5 45.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 65.239999999999995 110.964 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.9 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.243 . . . . 75.099999999999994 112.346 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.6 m -104.66 -74.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 52.340000000000003 110.855 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.48 -104.66 0.3 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.72 . . . . 73.030000000000001 112.556 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.88 -61.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 71.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.735 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.5 mp -57.2 -23.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.030000000000001 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.72 23.55 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 75.310000000000002 111.171 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -51.93 116.32 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 110.859 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.25 114.78 15.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 53.210000000000001 110.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -117.03 158.4 44.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.709 0.766 . . . . 74.439999999999998 111.05 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 136.71 33.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.621 2.214 . . . . 75.519999999999996 112.366 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.7 -26.2 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.509999999999998 110.97 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.01 13.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 70.530000000000001 110.916 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -108.38 46.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 72.420000000000002 110.88 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -121.26 133.08 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 73.25 110.816 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t 53.35 27.49 6.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 74.510000000000005 110.921 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -93.27 -41.68 9.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 110.824 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.43 41.45 0.8 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 74.340000000000003 112.512 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 144.45 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 62.43 110.827 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.7 t -86.05 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 73.150000000000006 111.104 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -38.67 -41.62 0.72 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.836 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.76 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.039999999999999 110.911 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 17' ' ' ILE . 3.7 t0 -97.76 -27.42 14.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.85 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.13 11.98 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 75.150000000000006 110.9 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.34 30.33 58.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 74.409999999999997 112.429 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -79.84 -3.9 49.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 62.219999999999999 110.88 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -88.7 -23.71 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 72.340000000000003 110.812 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.7 39.55 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -116.48 -29.4 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.239999999999995 110.863 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.47 15.01 9.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 62.32 112.535 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 119.286 -0.388 . . . . 74.209999999999994 110.919 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.522 -0.231 . . . . 54.009999999999998 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -108.74 82.77 1.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 73.400000000000006 110.862 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -27.03 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 44.509999999999998 110.939 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.74 154.64 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.84 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.438 HG11 ' HB ' ' A' ' 18' ' ' THR . 43.1 t -68.42 136.78 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 111.106 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.13 146.71 50.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 75.120000000000005 111.15 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.0 m -131.93 -169.67 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 72.209999999999994 110.879 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 -164.74 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 72.420000000000002 110.871 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 60.450000000000003 110.929 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.91 3.43 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.753 -0.737 . . . . 71.019999999999996 112.468 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.42 155.15 47.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 72.230000000000004 110.901 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.17 153.5 48.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.618 0.723 . . . . 74.230000000000004 110.889 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.76 167.39 24.57 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.638 2.225 . . . . 64.140000000000001 112.349 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.83 -75.2 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.340000000000003 110.903 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.34 -127.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 51.049999999999997 112.434 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' ND2' HG13 ' A' ' 17' ' ' ILE . 5.7 p-10 -54.3 -42.36 70.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 75.299999999999997 110.845 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 34' ' ' ASP . 72.1 mt -73.08 -20.13 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 42.219999999999999 111.111 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.789 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 58.85 23.79 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 52.409999999999997 111.156 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -51.15 111.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.040000000000006 110.833 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -70.38 122.45 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 73.400000000000006 110.927 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.7 pt -129.22 158.56 72.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.635 0.731 . . . . 75.239999999999995 111.139 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.81 135.66 30.89 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.718 2.279 . . . . 63.229999999999997 112.313 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -48.76 -26.68 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.958 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -28.4 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 72.030000000000001 110.838 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 m0 -108.59 39.66 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.16 -0.473 . . . . 71.239999999999995 110.874 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -109.77 126.41 53.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m 46.72 64.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.540000000000006 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -125.5 -45.37 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 64.230000000000004 110.873 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.81 40.33 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.677 -0.773 . . . . 64.200000000000003 112.478 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -135.8 145.9 46.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 61.329999999999998 110.854 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.7 t -86.62 13.13 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 111.157 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -38.7 -39.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.239999999999995 110.877 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.71 171.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 54.100000000000001 110.919 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.791 ' HB3' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -86.31 -30.17 22.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 44.119999999999997 110.882 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 20.42 10.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 75.140000000000001 110.796 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.64 29.55 25.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 73.530000000000001 112.437 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.4 t -71.99 -28.44 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 74.219999999999999 110.911 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -62.91 -22.13 66.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.540000000000006 110.876 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.87 38.28 2.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 53.149999999999999 110.823 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -113.32 68.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.140000000000001 110.959 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.96 -21.68 8.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.511 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 17.5 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 119.295 -0.383 . . . . 44.100000000000001 110.827 -179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.531 -0.228 . . . . 75.439999999999998 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -102.39 35.79 2.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 75.430000000000007 110.889 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.79 -31.22 5.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 62.100000000000001 110.993 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.84 177.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 110.81 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 m -59.18 125.35 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 111.164 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 152.68 37.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.420000000000002 111.117 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m -131.77 -170.53 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 64.430000000000007 110.834 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.49 -169.27 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 110.843 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 9' ' ' LEU . 4.3 mt -67.78 -67.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 35.039999999999999 110.904 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.71 45.42 3.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 42.310000000000002 112.517 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -139.5 147.86 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 73.140000000000001 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -135.68 153.1 77.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 62.399999999999999 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.666 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.4 Cg_endo -69.72 173.5 10.84 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.724 2.283 . . . . 52.409999999999997 112.378 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.7 m -107.93 -72.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 55.420000000000002 110.889 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.83 -122.85 0.89 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 63.009999999999998 112.502 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -56.12 -43.6 78.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 71.530000000000001 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' CB ' ' A' ' 34' ' ' ASP . 20.8 mt -74.36 -19.11 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 51.509999999999998 111.146 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 59.6 24.14 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.126 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 112.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.937 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.9 m -75.65 120.51 21.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 63.32 110.91 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 pt -123.7 158.85 58.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 63.310000000000002 111.158 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 137.34 35.14 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 64.099999999999994 112.386 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -25.96 3.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -52.52 -26.45 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.824 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.53 39.82 2.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 75.150000000000006 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -108.35 127.83 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 73.349999999999994 110.928 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 m 49.28 33.2 4.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.962 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -33.88 15.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 61.229999999999997 110.937 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.23 40.93 1.0 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 22.140000000000001 112.409 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -132.41 145.03 50.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 55.409999999999997 110.897 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 31' ' ' VAL . 3.5 t -87.76 13.27 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.420000000000002 111.112 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -38.42 -42.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.109999999999999 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.44 141.13 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 71.219999999999999 110.908 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.733 ' CB ' HD12 ' A' ' 17' ' ' ILE . 72.0 m-20 -55.46 -32.18 62.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.86 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.87 2.7 17.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 110.916 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.25 32.9 37.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 75.450000000000003 112.534 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -70.97 -23.7 62.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 71.299999999999997 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.3 -28.89 69.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 74.109999999999999 110.872 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.79 38.9 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 110.855 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -120.85 65.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 75.310000000000002 110.952 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.83 -11.19 12.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 72.150000000000006 112.493 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 119.222 -0.418 . . . . 74.140000000000001 110.91 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.437 -0.265 . . . . 63.140000000000001 112.437 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -116.45 81.8 1.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 73.349999999999994 110.854 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.61 152.38 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 62.240000000000002 110.941 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 55.85 42.64 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.019999999999996 110.915 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.97 150.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.102 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.47 163.95 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.120000000000005 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m -130.31 -169.65 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.92 -171.71 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 73.019999999999996 110.909 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 5.2 mt -63.81 -68.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 61.340000000000003 110.954 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.16 46.56 3.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 74.25 112.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.81 141.38 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 72.299999999999997 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -130.19 151.22 78.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.705 0.764 . . . . 72.120000000000005 110.818 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.59 14.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.267 . . . . 74.099999999999994 112.305 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 m -106.26 -74.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.340000000000003 110.888 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.58 -119.6 0.7 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 71.439999999999998 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -52.97 -63.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.784 0.326 . . . . 75.340000000000003 110.907 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.77 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.6 mp -57.31 -22.99 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 111.152 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 64.45 22.19 12.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.169 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -52.41 111.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 110.972 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.3 m -74.99 128.12 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 53.399999999999999 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -129.62 158.28 73.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.633 0.73 . . . . 60.130000000000003 111.091 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 137.25 35.29 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 41.039999999999999 112.397 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.67 -25.6 4.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.913 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -26.2 18.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -107.11 39.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.903 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -111.14 134.53 52.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 110.833 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t 50.94 30.12 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 65.209999999999994 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -93.17 -42.7 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 64.400000000000006 110.862 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.38 43.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 71.310000000000002 112.477 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.92 144.6 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 110.919 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.8 t -86.11 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 54.310000000000002 111.115 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -38.68 -41.54 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 53.25 110.844 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.42 170.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.825 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.77 ' HB3' HD13 ' A' ' 17' ' ' ILE . 5.7 t0 -93.46 -27.82 16.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.140000000000001 110.905 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.26 0.51 14.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.109999999999999 110.802 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.77 28.79 72.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 52.140000000000001 112.525 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -78.88 -2.66 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 74.129999999999995 110.852 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -88.41 -23.6 23.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 63.140000000000001 110.877 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -120.97 39.41 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.200000000000003 110.883 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -116.6 -28.82 6.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 72.140000000000001 110.919 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.72 14.3 9.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 54.32 112.523 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 119.367 -0.349 . . . . 55.049999999999997 110.876 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.238 . . . . 52.130000000000003 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -127.68 115.87 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 54.030000000000001 110.869 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.11 92.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.861 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -122.6 104.48 9.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.841 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.743 HG11 HG21 ' A' ' 18' ' ' THR . 60.1 t -71.33 140.87 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.13 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.84 147.45 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 71.439999999999998 111.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.7 m -133.54 -169.87 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 45.049999999999997 110.92 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -171.95 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 44.32 110.85 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.8 mt -65.62 -67.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.857 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 46.32 3.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.767 -0.73 . . . . 71.340000000000003 112.514 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -144.56 141.16 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 73.319999999999993 110.895 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -129.28 150.01 74.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 55.049999999999997 110.836 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.603 ' CB ' HG22 ' A' ' 18' ' ' THR . 54.1 Cg_endo -69.75 179.01 3.99 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.668 2.246 . . . . 72.519999999999996 112.364 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.0 m -113.83 -74.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 110.865 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.76 -113.11 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.752 . . . . 75.510000000000005 112.502 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -51.58 -65.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 73.530000000000001 110.86 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.71 HD12 ' CG ' ' A' ' 34' ' ' ASP . 26.4 mt -65.79 -18.78 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.25 111.12 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.743 HG21 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 57.11 26.29 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.329999999999998 111.138 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -51.49 109.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 75.409999999999997 110.842 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.0 m -68.7 123.67 21.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.874 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 pt -125.42 158.26 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.647 0.737 . . . . 63.140000000000001 111.12 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.6 Cg_endo -69.76 138.05 36.91 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 74.420000000000002 112.322 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -26.1 4.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.906 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.35 -27.43 15.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 72.030000000000001 110.818 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -109.59 39.91 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.865 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.09 122.66 45.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.877 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 m 49.3 35.88 8.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 54.420000000000002 110.868 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.69 -31.81 16.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 75.450000000000003 110.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.84 34.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 71.109999999999999 112.479 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.19 143.28 50.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 74.239999999999995 110.848 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.0 t -86.6 13.46 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 111.181 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 31' ' ' VAL . 28.1 m-20 -38.53 -41.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 64.200000000000003 110.803 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.88 173.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 73.209999999999994 110.836 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.71 ' CG ' HD12 ' A' ' 17' ' ' ILE . 9.4 m-20 -97.63 -24.05 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.919 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.57 -7.37 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.862 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 22.82 61.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 60.25 112.446 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -69.25 -13.47 62.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 65.430000000000007 110.824 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -80.11 -24.16 40.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.240000000000002 110.875 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -123.03 39.88 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.977 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -90.39 50.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 73.439999999999998 110.879 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.0 -5.93 72.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.731 . . . . 73.299999999999997 112.515 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 119.288 -0.387 . . . . 52.539999999999999 110.892 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.518 -0.233 . . . . 31.120000000000001 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m 52.03 31.41 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 73.349999999999994 110.909 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.15 -68.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 74.430000000000007 110.967 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 106.49 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.27 -0.423 . . . . 75.310000000000002 110.836 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.484 HG11 ' HB ' ' A' ' 18' ' ' THR . 27.9 t -75.44 135.18 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 75.329999999999998 111.147 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.97 170.46 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 71.209999999999994 111.162 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.25 -169.87 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.873 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -169.59 1.71 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.519999999999996 110.792 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.5 -63.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 73.140000000000001 110.926 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.78 46.33 3.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 54.149999999999999 112.5 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -138.61 158.75 43.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.329999999999998 110.942 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -143.8 148.18 41.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 71.129999999999995 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 163.59 37.67 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.256 . . . . 74.019999999999996 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 m -103.75 -65.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 52.409999999999997 110.858 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.21 -127.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 53.5 112.462 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -52.23 -52.43 52.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.420000000000002 110.875 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.61 -18.13 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 111.101 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' HB ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 58.43 22.27 9.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 61.140000000000001 111.143 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -62.12 113.73 3.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.941 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.0 m -82.56 130.94 35.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 64.109999999999999 110.911 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' OD1' ' A' ' 32' ' ' ASP . 7.1 pt -131.59 159.39 72.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 71.129999999999995 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.79 138.31 37.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 61.5 112.393 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -48.47 -27.6 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.17 -29.21 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.812 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.401 ' N ' ' CD1' ' A' ' 25' ' ' TRP . 4.9 m0 -109.5 52.91 0.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 70.450000000000003 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.31 122.78 45.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 75.230000000000004 110.897 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.2 m 49.02 32.32 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.0 -31.26 16.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 63.219999999999999 110.829 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 34.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 73.109999999999999 112.492 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -119.78 143.14 47.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 75.540000000000006 110.94 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.4 t -88.73 13.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 72.319999999999993 111.181 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.741 ' OD1' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -39.6 -37.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 72.329999999999998 110.893 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.1 m -70.91 125.05 25.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 75.519999999999996 110.871 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -31.93 63.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.814 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.96 7.15 46.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.82 27.25 19.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.734 . . . . 43.210000000000001 112.485 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t -66.57 -18.0 65.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 51.130000000000003 110.87 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -80.21 -21.21 43.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 70.319999999999993 110.916 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -119.19 39.31 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -112.44 69.25 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 73.329999999999998 110.923 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.88 -21.35 10.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.209999999999994 112.486 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 119.282 -0.389 . . . . 64.129999999999995 110.846 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.45 -0.26 . . . . 10.01 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 140.5 29.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 63.420000000000002 110.865 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -171.34 132.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.955 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.48 137.11 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 71.400000000000006 110.836 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 6' ' ' THR . 2.9 t 62.56 161.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 62.310000000000002 111.119 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.408 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 66.36 126.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 73.010000000000005 111.141 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.2 m -134.62 -169.25 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 73.430000000000007 110.928 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.2 -170.83 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 52.530000000000001 110.876 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.95 -64.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 71.329999999999998 110.957 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 46.63 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 53.219999999999999 112.458 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -139.77 156.6 46.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.386 . . . . 74.230000000000004 110.913 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.56 153.41 65.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.743 . . . . 74.319999999999993 110.873 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 165.76 29.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.709 2.273 . . . . 64.150000000000006 112.376 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 m -103.98 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 63.25 110.859 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.23 -121.96 0.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.715 -0.755 . . . . 70.140000000000001 112.48 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 2.0 p30 -57.61 -54.19 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 74.439999999999998 110.91 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.59 HD13 ' CB ' ' A' ' 34' ' ' ASP . 2.8 mp -63.55 -19.29 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 64.150000000000006 111.134 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.96 23.79 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 111.111 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.3 116.35 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 72.230000000000004 110.924 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.9 m -83.31 124.03 30.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 65.519999999999996 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -127.29 157.64 71.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.653 0.74 . . . . 71.409999999999997 111.054 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.4 Cg_endo -69.81 137.97 36.57 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.711 2.274 . . . . 55.340000000000003 112.29 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -49.28 -26.1 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 110.909 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -28.51 24.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 70.340000000000003 110.933 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -108.47 42.52 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 73.230000000000004 110.919 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -107.63 131.16 54.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.851 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 m 51.21 37.77 19.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 54.450000000000003 110.853 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -101.25 11.67 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 75.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.62 29.31 74.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 73.310000000000002 112.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -110.92 138.69 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 65.439999999999998 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.1 t -85.07 12.11 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 51.539999999999999 111.166 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -38.36 -42.03 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 74.319999999999993 110.848 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.28 136.14 57.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 110.852 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.59 ' CB ' HD13 ' A' ' 17' ' ' ILE . 32.9 m-20 -55.04 -26.38 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -10.57 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 40.219999999999999 110.911 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.26 16.12 70.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.692 -0.766 . . . . 64.329999999999998 112.483 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -18.65 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 72.319999999999993 110.79 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.26 -22.75 65.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.868 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -115.69 39.82 2.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 51.439999999999998 110.901 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -120.3 66.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.510000000000005 110.928 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.0 -13.54 9.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.716 -0.754 . . . . 30.41 112.454 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 119.345 -0.36 . . . . 63.119999999999997 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.461 -0.256 . . . . 54.409999999999997 112.461 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -61.66 124.1 19.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.805 0.336 . . . . 72.329999999999998 110.906 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.35 -73.81 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 72.409999999999997 110.892 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.91 -58.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 44.450000000000003 110.845 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 18' ' ' THR . 47.8 t -122.15 135.43 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 75.319999999999993 111.161 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.74 169.87 17.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 75.450000000000003 111.106 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.2 m -125.7 -169.78 2.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 71.109999999999999 110.892 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.0 -174.23 2.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 63.329999999999998 110.886 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -54.82 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 43.229999999999997 110.945 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.91 38.58 3.17 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.697 -0.763 . . . . 22.25 112.472 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -141.53 158.36 43.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 71.450000000000003 110.926 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -142.76 152.22 58.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.628 0.727 . . . . 73.239999999999995 110.842 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 164.15 35.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.277 . . . . 74.310000000000002 112.347 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.1 m -104.17 -69.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 65.219999999999999 110.877 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.46 -120.52 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 64.430000000000007 112.478 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -59.23 -53.18 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 75.329999999999998 110.798 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.9 mm -61.17 -17.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 73.510000000000005 111.154 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 61.04 22.17 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.439999999999998 111.147 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.97 121.78 12.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 71.519999999999996 110.874 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.6 m -90.06 123.99 34.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.340000000000003 110.915 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -124.31 157.59 64.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 72.430000000000007 111.192 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.9 Cg_endo -69.85 138.37 37.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.040000000000006 112.347 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -48.4 -27.08 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 110.904 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -29.73 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 110.969 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 3.6 m0 -110.41 58.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 63.140000000000001 110.904 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -125.58 126.53 44.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 110.883 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t 48.25 47.47 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 75.400000000000006 110.859 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -116.93 -25.15 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 75.230000000000004 110.823 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.87 42.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 54.240000000000002 112.498 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -125.93 134.9 51.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.863 0.363 . . . . 71.530000000000001 110.922 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.5 t -87.17 11.82 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 70.299999999999997 111.191 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.97 -38.77 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.815 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.1 131.68 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.417 . . . . 63.329999999999998 110.816 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.4 -35.99 68.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.230000000000004 110.852 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.33 2.52 39.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 72.319999999999993 110.913 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 50.89 33.72 28.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 62.030000000000001 112.469 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -77.12 -3.25 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.895 0.378 . . . . 62.329999999999998 110.858 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.14 -20.56 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.310000000000002 110.846 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -120.5 38.49 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.099999999999994 110.946 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -114.55 64.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 73.299999999999997 110.936 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.45 -16.85 7.03 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 44.549999999999997 112.47 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 119.353 -0.356 . . . . 54.409999999999997 110.903 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.447 -0.261 . . . . 30.5 112.447 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.3 m -153.37 34.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.372 . . . . 44.43 110.887 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.98 159.39 29.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 74.219999999999999 110.962 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.46 125.02 45.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.310000000000002 110.878 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG11 ' HB ' ' A' ' 18' ' ' THR . 35.5 t -96.85 126.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 51.100000000000001 111.072 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 176.01 8.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 61.439999999999998 111.094 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.3 m -126.62 -171.95 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 110.872 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.08 -169.59 2.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.049999999999997 110.855 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.7 mt -65.42 -67.68 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 110.917 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.01 47.51 3.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.773 -0.727 . . . . 64.219999999999999 112.555 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -143.99 155.1 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 53.409999999999997 110.903 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.16 153.39 69.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 74.099999999999994 110.91 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 165.34 31.28 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.723 2.282 . . . . 71.530000000000001 112.321 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -107.52 -71.25 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 52.009999999999998 110.864 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.22 -128.58 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 54.229999999999997 112.507 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.31 -48.34 68.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.744 0.307 . . . . 73.099999999999994 110.895 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 mm -66.24 -14.97 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 53.020000000000003 111.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 ' HB ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 55.99 24.59 7.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 111.164 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -60.86 120.01 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.903 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.4 m -86.63 124.42 32.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.309 -0.405 . . . . 62.299999999999997 110.908 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 12.4 pt -125.34 157.45 67.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 75.310000000000002 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.0 Cg_endo -69.84 138.43 37.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 61.32 112.327 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -48.74 -27.03 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.84 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.140000000000001 110.9 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -109.78 57.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -126.14 127.74 46.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.882 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t 51.84 29.76 6.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.150000000000006 110.895 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.71 -34.71 11.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 110.779 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.99 44.92 0.52 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 75.310000000000002 112.422 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -128.12 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 72.420000000000002 110.962 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.6 t -87.26 12.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 111.18 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.6 -39.14 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.875 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.11 123.96 19.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 72.430000000000007 110.883 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.49 -26.74 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 110.848 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -14.46 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 62.219999999999999 110.875 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.22 26.57 72.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 44.229999999999997 112.492 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 t -74.0 -7.13 51.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 74.150000000000006 110.887 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.89 -20.13 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.888 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -122.44 38.98 4.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 52.219999999999999 110.888 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -119.54 -30.9 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 70.340000000000003 110.878 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.09 15.46 8.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.783 -0.723 . . . . 52.439999999999998 112.513 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 119.371 -0.347 . . . . 64.109999999999999 110.886 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.504 -0.238 . . . . 41.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -130.7 142.81 50.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.781 0.324 . . . . 54.340000000000003 110.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -160.43 160.06 31.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.120000000000005 110.873 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.5 138.0 44.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 75.549999999999997 110.89 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 175.26 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 111.17 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 141.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 111.079 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 m -129.49 -169.68 2.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 110.888 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -169.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 63.450000000000003 110.822 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.52 -67.51 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 62.299999999999997 110.96 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.53 46.02 3.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 62.539999999999999 112.439 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -140.19 150.33 44.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 63.020000000000003 110.921 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -140.8 152.78 66.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.718 0.771 . . . . 73.329999999999998 110.82 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 164.48 34.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 33.310000000000002 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -98.69 -75.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.230000000000004 110.853 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.21 -132.52 2.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 73.430000000000007 112.475 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.1 p30 -52.35 -49.69 63.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 71.019999999999996 110.874 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.547 HD12 ' OD1' ' A' ' 35' ' ' ASN . 11.8 mt -58.99 -21.69 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.25 111.154 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.59 21.09 11.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 71.340000000000003 111.127 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -58.8 117.07 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 63.329999999999998 110.888 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.9 m -81.96 138.79 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.853 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.455 HG23 ' HD3' ' A' ' 19' ' ' LYS . 1.8 pt -140.16 159.52 63.7 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 111.118 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.74 136.17 32.38 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.752 2.302 . . . . 73.310000000000002 112.334 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -26.15 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.9 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.99 -26.96 11.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 71.150000000000006 110.904 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -110.15 40.21 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 75.129999999999995 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -109.24 131.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 74.140000000000001 110.823 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.0 m 48.8 32.99 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.310000000000002 110.845 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -92.66 -27.4 17.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 75.040000000000006 110.909 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.79 31.53 5.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 52.509999999999998 112.445 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -118.24 142.08 47.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 73.430000000000007 110.96 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 31' ' ' VAL . 4.9 t -85.66 12.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 62.210000000000001 111.151 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -38.46 -42.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.915 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.98 173.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 53.030000000000001 110.916 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -106.4 -11.97 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 71.109999999999999 110.868 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.547 ' OD1' HD12 ' A' ' 17' ' ' ILE . 4.7 m-80 -121.09 9.15 10.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 73.140000000000001 110.868 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.29 37.46 38.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.747 . . . . 62.240000000000002 112.487 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -94.96 -6.79 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 74.109999999999999 110.842 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -83.24 -22.96 32.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 62.520000000000003 110.893 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.06 39.95 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.89 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -104.08 65.84 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.319999999999993 110.874 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.55 -15.75 10.58 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.735 -0.745 . . . . 44.439999999999998 112.461 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 119.369 -0.348 . . . . 72.329999999999998 110.918 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.432 -0.267 . . . . 74.5 112.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -54.76 -60.61 3.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.140000000000001 110.843 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -66.54 154.77 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 62.43 110.951 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -158.72 29.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.450000000000003 110.822 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 6' ' ' THR . 1.7 t -94.33 168.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 111.124 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.494 ' H ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -89.46 13.36 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 64.319999999999993 111.189 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 m -64.5 -175.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 51.229999999999997 110.895 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 -164.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.209999999999994 110.871 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -62.94 1.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 74.439999999999998 110.909 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.58 46.13 3.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 12.539999999999999 112.51 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.5 151.21 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 72.530000000000001 110.913 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -139.8 152.96 69.4 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.642 0.734 . . . . 71.329999999999998 110.9 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.74 175.11 8.53 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.695 2.264 . . . . 55.219999999999999 112.392 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 m -108.03 -75.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 71.430000000000007 110.909 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.86 -105.73 0.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.724 -0.75 . . . . 75.120000000000005 112.508 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' ND2' HG13 ' A' ' 17' ' ' ILE . 5.2 p-10 -74.25 -46.45 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.324 . . . . 74.319999999999993 110.861 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 34' ' ' ASP . 19.9 mt -70.81 -12.0 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.456 . . . . 74.230000000000004 111.097 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 55.84 26.16 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.120000000000005 111.159 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.12 116.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.019999999999996 110.916 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.0 m -80.53 120.68 24.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.439999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 10.7 pt -126.9 157.71 70.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 75.0 111.162 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.81 136.85 33.88 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.728 2.286 . . . . 63.310000000000002 112.29 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -26.36 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.239999999999995 110.943 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.53 -27.7 17.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 63.420000000000002 110.846 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -108.88 42.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 74.099999999999994 110.92 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -108.29 128.17 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 72.209999999999994 110.851 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m 54.08 37.07 26.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.450000000000003 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.79 14.3 32.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.430000000000007 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 65.219999999999999 112.474 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -108.12 137.49 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 75.329999999999998 110.887 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.1 t -83.59 11.61 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 61.340000000000003 111.17 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -38.9 -41.16 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 71.299999999999997 110.811 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.56 141.76 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 50.43 110.894 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.596 ' CG ' HD12 ' A' ' 17' ' ' ILE . 1.1 p30 -54.57 -35.73 63.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 61.399999999999999 110.892 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.95 8.45 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 61.229999999999997 110.907 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.2 31.8 27.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.772 . . . . 62.340000000000003 112.475 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -71.81 -16.14 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.349 . . . . 74.099999999999994 110.875 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.69 -16.2 61.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 72.120000000000005 110.849 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.51 38.89 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.030000000000001 110.873 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -28.47 7.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.120000000000005 110.973 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.72 11.76 18.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.775 -0.726 . . . . 53.109999999999999 112.541 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 119.281 -0.39 . . . . 70.430000000000007 110.892 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.494 -0.242 . . . . 52.329999999999998 112.494 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -128.39 63.19 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 110.86 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.82 26.46 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 62.210000000000001 110.921 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -154.47 26.04 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.812 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG11 ' CG2' ' A' ' 18' ' ' THR . 21.6 t 65.31 118.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 111.16 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.5 131.59 41.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 73.450000000000003 111.131 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 m -133.68 -169.5 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 24.34 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -167.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 73.209999999999994 110.883 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -86.84 -11.07 51.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 70.200000000000003 110.908 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -122.98 25.37 6.43 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.721 -0.752 . . . . 73.019999999999996 112.498 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.97 162.26 32.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.010000000000005 110.886 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.52 152.98 46.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.643 0.735 . . . . 75.200000000000003 110.843 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 162.45 42.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 63.009999999999998 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -102.48 -75.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 72.200000000000003 110.922 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.76 -115.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.765 -0.731 . . . . 55.539999999999999 112.466 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -52.6 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 74.25 110.915 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' CB ' ' A' ' 34' ' ' ASP . 46.5 mt -58.33 -21.96 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 111.139 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.431 ' CG2' HG11 ' A' ' 5' ' ' VAL . 1.6 m 59.42 22.18 10.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 64.319999999999993 111.194 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -54.09 121.36 7.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.019999999999996 110.929 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 m -75.47 116.51 16.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 73.019999999999996 110.914 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 pt -114.51 158.06 41.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 74.430000000000007 111.134 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.1 Cg_endo -69.73 136.67 33.67 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.71 2.273 . . . . 74.409999999999997 112.339 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.3 -26.62 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 110.934 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.52 -27.7 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -106.31 44.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 73.049999999999997 110.903 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -116.28 128.49 55.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.040000000000006 110.878 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t 50.02 31.68 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.795 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -33.2 14.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.462 . . . . 61.450000000000003 110.914 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.69 47.44 0.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.742 . . . . 60.340000000000003 112.502 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -138.03 146.24 42.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.310000000000002 110.905 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 31' ' ' VAL . 5.1 t -89.2 13.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 111.123 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' VAL . 13.9 m-20 -36.98 -44.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 71.420000000000002 110.874 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.42 135.28 33.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 64.239999999999995 110.925 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.698 ' CB ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -55.43 -30.19 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.872 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 13.4 20.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 65.230000000000004 110.87 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.66 30.51 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 52.240000000000002 112.459 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 m -72.4 -31.06 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 74.219999999999999 110.809 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.95 -28.47 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 75.040000000000006 110.892 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -107.82 38.66 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 70.420000000000002 110.821 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.36 57.95 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 75.439999999999998 110.934 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.71 9.23 21.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 32.119999999999997 112.487 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.3 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 119.311 -0.376 . . . . 54.439999999999998 110.907 -179.903 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.807 0.336 . . . . 71.14 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -169.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 72.11 110.855 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -68.88 -63.86 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 72.33 110.92 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.54 47.07 3.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 61.44 112.493 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -138.49 154.23 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 51.53 110.914 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -144.18 153.14 56.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 72.32 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.81 172.59 12.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 62.22 112.327 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 m -109.83 -74.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 61.33 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.92 -119.25 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 75.33 112.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -51.82 -64.08 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 73.55 110.87 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.4 mp -58.66 -21.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 71.33 111.169 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 61.13 21.7 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 64.35 111.117 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -52.61 121.05 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 65.11 110.901 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.4 m -77.59 130.8 37.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 53.03 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.2 pt -132.92 158.09 76.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.625 0.726 . . . . 64.25 111.096 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.73 137.35 35.35 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 53.15 112.343 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.81 -26.39 3.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 63.14 110.93 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -27.03 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 54.02 110.856 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.47 39.45 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -112.71 131.17 55.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.44 110.87 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.1 t 49.37 51.23 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 74.55 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.45 -53.48 2.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.76 41.78 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 55.34 112.487 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -133.21 147.39 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 71.23 110.941 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.2 t -86.48 12.71 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.097 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -38.58 -40.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.885 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 170.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 71.12 110.871 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 17' ' ' ILE . 7.9 t0 -86.7 -29.23 22.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.83 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.83 19.15 11.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.891 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.91 28.81 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 61.11 112.443 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -70.95 -26.57 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.372 . . . . 73.11 110.85 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -65.64 -21.39 66.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 51.34 110.856 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -114.21 38.81 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 44.34 110.878 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 72.32 110.937 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.893 0.378 . . . . 60.14 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -169.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 65.45 110.831 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -70.42 -62.66 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 71.33 110.881 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.68 46.65 3.34 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.727 . . . . 70.52 112.511 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.36 153.9 48.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 73.24 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -142.51 152.78 61.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.603 0.716 . . . . 65.12 110.916 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.615 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.86 176.85 6.29 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.58 2.187 . . . . 71.33 112.383 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.97 -75.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 41.25 110.82 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.2 -114.9 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.793 -0.717 . . . . 52.14 112.531 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.91 -66.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 72.53 110.851 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.655 HD12 ' HB3' ' A' ' 34' ' ' ASP . 33.2 mt -62.39 -21.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 53.13 111.141 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.83 25.65 15.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 62.22 111.142 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -51.63 120.05 4.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.873 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.7 m -75.69 126.42 30.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 64.31 110.892 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 pt -129.57 157.94 74.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.631 0.729 . . . . 75.14 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 138.08 36.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.711 2.274 . . . . 62.11 112.322 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.93 -26.31 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 70.42 110.869 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.73 -27.17 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 52.31 110.831 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -108.74 39.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 75.12 110.954 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.77 120.91 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.865 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.9 m 48.24 37.14 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.912 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -34.56 15.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 62.24 110.871 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.19 41.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 71.31 112.492 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -135.8 146.54 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 71.02 110.93 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.2 t -87.57 13.44 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.193 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -38.21 -41.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 54.12 110.842 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.8 169.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.913 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' ILE . 18.7 m-20 -88.71 -25.93 22.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.03 110.851 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -9.27 12.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 42.12 110.901 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.0 20.7 62.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 65.32 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -64.9 -28.54 69.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 64.55 110.833 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -61.89 -19.87 63.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 72.21 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -122.33 39.36 3.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.903 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.899 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.863 0.363 . . . . 71.43 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -169.8 1.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.02 110.809 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.85 -66.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 51.1 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.87 3.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 73.35 112.52 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -134.89 149.76 50.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.388 . . . . 65.14 110.922 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -137.52 153.25 74.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 73.4 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.73 177.62 5.38 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.636 2.224 . . . . 54.23 112.316 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 m -111.53 -73.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.35 110.811 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.26 -120.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 75.13 112.483 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -60.86 -42.13 97.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 64.34 110.937 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' CB ' ' A' ' 34' ' ' ASP . 60.6 mt -72.79 -22.32 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 60.13 111.15 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.68 21.93 13.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 73.5 111.172 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -51.57 111.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 72.03 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 m -73.78 125.01 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.904 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.2 pt -127.94 157.74 72.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.658 0.742 . . . . 71.35 111.089 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.66 137.59 36.11 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.702 2.268 . . . . 62.34 112.352 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.17 -26.0 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -26.64 15.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.847 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -108.53 39.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.906 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -110.77 131.16 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 63.44 110.884 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.4 m 48.88 32.83 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.03 110.843 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.2 -33.51 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 51.31 110.812 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 46.79 0.83 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 13.23 112.498 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -137.2 144.59 42.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.35 110.931 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -87.19 13.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.112 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' VAL . 30.3 m-20 -38.1 -42.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.21 110.845 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.68 141.18 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.41 110.859 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.713 ' CB ' HD12 ' A' ' 17' ' ' ILE . 38.3 m-20 -56.02 -33.83 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 72.44 110.859 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.45 6.97 20.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.21 110.885 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.61 30.99 28.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.22 112.476 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.3 t -70.64 -23.9 62.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 72.12 110.845 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -62.03 -25.92 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -108.33 38.59 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.856 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.931 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.879 0.371 . . . . 63.41 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -168.47 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.03 110.886 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.1 mt -67.32 -68.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 65.12 110.894 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.28 45.52 3.15 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.772 -0.728 . . . . 74.54 112.5 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -139.35 153.76 47.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.948 0.404 . . . . 74.12 110.858 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.69 153.09 67.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.743 . . . . 60.5 110.942 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.79 13.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 65.34 112.37 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -110.89 -75.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 52.05 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.97 -118.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.737 . . . . 62.51 112.505 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.8 m-80 -61.48 -58.56 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 72.05 110.91 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.773 HD13 ' HB3' ' A' ' 34' ' ' ASP . 2.7 mp -56.53 -22.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.203 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.49 21.0 12.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 65.02 111.119 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 21' ' ' ILE . 5.1 tttp -51.69 115.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 73.12 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.56 122.76 27.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 64.21 110.876 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 pt -123.59 158.14 60.11 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.634 0.731 . . . . 71.31 111.111 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.73 137.25 35.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.286 . . . . 70.31 112.316 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.0 -26.74 2.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.22 -0.446 . . . . 72.03 110.939 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -28.96 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 65.42 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 4.7 m0 -109.91 55.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -122.44 129.02 51.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 72.05 110.826 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.7 t 45.85 36.36 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 71.41 110.836 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -101.54 -35.29 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.881 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.38 45.54 0.39 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -132.12 144.51 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 52.34 110.954 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 31' ' ' VAL . 3.9 t -93.48 10.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.23 111.093 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.42 -37.63 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.53 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.29 133.42 55.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 61.34 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 17' ' ' ILE . 37.1 m-20 -57.69 -30.79 65.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.45 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.622 ' OD1' HD12 ' A' ' 17' ' ' ILE . 15.5 m-80 -109.51 5.35 23.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.873 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.76 29.14 25.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 53.23 112.498 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -24.19 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 73.43 110.889 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -71.13 -21.02 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.909 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -113.17 38.03 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.918 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.945 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 72.44 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.04 -175.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 70.15 110.843 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 -53.97 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.926 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.05 35.47 4.08 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.676 -0.773 . . . . 72.31 112.442 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -137.88 158.01 45.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.89 0.376 . . . . 73.32 110.941 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -143.76 153.03 57.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.717 0.77 . . . . 73.21 110.828 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 173.56 10.78 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 54.41 112.33 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.95 -74.46 0.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.914 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.16 -120.01 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 70.12 112.481 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.83 -56.12 15.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 71.22 110.892 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.558 HG21 ' OD2' ' A' ' 34' ' ' ASP . 16.5 mm -65.8 -20.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.41 111.158 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.0 22.28 8.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -55.42 121.39 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.946 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 m -80.69 120.82 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.87 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.4 pt -121.52 158.72 53.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 62.4 111.097 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.8 Cg_endo -69.83 137.52 35.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.264 . . . . 75.03 112.294 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -49.47 -26.7 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 70.3 110.946 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.77 -26.87 10.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 72.53 110.904 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -108.87 52.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 75.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -123.83 132.15 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 70.1 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.5 m 48.18 48.41 18.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.857 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -59.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.868 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.14 42.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 72.11 112.509 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -125.34 140.06 53.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 52.11 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.3 t -88.55 11.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 64.21 111.131 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -39.98 -38.21 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.848 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.79 134.84 57.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.888 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD2' HG21 ' A' ' 17' ' ' ILE . 5.0 m-20 -53.07 -42.02 65.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.868 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.03 12.83 31.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.909 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.67 27.74 20.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 64.34 112.509 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -63.03 -22.0 66.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 74.24 110.859 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -72.5 -20.44 61.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 61.21 110.868 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -113.4 37.77 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.946 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.83 0.348 . . . . 75.4 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.25 -175.32 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -54.12 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 53.42 110.952 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.79 35.54 4.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.25 112.461 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -141.1 151.49 44.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 61.03 110.941 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.8 149.06 63.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.612 0.72 . . . . 73.21 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 171.23 14.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 65.05 112.375 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.4 m -106.66 -76.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 61.41 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.8 -115.58 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 63.41 112.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -53.89 -58.29 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 70.54 110.939 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.6 mm -61.78 -19.5 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 75.42 111.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.73 21.68 9.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 70.15 111.195 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.04 122.41 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.9 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.41 126.72 34.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.898 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.9 pt -125.38 157.91 66.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 64.12 111.172 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.6 Cg_endo -69.7 138.46 38.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 73.51 112.358 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.11 -26.18 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 63.51 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.67 -27.62 18.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.82 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -109.44 42.23 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.898 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -105.51 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 60.31 110.902 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t 51.41 43.15 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -106.7 18.09 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.849 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.33 32.33 72.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 54.5 112.402 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -116.34 136.51 52.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 65.23 110.942 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.8 t -83.7 11.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.05 111.169 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -38.82 -41.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 62.53 110.807 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.66 140.78 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.894 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.62 -50.77 53.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.892 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.53 11.95 38.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 45.12 110.861 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.43 37.14 39.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.771 -0.728 . . . . 33.22 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 t -74.74 -7.25 52.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 73.41 110.817 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.1 -21.05 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.872 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -119.19 38.87 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.909 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 53.52 110.985 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.905 0.384 . . . . 72.03 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 71.12 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -66.48 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.933 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.93 44.92 2.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 45.42 112.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.9 148.8 52.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 65.33 110.949 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -137.64 153.64 74.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 72.34 110.859 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.89 11.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.697 2.264 . . . . 71.21 112.328 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -105.71 -73.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 52.23 110.864 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.36 -118.51 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.697 -0.764 . . . . 31.21 112.465 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -51.31 -45.03 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 75.33 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mm -72.02 -23.31 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.24 111.148 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.91 21.52 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.12 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -66.36 131.29 45.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 60.03 110.89 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.9 m -84.51 130.63 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.22 110.8 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.4 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.2 pt -128.56 157.48 74.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 62.42 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.79 138.0 36.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 2.236 . . . . 65.12 112.373 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.67 -25.82 4.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 70.15 110.9 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -28.45 13.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 63.54 110.901 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -106.24 44.2 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.955 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -121.43 134.71 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.939 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t 56.97 23.74 8.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 65.32 110.874 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -32.53 15.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 62.35 110.88 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.91 43.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.684 -0.769 . . . . 31.23 112.481 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -127.49 143.07 51.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 72.41 110.876 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.1 t -86.0 13.07 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 51.33 111.153 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 31' ' ' VAL . 35.1 m-20 -37.91 -42.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.51 110.898 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.25 137.22 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 61.53 110.882 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.92 -31.47 40.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 53.01 110.903 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -11.26 15.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 51.1 110.837 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.74 18.06 67.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 73.24 112.482 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -20.85 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 62.44 110.843 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -63.39 -24.53 67.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 51.22 110.865 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.63 38.53 2.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 62.2 110.893 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.21 110.908 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.836 0.351 . . . . 71.21 110.873 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.33 -164.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.41 110.863 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -61.34 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 52.24 110.879 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.69 46.76 3.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 55.03 112.477 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -138.79 158.2 44.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 74.32 110.863 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -146.05 152.76 48.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.609 0.719 . . . . 73.51 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.1 Cg_endo -69.78 174.12 9.99 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.665 2.243 . . . . 61.02 112.325 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 m -113.79 -73.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.92 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.7 -116.32 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 70.42 112.444 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -51.37 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.15 110.931 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 34' ' ' ASP . 27.8 mt -62.26 -21.46 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 64.54 111.161 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.64 27.03 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.45 111.167 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -51.43 114.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 71.33 110.946 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.05 125.05 25.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.876 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 pt -128.92 158.7 71.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 70.33 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 137.17 34.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.0 112.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -49.0 -27.01 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -27.63 12.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.894 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -108.63 52.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.907 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -121.57 129.21 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 52.14 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.1 t 45.83 53.92 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 54.13 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -66.44 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.52 41.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.668 -0.777 . . . . 63.54 112.405 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -126.78 138.05 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.335 . . . . 71.32 110.912 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.0 t -87.53 12.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.125 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -40.02 -39.2 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 62.4 110.849 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.03 140.49 52.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.846 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.661 ' CB ' HD12 ' A' ' 17' ' ' ILE . 53.0 m-20 -64.48 -32.22 73.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 71.52 110.854 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.03 11.25 22.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 72.04 110.859 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.75 25.56 22.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 52.33 112.41 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.7 t -67.31 -13.27 61.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 61.43 110.952 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -82.54 -19.15 39.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 74.04 110.867 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -120.97 39.18 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.94 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 m . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.839 0.352 . . . . 61.33 110.822 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.76 -171.06 1.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 73.13 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 10' ' ' GLY . 4.1 pp -79.61 -29.97 41.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 75.44 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -107.85 28.84 11.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.74 . . . . 63.31 112.496 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -135.81 157.9 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 71.11 110.944 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -146.02 151.5 45.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 65.24 110.964 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.9 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.243 . . . . 75.1 112.346 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.6 m -104.66 -74.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 52.34 110.855 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.48 -104.66 0.3 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.72 . . . . 73.03 112.556 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.88 -61.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 71.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.735 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.5 mp -57.2 -23.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.72 23.55 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 75.31 111.171 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -51.93 116.32 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 70.31 110.859 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.25 114.78 15.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 53.21 110.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -117.03 158.4 44.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.709 0.766 . . . . 74.44 111.05 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 136.71 33.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.621 2.214 . . . . 75.52 112.366 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.7 -26.2 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.51 110.97 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.01 13.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 70.53 110.916 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -108.38 46.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 72.42 110.88 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -121.26 133.08 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 73.25 110.816 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t 53.35 27.49 6.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.921 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -93.27 -41.68 9.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.824 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.43 41.45 0.8 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 74.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 144.45 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 62.43 110.827 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.7 t -86.05 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 73.15 111.104 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -38.67 -41.62 0.72 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.836 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.76 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.04 110.911 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 17' ' ' ILE . 3.7 t0 -97.76 -27.42 14.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.85 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.13 11.98 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 75.15 110.9 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.34 30.33 58.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 74.41 112.429 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -79.84 -3.9 49.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 62.22 110.88 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -88.7 -23.71 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 72.34 110.812 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.7 39.55 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.24 110.863 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.0 m . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.806 0.336 . . . . 72.21 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 -164.74 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 72.42 110.871 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 60.45 110.929 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.91 3.43 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.753 -0.737 . . . . 71.02 112.468 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.42 155.15 47.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 72.23 110.901 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.17 153.5 48.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.618 0.723 . . . . 74.23 110.889 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.76 167.39 24.57 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.638 2.225 . . . . 64.14 112.349 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.83 -75.2 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.34 110.903 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.34 -127.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 51.05 112.434 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.415 ' ND2' HD22 ' A' ' 35' ' ' ASN . 6.1 p30 -54.3 -42.36 70.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 75.3 110.845 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 34' ' ' ASP . 72.1 mt -73.08 -20.13 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 42.22 111.111 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.789 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 58.85 23.79 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 52.41 111.156 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -51.15 111.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.833 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -70.38 122.45 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 73.4 110.927 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.7 pt -129.22 158.56 72.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.635 0.731 . . . . 75.24 111.139 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.81 135.66 30.89 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.718 2.279 . . . . 63.23 112.313 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -48.76 -26.68 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.958 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -28.4 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 72.03 110.838 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 m0 -108.59 39.66 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.16 -0.473 . . . . 71.24 110.874 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -109.77 126.41 53.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 64.11 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m 46.72 64.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -125.5 -45.37 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 64.23 110.873 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.81 40.33 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.677 -0.773 . . . . 64.2 112.478 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -135.8 145.9 46.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 61.33 110.854 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.7 t -86.62 13.13 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.157 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -38.7 -39.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.71 171.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 54.1 110.919 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.791 ' HB3' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -86.31 -30.17 22.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 44.12 110.882 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.415 HD22 ' ND2' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -121.99 20.42 10.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 75.14 110.796 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.64 29.55 25.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 73.53 112.437 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.4 t -71.99 -28.44 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 74.22 110.911 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -62.91 -22.13 66.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.54 110.876 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.87 38.28 2.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 53.15 110.823 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.14 110.959 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.835 0.35 . . . . 64.43 110.834 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.49 -169.27 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 73.21 110.843 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 9' ' ' LEU . 4.3 mt -67.78 -67.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 35.04 110.904 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.71 45.42 3.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 42.31 112.517 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -139.5 147.86 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 73.14 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -135.68 153.1 77.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 62.4 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.666 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.4 Cg_endo -69.72 173.5 10.84 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.724 2.283 . . . . 52.41 112.378 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.7 m -107.93 -72.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 55.42 110.889 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.83 -122.85 0.89 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 63.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -56.12 -43.6 78.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 71.53 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' CB ' ' A' ' 34' ' ' ASP . 20.8 mt -74.36 -19.11 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 51.51 111.146 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 59.6 24.14 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 72.42 111.126 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 112.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 63.53 110.937 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.9 m -75.65 120.51 21.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 63.32 110.91 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 pt -123.7 158.85 58.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 63.31 111.158 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 137.34 35.14 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 64.1 112.386 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -25.96 3.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -52.52 -26.45 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.21 110.824 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.53 39.82 2.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -108.35 127.83 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 73.35 110.928 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 m 49.28 33.2 4.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.962 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -33.88 15.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 61.23 110.937 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.23 40.93 1.0 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 22.14 112.409 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -132.41 145.03 50.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 55.41 110.897 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 31' ' ' VAL . 3.5 t -87.76 13.27 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.42 111.112 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -38.42 -42.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.44 141.13 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.908 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.733 ' CB ' HD12 ' A' ' 17' ' ' ILE . 72.0 m-20 -55.46 -32.18 62.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.86 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.87 2.7 17.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 72.13 110.916 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.25 32.9 37.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 75.45 112.534 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -70.97 -23.7 62.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 71.3 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.3 -28.89 69.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 74.11 110.872 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.79 38.9 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.855 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 75.31 110.952 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.857 0.36 . . . . 65.24 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.92 -171.71 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 73.02 110.909 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 5.2 mt -63.81 -68.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 61.34 110.954 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.16 46.56 3.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 74.25 112.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.81 141.38 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 72.3 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -130.19 151.22 78.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.705 0.764 . . . . 72.12 110.818 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.59 14.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.267 . . . . 74.1 112.305 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 m -106.26 -74.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.888 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.58 -119.6 0.7 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -52.97 -63.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.784 0.326 . . . . 75.34 110.907 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.77 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.6 mp -57.31 -22.99 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.152 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 64.45 22.19 12.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.42 111.169 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -52.41 111.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.972 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.3 m -74.99 128.12 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 53.4 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -129.62 158.28 73.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.633 0.73 . . . . 60.13 111.091 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 137.25 35.29 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 41.04 112.397 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.67 -25.6 4.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.913 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -26.2 18.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -107.11 39.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.903 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -111.14 134.53 52.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.15 110.833 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t 50.94 30.12 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 65.21 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -93.17 -42.7 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 64.4 110.862 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.38 43.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 71.31 112.477 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.92 144.6 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 75.34 110.919 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.8 t -86.11 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 54.31 111.115 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -38.68 -41.54 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 53.25 110.844 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.42 170.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.45 110.825 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.77 ' HB3' HD13 ' A' ' 17' ' ' ILE . 5.7 t0 -93.46 -27.82 16.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.905 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.26 0.51 14.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.802 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.77 28.79 72.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 52.14 112.525 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -78.88 -2.66 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 74.13 110.852 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -88.41 -23.6 23.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -120.97 39.41 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.2 110.883 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 72.14 110.919 -179.927 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.883 0.373 . . . . 45.05 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -171.95 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 44.32 110.85 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.8 mt -65.62 -67.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.857 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 46.32 3.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.767 -0.73 . . . . 71.34 112.514 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -144.56 141.16 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 73.32 110.895 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -129.28 150.01 74.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 55.05 110.836 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.603 ' CB ' HG22 ' A' ' 18' ' ' THR . 54.1 Cg_endo -69.75 179.01 3.99 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.668 2.246 . . . . 72.52 112.364 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.0 m -113.83 -74.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 73.15 110.865 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.76 -113.11 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.752 . . . . 75.51 112.502 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -51.58 -65.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 73.53 110.86 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.71 HD12 ' CG ' ' A' ' 34' ' ' ASP . 26.4 mt -65.79 -18.78 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.25 111.12 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 57.11 26.29 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.33 111.138 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -51.49 109.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 75.41 110.842 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.0 m -68.7 123.67 21.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.54 110.874 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 pt -125.42 158.26 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.647 0.737 . . . . 63.14 111.12 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.6 Cg_endo -69.76 138.05 36.91 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 74.42 112.322 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -26.1 4.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.906 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.35 -27.43 15.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 72.03 110.818 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -109.59 39.91 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.865 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.09 122.66 45.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.877 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 m 49.3 35.88 8.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 54.42 110.868 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.69 -31.81 16.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.84 34.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 71.11 112.479 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.19 143.28 50.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 74.24 110.848 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.0 t -86.6 13.46 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.181 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 31' ' ' VAL . 28.1 m-20 -38.53 -41.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 64.2 110.803 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.88 173.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 73.21 110.836 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.71 ' CG ' HD12 ' A' ' 17' ' ' ILE . 9.4 m-20 -97.63 -24.05 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.57 -7.37 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.862 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 22.82 61.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 60.25 112.446 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -69.25 -13.47 62.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 65.43 110.824 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -80.11 -24.16 40.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.24 110.875 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -123.03 39.88 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.977 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 73.44 110.879 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.859 0.361 . . . . 75.32 110.873 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -169.59 1.71 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.792 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.5 -63.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 73.14 110.926 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.78 46.33 3.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 54.15 112.5 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -138.61 158.75 43.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.33 110.942 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -143.8 148.18 41.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 71.13 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 163.59 37.67 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.256 . . . . 74.02 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 m -103.75 -65.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.858 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.21 -127.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 53.5 112.462 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 3.3 m-80 -52.23 -52.43 52.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.42 110.875 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.61 -18.13 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.22 111.101 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.43 22.27 9.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.143 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -62.12 113.73 3.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.45 110.941 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.0 m -82.56 130.94 35.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 64.11 110.911 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' OD1' ' A' ' 32' ' ' ASP . 7.1 pt -131.59 159.39 72.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 71.13 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.79 138.31 37.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 61.5 112.393 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -48.47 -27.6 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.17 -29.21 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.812 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.401 ' N ' ' CD1' ' A' ' 25' ' ' TRP . 4.9 m0 -109.5 52.91 0.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 70.45 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.31 122.78 45.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 75.23 110.897 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.2 m 49.02 32.32 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.0 -31.26 16.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 63.22 110.829 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 34.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.492 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 143.14 47.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 75.54 110.94 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -88.73 13.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 72.32 111.181 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.741 ' OD1' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -39.6 -37.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 72.33 110.893 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.1 m -70.91 125.05 25.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 75.52 110.871 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -31.93 63.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.814 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.96 7.15 46.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 75.32 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.82 27.25 19.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.734 . . . . 43.21 112.485 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t -66.57 -18.0 65.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 51.13 110.87 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -80.21 -21.21 43.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.916 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -119.19 39.31 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 73.33 110.923 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.832 0.349 . . . . 73.43 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.2 -170.83 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 52.53 110.876 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.95 -64.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 71.33 110.957 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 46.63 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 53.22 112.458 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -139.77 156.6 46.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.386 . . . . 74.23 110.913 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.56 153.41 65.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.743 . . . . 74.32 110.873 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 165.76 29.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.709 2.273 . . . . 64.15 112.376 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 m -103.98 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 63.25 110.859 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.23 -121.96 0.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.715 -0.755 . . . . 70.14 112.48 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 2.0 p30 -57.61 -54.19 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 74.44 110.91 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.59 HD13 ' CB ' ' A' ' 34' ' ' ASP . 2.8 mp -63.55 -19.29 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 64.15 111.134 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.96 23.79 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.35 111.111 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.3 116.35 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 72.23 110.924 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.9 m -83.31 124.03 30.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 65.52 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -127.29 157.64 71.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.653 0.74 . . . . 71.41 111.054 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.4 Cg_endo -69.81 137.97 36.57 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.711 2.274 . . . . 55.34 112.29 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -49.28 -26.1 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.909 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -28.51 24.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 70.34 110.933 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -108.47 42.52 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 73.23 110.919 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -107.63 131.16 54.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.851 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 m 51.21 37.77 19.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 54.45 110.853 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -101.25 11.67 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 75.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.62 29.31 74.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 73.31 112.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -110.92 138.69 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 65.44 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -85.07 12.11 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 51.54 111.166 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -38.36 -42.03 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 74.32 110.848 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.28 136.14 57.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 73.34 110.852 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.59 ' CB ' HD13 ' A' ' 17' ' ' ILE . 32.9 m-20 -55.04 -26.38 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -10.57 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 40.22 110.911 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.26 16.12 70.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.692 -0.766 . . . . 64.33 112.483 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -18.65 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 72.32 110.79 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.26 -22.75 65.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.868 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -115.69 39.82 2.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 51.44 110.901 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.928 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.873 0.368 . . . . 71.11 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.0 -174.23 2.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 63.33 110.886 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -54.82 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 43.23 110.945 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.91 38.58 3.17 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.697 -0.763 . . . . 22.25 112.472 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -141.53 158.36 43.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 71.45 110.926 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -142.76 152.22 58.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.628 0.727 . . . . 73.24 110.842 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 164.15 35.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.277 . . . . 74.31 112.347 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.1 m -104.17 -69.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 65.22 110.877 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.46 -120.52 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 64.43 112.478 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 2.2 m-80 -59.23 -53.18 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 75.33 110.798 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.9 mm -61.17 -17.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 73.51 111.154 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.04 22.17 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.147 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.97 121.78 12.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 71.52 110.874 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.6 m -90.06 123.99 34.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.915 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -124.31 157.59 64.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 72.43 111.192 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.9 Cg_endo -69.85 138.37 37.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.04 112.347 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -48.4 -27.08 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.54 110.904 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -29.73 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.969 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 3.6 m0 -110.41 58.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 63.14 110.904 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -125.58 126.53 44.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 72.45 110.883 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t 48.25 47.47 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 75.4 110.859 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -116.93 -25.15 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 75.23 110.823 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.87 42.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 54.24 112.498 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -125.93 134.9 51.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.863 0.363 . . . . 71.53 110.922 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.5 t -87.17 11.82 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 70.3 111.191 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.97 -38.77 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.815 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.1 131.68 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.417 . . . . 63.33 110.816 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.4 -35.99 68.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.852 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.33 2.52 39.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.913 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 50.89 33.72 28.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 62.03 112.469 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -77.12 -3.25 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.895 0.378 . . . . 62.33 110.858 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.14 -20.56 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.31 110.846 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -120.5 38.49 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.946 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 73.3 110.936 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.856 0.36 . . . . 64.44 110.872 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.08 -169.59 2.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.855 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.7 mt -65.42 -67.68 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 74.12 110.917 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.01 47.51 3.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.555 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -143.99 155.1 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 53.41 110.903 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.16 153.39 69.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 74.1 110.91 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 165.34 31.28 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.723 2.282 . . . . 71.53 112.321 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -107.52 -71.25 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 52.01 110.864 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.22 -128.58 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 54.23 112.507 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.31 -48.34 68.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.744 0.307 . . . . 73.1 110.895 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 mm -66.24 -14.97 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 53.02 111.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.99 24.59 7.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 73.43 111.164 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -60.86 120.01 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.903 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.4 m -86.63 124.42 32.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.309 -0.405 . . . . 62.3 110.908 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 12.4 pt -125.34 157.45 67.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 75.31 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.0 Cg_endo -69.84 138.43 37.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 61.32 112.327 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -48.74 -27.03 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.84 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.14 110.9 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -109.78 57.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -126.14 127.74 46.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.882 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t 51.84 29.76 6.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.15 110.895 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.71 -34.71 11.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.779 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.99 44.92 0.52 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 75.31 112.422 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -128.12 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 72.42 110.962 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.6 t -87.26 12.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.18 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.6 -39.14 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.875 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.11 123.96 19.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 72.43 110.883 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.49 -26.74 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 73.11 110.848 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -14.46 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.875 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.22 26.57 72.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 44.23 112.492 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 t -74.0 -7.13 51.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 74.15 110.887 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.89 -20.13 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.888 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -122.44 38.98 4.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 52.22 110.888 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 70.34 110.878 -179.919 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.832 0.348 . . . . 73.32 110.888 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -169.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 63.45 110.822 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.52 -67.51 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 62.3 110.96 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.53 46.02 3.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 62.54 112.439 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -140.19 150.33 44.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 63.02 110.921 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -140.8 152.78 66.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.718 0.771 . . . . 73.33 110.82 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 164.48 34.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 33.31 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -98.69 -75.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.853 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.21 -132.52 2.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 73.43 112.475 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.1 p30 -52.35 -49.69 63.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 71.02 110.874 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.547 HD12 ' OD1' ' A' ' 35' ' ' ASN . 11.8 mt -58.99 -21.69 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.25 111.154 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.59 21.09 11.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 71.34 111.127 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -58.8 117.07 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 63.33 110.888 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.9 m -81.96 138.79 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.12 110.853 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.455 HG23 ' HD3' ' A' ' 19' ' ' LYS . 1.8 pt -140.16 159.52 63.7 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.606 0.717 . . . . 74.43 111.118 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.74 136.17 32.38 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.752 2.302 . . . . 73.31 112.334 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -26.15 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.9 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.99 -26.96 11.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.904 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -110.15 40.21 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -109.24 131.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 74.14 110.823 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.0 m 48.8 32.99 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.845 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -92.66 -27.4 17.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 75.04 110.909 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.79 31.53 5.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 52.51 112.445 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -118.24 142.08 47.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 73.43 110.96 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.9 t -85.66 12.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 62.21 111.151 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -38.46 -42.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.915 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.98 173.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 53.03 110.916 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -106.4 -11.97 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.868 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.547 ' OD1' HD12 ' A' ' 17' ' ' ILE . 4.7 m-80 -121.09 9.15 10.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.868 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.29 37.46 38.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.747 . . . . 62.24 112.487 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -94.96 -6.79 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 74.11 110.842 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -83.24 -22.96 32.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 62.52 110.893 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.06 39.95 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.15 110.89 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.32 110.874 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.873 0.368 . . . . 51.23 110.895 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 -164.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.21 110.871 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -62.94 1.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 74.44 110.909 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.58 46.13 3.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 12.54 112.51 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.5 151.21 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 72.53 110.913 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -139.8 152.96 69.4 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.642 0.734 . . . . 71.33 110.9 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.74 175.11 8.53 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.695 2.264 . . . . 55.22 112.392 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 m -108.03 -75.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.909 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.86 -105.73 0.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.508 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' ND2' HD22 ' A' ' 35' ' ' ASN . 6.8 p30 -74.25 -46.45 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.324 . . . . 74.32 110.861 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 34' ' ' ASP . 19.9 mt -70.81 -12.0 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.097 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 55.84 26.16 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.12 111.159 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.12 116.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.02 110.916 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.0 m -80.53 120.68 24.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.44 110.918 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 10.7 pt -126.9 157.71 70.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 75.0 111.162 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.81 136.85 33.88 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.728 2.286 . . . . 63.31 112.29 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -26.36 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.24 110.943 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.53 -27.7 17.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.846 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -108.88 42.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.92 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -108.29 128.17 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 72.21 110.851 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m 54.08 37.07 26.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.45 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.79 14.3 32.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 65.22 112.474 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -108.12 137.49 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 75.33 110.887 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -83.59 11.61 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 61.34 111.17 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -38.9 -41.16 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 71.3 110.811 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.56 141.76 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 50.43 110.894 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.596 ' CG ' HD12 ' A' ' 17' ' ' ILE . 1.1 p30 -54.57 -35.73 63.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 61.4 110.892 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.482 HD22 ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -111.95 8.45 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 61.23 110.907 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.2 31.8 27.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.772 . . . . 62.34 112.475 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -71.81 -16.14 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.349 . . . . 74.1 110.875 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.69 -16.2 61.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 72.12 110.849 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.51 38.89 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.03 110.873 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.973 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.851 0.358 . . . . 24.34 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -167.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 73.21 110.883 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -86.84 -11.07 51.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 70.2 110.908 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -122.98 25.37 6.43 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.721 -0.752 . . . . 73.02 112.498 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.97 162.26 32.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.01 110.886 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.52 152.98 46.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.643 0.735 . . . . 75.2 110.843 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 162.45 42.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 63.01 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -102.48 -75.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 72.2 110.922 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.76 -115.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.765 -0.731 . . . . 55.54 112.466 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -52.6 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 74.25 110.915 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' CB ' ' A' ' 34' ' ' ASP . 46.5 mt -58.33 -21.96 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 74.24 111.139 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m 59.42 22.18 10.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 64.32 111.194 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -54.09 121.36 7.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.02 110.929 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 m -75.47 116.51 16.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 73.02 110.914 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 pt -114.51 158.06 41.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 74.43 111.134 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.1 Cg_endo -69.73 136.67 33.67 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.71 2.273 . . . . 74.41 112.339 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.3 -26.62 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.934 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.52 -27.7 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -106.31 44.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 73.05 110.903 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -116.28 128.49 55.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.04 110.878 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t 50.02 31.68 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.795 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -33.2 14.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.462 . . . . 61.45 110.914 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.69 47.44 0.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.742 . . . . 60.34 112.502 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -138.03 146.24 42.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.31 110.905 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -89.2 13.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.13 111.123 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' VAL . 13.9 m-20 -36.98 -44.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 71.42 110.874 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.42 135.28 33.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 64.24 110.925 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.698 ' CB ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -55.43 -30.19 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.872 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 13.4 20.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.87 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.66 30.51 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 52.24 112.459 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 m -72.4 -31.06 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 74.22 110.809 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.95 -28.47 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 75.04 110.892 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -107.82 38.66 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 70.42 110.821 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 75.44 110.934 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.245 . . . . 45.03 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.81 91.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 71.34 110.888 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -161.58 161.57 29.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 53.05 110.882 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.88 -60.51 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.91 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 m -59.75 141.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 75.33 111.094 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.16 143.64 23.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 60.33 111.103 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.2 m -134.2 -169.81 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 71.14 110.894 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -169.61 1.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 72.11 110.855 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -68.88 -63.86 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.096 -0.502 . . . . 72.33 110.92 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.54 47.07 3.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 61.44 112.493 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -138.49 154.23 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 51.53 110.914 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -144.18 153.14 56.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 72.32 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.81 172.59 12.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.647 2.231 . . . . 62.22 112.327 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 m -109.83 -74.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 61.33 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.92 -119.25 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 75.33 112.523 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -51.82 -64.08 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 73.55 110.87 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.4 mp -58.66 -21.74 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 71.33 111.169 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 61.13 21.7 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 64.35 111.117 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -52.61 121.05 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 65.11 110.901 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.4 m -77.59 130.8 37.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 53.03 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.2 pt -132.92 158.09 76.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.625 0.726 . . . . 64.25 111.096 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.73 137.35 35.35 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 53.15 112.343 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.81 -26.39 3.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 63.14 110.93 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -27.03 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 54.02 110.856 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.47 39.45 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -112.71 131.17 55.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.44 110.87 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.1 t 49.37 51.23 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 74.55 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.45 -53.48 2.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.76 41.78 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 55.34 112.487 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -133.21 147.39 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 71.23 110.941 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.2 t -86.48 12.71 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.097 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -38.58 -40.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.885 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 170.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 71.12 110.871 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 17' ' ' ILE . 7.9 t0 -86.7 -29.23 22.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.83 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.83 19.15 11.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.891 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.91 28.81 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 61.11 112.443 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -70.95 -26.57 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.372 . . . . 73.11 110.85 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -65.64 -21.39 66.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 51.34 110.856 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -114.21 38.81 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 44.34 110.878 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -118.5 64.58 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 72.32 110.937 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.41 -13.07 6.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 41.15 112.501 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 119.281 -0.39 . . . . 64.14 110.881 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.464 -0.254 . . . . 34.31 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -79.24 -68.15 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 71.15 110.868 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 54.46 53.17 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 71.04 110.9 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 52.18 68.12 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 43.2 110.886 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.445 HG21 HG21 ' A' ' 18' ' ' THR . 7.8 m -59.31 137.27 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 62.24 111.156 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.36 144.69 51.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 63.35 111.116 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -134.59 -169.85 2.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 60.14 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -169.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 65.45 110.831 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -70.42 -62.66 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 71.33 110.881 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.68 46.65 3.34 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.727 . . . . 70.52 112.511 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -138.36 153.9 48.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 73.24 110.948 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -142.51 152.78 61.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.603 0.716 . . . . 65.12 110.916 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.615 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.86 176.85 6.29 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.58 2.187 . . . . 71.33 112.383 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.97 -75.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 41.25 110.82 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.2 -114.9 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.793 -0.717 . . . . 52.14 112.531 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.91 -66.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 72.53 110.851 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.655 HD12 ' HB3' ' A' ' 34' ' ' ASP . 33.2 mt -62.39 -21.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 53.13 111.141 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.83 25.65 15.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 62.22 111.142 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -51.63 120.05 4.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.873 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.7 m -75.69 126.42 30.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 64.31 110.892 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 pt -129.57 157.94 74.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.631 0.729 . . . . 75.14 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 138.08 36.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.711 2.274 . . . . 62.11 112.322 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.93 -26.31 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 70.42 110.869 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.73 -27.17 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 52.31 110.831 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -108.74 39.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 75.12 110.954 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.77 120.91 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.865 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.9 m 48.24 37.14 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.912 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -34.56 15.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 62.24 110.871 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.19 41.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 71.31 112.492 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -135.8 146.54 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 71.02 110.93 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.2 t -87.57 13.44 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.193 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -38.21 -41.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 54.12 110.842 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.8 169.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.913 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' ILE . 18.7 m-20 -88.71 -25.93 22.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.03 110.851 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -9.27 12.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 42.12 110.901 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.0 20.7 62.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 65.32 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -64.9 -28.54 69.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 64.55 110.833 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -61.89 -19.87 63.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 72.21 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -122.33 39.36 3.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.903 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -100.26 70.41 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.899 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.22 -21.73 23.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 72.42 112.483 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 119.291 -0.385 . . . . 44.35 110.877 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.517 -0.233 . . . . 72.11 112.517 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -42.93 91.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 74.44 110.907 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.98 176.49 5.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.883 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -151.95 84.61 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 64.14 110.86 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG21 HG21 ' A' ' 18' ' ' THR . 6.8 m -58.52 139.75 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.04 111.137 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.62 52.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 71.23 111.161 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.8 m -131.66 -169.99 2.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.43 . . . . 71.43 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -169.8 1.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.02 110.809 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.85 -66.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 51.1 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.87 3.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 73.35 112.52 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -134.89 149.76 50.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.388 . . . . 65.14 110.922 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -137.52 153.25 74.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.661 0.743 . . . . 73.4 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.73 177.62 5.38 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.636 2.224 . . . . 54.23 112.316 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 m -111.53 -73.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.35 110.811 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.26 -120.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 75.13 112.483 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -60.86 -42.13 97.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 64.34 110.937 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' CB ' ' A' ' 34' ' ' ASP . 60.6 mt -72.79 -22.32 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 60.13 111.15 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.591 HG21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 62.68 21.93 13.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 73.5 111.172 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -51.57 111.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 72.03 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 m -73.78 125.01 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.904 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.2 pt -127.94 157.74 72.85 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.658 0.742 . . . . 71.35 111.089 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.66 137.59 36.11 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.702 2.268 . . . . 62.34 112.352 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.17 -26.0 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -26.64 15.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.847 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -108.53 39.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.906 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -110.77 131.16 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 63.44 110.884 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.4 m 48.88 32.83 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.03 110.843 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.2 -33.51 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 51.31 110.812 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 46.79 0.83 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 13.23 112.498 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -137.2 144.59 42.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.35 110.931 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -87.19 13.24 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.112 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' VAL . 30.3 m-20 -38.1 -42.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.21 110.845 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.68 141.18 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.41 110.859 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.713 ' CB ' HD12 ' A' ' 17' ' ' ILE . 38.3 m-20 -56.02 -33.83 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 72.44 110.859 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.45 6.97 20.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.21 110.885 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.61 30.99 28.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.22 112.476 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.3 t -70.64 -23.9 62.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 72.12 110.845 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -62.03 -25.92 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -108.33 38.59 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.856 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -121.57 63.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.931 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.29 -11.84 6.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 60.41 112.505 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 119.31 -0.376 . . . . 72.24 110.9 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.473 -0.251 . . . . 72.33 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.65 26.6 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.944 0.402 . . . . 73.24 110.973 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.51 -172.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 63.12 110.937 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -174.4 36.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.145 -0.479 . . . . 75.41 110.83 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.1 m -58.64 133.12 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 64.22 111.124 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.28 167.17 23.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.31 111.113 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -130.81 -172.21 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 63.41 110.906 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -168.47 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.03 110.886 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.1 mt -67.32 -68.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 65.12 110.894 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.28 45.52 3.15 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.772 -0.728 . . . . 74.54 112.5 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -139.35 153.76 47.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.948 0.404 . . . . 74.12 110.858 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.69 153.09 67.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.743 . . . . 60.5 110.942 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.79 13.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 65.34 112.37 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -110.89 -75.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 52.05 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.97 -118.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.737 . . . . 62.51 112.505 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.8 m-80 -61.48 -58.56 7.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 72.05 110.91 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.773 HD13 ' HB3' ' A' ' 34' ' ' ASP . 2.7 mp -56.53 -22.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.203 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.49 21.0 12.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 65.02 111.119 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 21' ' ' ILE . 5.1 tttp -51.69 115.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 73.12 110.927 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.56 122.76 27.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 64.21 110.876 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 pt -123.59 158.14 60.11 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.634 0.731 . . . . 71.31 111.111 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.73 137.25 35.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.73 2.286 . . . . 70.31 112.316 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.0 -26.74 2.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.22 -0.446 . . . . 72.03 110.939 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -28.96 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 65.42 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 4.7 m0 -109.91 55.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -122.44 129.02 51.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 72.05 110.826 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.7 t 45.85 36.36 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 71.41 110.836 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -101.54 -35.29 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.881 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.38 45.54 0.39 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -132.12 144.51 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 52.34 110.954 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 31' ' ' VAL . 3.9 t -93.48 10.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.23 111.093 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.42 -37.63 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.53 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.29 133.42 55.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 61.34 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 17' ' ' ILE . 37.1 m-20 -57.69 -30.79 65.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.45 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.622 ' OD1' HD12 ' A' ' 17' ' ' ILE . 15.5 m-80 -109.51 5.35 23.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.873 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.76 29.14 25.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 53.23 112.498 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -24.19 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 73.43 110.889 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -71.13 -21.02 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.909 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -113.17 38.03 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.918 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -125.11 63.23 1.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.945 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.49 -11.54 6.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 74.13 112.43 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 119.333 -0.365 . . . . 61.53 110.831 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.489 -0.244 . . . . 60.13 112.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m -109.05 -171.17 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 74.21 110.86 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -49.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.889 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.9 68.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 64.53 110.889 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.86 134.38 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 55.11 111.132 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.95 154.36 41.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 64.11 111.14 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m -131.12 -170.29 2.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.84 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.04 -175.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 70.15 110.843 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 -53.97 16.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.926 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.05 35.47 4.08 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.676 -0.773 . . . . 72.31 112.442 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -137.88 158.01 45.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.89 0.376 . . . . 73.32 110.941 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -143.76 153.03 57.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.717 0.77 . . . . 73.21 110.828 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 173.56 10.78 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 54.41 112.33 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.95 -74.46 0.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.914 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.16 -120.01 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 70.12 112.481 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.83 -56.12 15.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 71.22 110.892 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.558 HG21 ' OD2' ' A' ' 34' ' ' ASP . 16.5 mm -65.8 -20.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.41 111.158 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.0 22.28 8.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -55.42 121.39 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.946 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 m -80.69 120.82 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.87 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.4 pt -121.52 158.72 53.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.661 0.743 . . . . 62.4 111.097 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.8 Cg_endo -69.83 137.52 35.45 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.697 2.264 . . . . 75.03 112.294 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -49.47 -26.7 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 70.3 110.946 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.77 -26.87 10.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 72.53 110.904 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -108.87 52.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 75.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -123.83 132.15 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 70.1 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.5 m 48.18 48.41 18.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.857 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -59.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.868 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.14 42.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 72.11 112.509 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -125.34 140.06 53.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 52.11 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.3 t -88.55 11.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 64.21 111.131 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -39.98 -38.21 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.848 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.79 134.84 57.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.888 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD2' HG21 ' A' ' 17' ' ' ILE . 5.0 m-20 -53.07 -42.02 65.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.868 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.03 12.83 31.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.909 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.67 27.74 20.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 64.34 112.509 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -63.03 -22.0 66.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 74.24 110.859 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -72.5 -20.44 61.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 61.21 110.868 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -113.4 37.77 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -119.47 -16.07 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.946 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.14 10.78 5.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.774 . . . . 61.22 112.476 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 119.313 -0.375 . . . . 75.24 110.905 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.461 -0.256 . . . . 74.12 112.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.48 -51.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 61.14 110.867 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -126.12 99.43 5.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.951 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.48 144.19 44.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.23 110.918 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 18' ' ' THR . 45.4 t -88.15 135.44 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 64.54 111.157 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.61 168.44 27.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.43 111.174 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -127.99 -169.62 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 75.4 110.898 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.25 -175.32 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -54.12 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 53.42 110.952 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.79 35.54 4.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.25 112.461 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -141.1 151.49 44.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 61.03 110.941 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.8 149.06 63.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.612 0.72 . . . . 73.21 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 171.23 14.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.643 2.229 . . . . 65.05 112.375 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.4 m -106.66 -76.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 61.41 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.8 -115.58 0.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 63.41 112.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -53.89 -58.29 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 70.54 110.939 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.6 mm -61.78 -19.5 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 75.42 111.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.53 ' CG2' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 58.73 21.68 9.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 70.15 111.195 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.04 122.41 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.9 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.41 126.72 34.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.898 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 5.9 pt -125.38 157.91 66.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 64.12 111.172 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.6 Cg_endo -69.7 138.46 38.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.633 2.222 . . . . 73.51 112.358 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.11 -26.18 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 63.51 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.67 -27.62 18.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.82 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -109.44 42.23 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.898 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -105.51 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 60.31 110.902 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t 51.41 43.15 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -106.7 18.09 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.849 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.33 32.33 72.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 54.5 112.402 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -116.34 136.51 52.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 65.23 110.942 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.8 t -83.7 11.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.05 111.169 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -38.82 -41.97 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 62.53 110.807 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.66 140.78 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.894 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.62 -50.77 53.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.892 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.53 11.95 38.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 45.12 110.861 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.43 37.14 39.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.771 -0.728 . . . . 33.22 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 t -74.74 -7.25 52.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 73.41 110.817 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.1 -21.05 33.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.872 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -119.19 38.87 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.909 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.89 66.85 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 53.52 110.985 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.83 -17.63 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.694 -0.765 . . . . 62.24 112.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 119.341 -0.361 . . . . 75.11 110.836 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.394 -0.282 . . . . 44.22 112.394 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -75.77 -45.09 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 54.12 110.847 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 52.23 63.59 2.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.31 110.941 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -99.62 25.28 7.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.892 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.753 HG21 HG21 ' A' ' 18' ' ' THR . 23.3 t 64.93 150.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 71.44 111.122 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.94 142.79 36.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 63.31 111.116 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.8 m -134.31 -169.85 2.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 72.03 110.835 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 71.12 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -66.48 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.933 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.93 44.92 2.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 45.42 112.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.9 148.8 52.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 65.33 110.949 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -137.64 153.64 74.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 72.34 110.859 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.89 11.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.697 2.264 . . . . 71.21 112.328 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -105.71 -73.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 52.23 110.864 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.36 -118.51 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.697 -0.764 . . . . 31.21 112.465 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -51.31 -45.03 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 75.33 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mm -72.02 -23.31 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.24 111.148 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.753 HG21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 58.91 21.52 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.12 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -66.36 131.29 45.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 60.03 110.89 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.9 m -84.51 130.63 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.22 110.8 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.4 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.2 pt -128.56 157.48 74.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 62.42 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.79 138.0 36.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 2.236 . . . . 65.12 112.373 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.67 -25.82 4.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 70.15 110.9 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -28.45 13.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 63.54 110.901 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -106.24 44.2 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.955 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -121.43 134.71 55.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.939 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 t 56.97 23.74 8.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 65.32 110.874 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -32.53 15.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 62.35 110.88 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.91 43.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.684 -0.769 . . . . 31.23 112.481 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -127.49 143.07 51.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 72.41 110.876 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.1 t -86.0 13.07 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 51.33 111.153 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 31' ' ' VAL . 35.1 m-20 -37.91 -42.44 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.51 110.898 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.25 137.22 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 61.53 110.882 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.92 -31.47 40.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 53.01 110.903 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -11.26 15.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 51.1 110.837 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.74 18.06 67.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 73.24 112.482 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -20.85 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 62.44 110.843 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -63.39 -24.53 67.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 51.22 110.865 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.63 38.53 2.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 62.2 110.893 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -117.94 -15.81 9.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 72.21 110.908 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.64 5.8 7.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 63.1 112.446 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 119.357 -0.354 . . . . 61.02 110.919 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.456 -0.258 . . . . 71.23 112.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -61.78 144.95 53.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.87 0.367 . . . . 73.41 110.945 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.28 -28.46 8.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 73.2 110.908 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.11 117.82 12.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.847 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 m -54.47 136.79 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.15 51.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 71.41 111.099 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 m -134.3 -169.87 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.873 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.33 -164.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.41 110.863 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -61.34 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 52.24 110.879 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.69 46.76 3.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 55.03 112.477 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -138.79 158.2 44.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 74.32 110.863 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -146.05 152.76 48.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.609 0.719 . . . . 73.51 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.1 Cg_endo -69.78 174.12 9.99 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.665 2.243 . . . . 61.02 112.325 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 m -113.79 -73.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.92 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.7 -116.32 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 70.42 112.444 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -51.37 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.15 110.931 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.661 HD12 ' CB ' ' A' ' 34' ' ' ASP . 27.8 mt -62.26 -21.46 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 64.54 111.161 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.64 27.03 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.45 111.167 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -51.43 114.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 71.33 110.946 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.05 125.05 25.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.876 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 pt -128.92 158.7 71.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 70.33 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.9 Cg_endo -69.78 137.17 34.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.282 . . . . 74.0 112.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -49.0 -27.01 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -27.63 12.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.894 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -108.63 52.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.907 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -121.57 129.21 52.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 52.14 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.1 t 45.83 53.92 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 54.13 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -66.44 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.52 41.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.668 -0.777 . . . . 63.54 112.405 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -126.78 138.05 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.335 . . . . 71.32 110.912 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.0 t -87.53 12.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.125 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -40.02 -39.2 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 62.4 110.849 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.03 140.49 52.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.846 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.661 ' CB ' HD12 ' A' ' 17' ' ' ILE . 53.0 m-20 -64.48 -32.22 73.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 71.52 110.854 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.03 11.25 22.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 72.04 110.859 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.75 25.56 22.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 52.33 112.41 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.7 t -67.31 -13.27 61.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 61.43 110.952 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -82.54 -19.15 39.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 74.04 110.867 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -120.97 39.18 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -108.41 63.66 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.94 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.38 -14.71 10.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 65.41 112.444 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 119.296 -0.383 . . . . 75.51 110.934 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.432 -0.267 . . . . 73.25 112.432 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 61.68 84.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 54.53 110.874 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.424 ' O ' HG23 ' A' ' 5' ' ' VAL . 20.6 pt20 -91.97 -36.17 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.4 110.948 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.18 98.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 55.12 110.86 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 3' ' ' GLN . 61.8 t -113.35 142.4 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 74.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.68 149.19 40.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.138 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 m -131.47 -169.93 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.33 110.822 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.76 -171.06 1.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 73.13 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 10' ' ' GLY . 4.1 pp -79.61 -29.97 41.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 75.44 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -107.85 28.84 11.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.74 . . . . 63.31 112.496 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -135.81 157.9 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 71.11 110.944 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -146.02 151.5 45.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 65.24 110.964 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.9 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.243 . . . . 75.1 112.346 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.6 m -104.66 -74.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 52.34 110.855 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.48 -104.66 0.3 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.72 . . . . 73.03 112.556 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.88 -61.5 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 71.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.735 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.5 mp -57.2 -23.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.72 23.55 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 75.31 111.171 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -51.93 116.32 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 70.31 110.859 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.25 114.78 15.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 53.21 110.854 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -117.03 158.4 44.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.709 0.766 . . . . 74.44 111.05 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 136.71 33.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.621 2.214 . . . . 75.52 112.366 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.7 -26.2 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.51 110.97 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.01 13.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 70.53 110.916 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -108.38 46.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 72.42 110.88 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -121.26 133.08 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 73.25 110.816 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t 53.35 27.49 6.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.921 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -93.27 -41.68 9.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.824 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.43 41.45 0.8 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 74.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 144.45 50.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 62.43 110.827 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.7 t -86.05 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 73.15 111.104 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -38.67 -41.62 0.72 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.836 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.76 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.04 110.911 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 17' ' ' ILE . 3.7 t0 -97.76 -27.42 14.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.85 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.13 11.98 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 75.15 110.9 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.34 30.33 58.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 74.41 112.429 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -79.84 -3.9 49.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 62.22 110.88 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -88.7 -23.71 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 72.34 110.812 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -120.7 39.55 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -116.48 -29.4 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.24 110.863 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.47 15.01 9.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 62.32 112.535 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 119.286 -0.388 . . . . 74.21 110.919 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.522 -0.231 . . . . 54.01 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -108.74 82.77 1.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 73.4 110.862 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -27.03 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 44.51 110.939 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.74 154.64 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.84 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.438 HG11 ' HB ' ' A' ' 18' ' ' THR . 43.1 t -68.42 136.78 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.23 111.106 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.13 146.71 50.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.15 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.0 m -131.93 -169.67 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 72.21 110.879 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 -164.74 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 72.42 110.871 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 60.45 110.929 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.91 3.43 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.753 -0.737 . . . . 71.02 112.468 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.42 155.15 47.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 72.23 110.901 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.17 153.5 48.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.618 0.723 . . . . 74.23 110.889 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.6 Cg_endo -69.76 167.39 24.57 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.638 2.225 . . . . 64.14 112.349 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.83 -75.2 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.34 110.903 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.34 -127.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 51.05 112.434 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.415 ' ND2' HD22 ' A' ' 35' ' ' ASN . 6.1 p30 -54.3 -42.36 70.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 75.3 110.845 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 34' ' ' ASP . 72.1 mt -73.08 -20.13 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 42.22 111.111 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.789 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 58.85 23.79 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 52.41 111.156 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -51.15 111.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.833 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -70.38 122.45 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 73.4 110.927 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.7 pt -129.22 158.56 72.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.635 0.731 . . . . 75.24 111.139 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.81 135.66 30.89 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.718 2.279 . . . . 63.23 112.313 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -48.76 -26.68 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.958 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -28.4 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 72.03 110.838 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 m0 -108.59 39.66 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.16 -0.473 . . . . 71.24 110.874 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -109.77 126.41 53.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 64.11 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m 46.72 64.36 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -125.5 -45.37 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 64.23 110.873 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.81 40.33 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.677 -0.773 . . . . 64.2 112.478 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -135.8 145.9 46.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 61.33 110.854 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.7 t -86.62 13.13 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.157 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -38.7 -39.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.71 171.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 54.1 110.919 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.791 ' HB3' HD12 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -86.31 -30.17 22.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 44.12 110.882 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.415 HD22 ' ND2' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -121.99 20.42 10.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 75.14 110.796 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.64 29.55 25.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 73.53 112.437 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.4 t -71.99 -28.44 63.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 74.22 110.911 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -62.91 -22.13 66.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.54 110.876 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.87 38.28 2.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 53.15 110.823 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -113.32 68.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.14 110.959 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.96 -21.68 8.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 71.31 112.511 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 17.5 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 119.295 -0.383 . . . . 44.1 110.827 -179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.531 -0.228 . . . . 75.44 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -102.39 35.79 2.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 75.43 110.889 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.79 -31.22 5.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 62.1 110.993 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.84 177.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 74.33 110.81 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 m -59.18 125.35 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 74.51 111.164 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 152.68 37.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.42 111.117 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m -131.77 -170.53 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 64.43 110.834 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.49 -169.27 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 73.21 110.843 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 9' ' ' LEU . 4.3 mt -67.78 -67.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 35.04 110.904 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.71 45.42 3.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 42.31 112.517 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -139.5 147.86 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 73.14 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -135.68 153.1 77.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 62.4 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.666 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.4 Cg_endo -69.72 173.5 10.84 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.724 2.283 . . . . 52.41 112.378 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.7 m -107.93 -72.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 55.42 110.889 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.83 -122.85 0.89 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 63.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -56.12 -43.6 78.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 71.53 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.733 HD12 ' CB ' ' A' ' 34' ' ' ASP . 20.8 mt -74.36 -19.11 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 51.51 111.146 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 59.6 24.14 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 72.42 111.126 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 112.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 63.53 110.937 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.9 m -75.65 120.51 21.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 63.32 110.91 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 3.2 pt -123.7 158.85 58.16 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 63.31 111.158 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.8 Cg_endo -69.79 137.34 35.14 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 64.1 112.386 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -25.96 3.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -52.52 -26.45 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.21 110.824 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.53 39.82 2.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -108.35 127.83 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 73.35 110.928 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 m 49.28 33.2 4.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.962 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -33.88 15.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.494 . . . . 61.23 110.937 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.23 40.93 1.0 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 22.14 112.409 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -132.41 145.03 50.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 55.41 110.897 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 31' ' ' VAL . 3.5 t -87.76 13.27 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.42 111.112 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -38.42 -42.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.44 141.13 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.908 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.733 ' CB ' HD12 ' A' ' 17' ' ' ILE . 72.0 m-20 -55.46 -32.18 62.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.86 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.87 2.7 17.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 72.13 110.916 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 52.25 32.9 37.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 75.45 112.534 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -70.97 -23.7 62.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 71.3 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.3 -28.89 69.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 74.11 110.872 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.79 38.9 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.855 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -120.85 65.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 75.31 110.952 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.83 -11.19 12.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 72.15 112.493 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 119.222 -0.418 . . . . 74.14 110.91 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.437 -0.265 . . . . 63.14 112.437 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -116.45 81.8 1.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 73.35 110.854 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.61 152.38 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 62.24 110.941 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 55.85 42.64 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.02 110.915 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.97 150.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 73.12 111.102 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.47 163.95 31.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m -130.31 -169.65 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.869 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.92 -171.71 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 73.02 110.909 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 9' ' ' LEU . 5.2 mt -63.81 -68.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 61.34 110.954 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.16 46.56 3.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 74.25 112.514 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.81 141.38 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 72.3 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -130.19 151.22 78.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.705 0.764 . . . . 72.12 110.818 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.59 14.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.267 . . . . 74.1 112.305 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 m -106.26 -74.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.888 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.58 -119.6 0.7 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -52.97 -63.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.784 0.326 . . . . 75.34 110.907 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.77 HD13 ' HB3' ' A' ' 34' ' ' ASP . 4.6 mp -57.31 -22.99 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.152 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 64.45 22.19 12.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.42 111.169 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -52.41 111.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.972 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.3 m -74.99 128.12 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 53.4 110.909 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 pt -129.62 158.28 73.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.633 0.73 . . . . 60.13 111.091 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 137.25 35.29 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.255 . . . . 41.04 112.397 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.67 -25.6 4.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.913 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -26.2 18.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -107.11 39.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.903 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -111.14 134.53 52.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.15 110.833 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t 50.94 30.12 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 65.21 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -93.17 -42.7 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 64.4 110.862 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.38 43.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 71.31 112.477 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.92 144.6 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 75.34 110.919 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.8 t -86.11 12.76 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 54.31 111.115 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -38.68 -41.54 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 53.25 110.844 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -51.42 170.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.45 110.825 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.77 ' HB3' HD13 ' A' ' 17' ' ' ILE . 5.7 t0 -93.46 -27.82 16.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.905 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.26 0.51 14.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.802 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.77 28.79 72.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 52.14 112.525 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -78.88 -2.66 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 74.13 110.852 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -88.41 -23.6 23.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -120.97 39.41 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.2 110.883 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -116.6 -28.82 6.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 72.14 110.919 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.72 14.3 9.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 54.32 112.523 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 119.367 -0.349 . . . . 55.05 110.876 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.238 . . . . 52.13 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -127.68 115.87 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 54.03 110.869 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.11 92.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.861 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -122.6 104.48 9.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.841 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.743 HG11 HG21 ' A' ' 18' ' ' THR . 60.1 t -71.33 140.87 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.3 111.13 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.84 147.45 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 71.44 111.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 55.7 m -133.54 -169.87 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 45.05 110.92 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -171.95 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 44.32 110.85 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.8 mt -65.62 -67.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.857 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 46.32 3.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.767 -0.73 . . . . 71.34 112.514 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -144.56 141.16 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 73.32 110.895 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -129.28 150.01 74.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 55.05 110.836 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.603 ' CB ' HG22 ' A' ' 18' ' ' THR . 54.1 Cg_endo -69.75 179.01 3.99 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.668 2.246 . . . . 72.52 112.364 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.0 m -113.83 -74.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 73.15 110.865 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.76 -113.11 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.752 . . . . 75.51 112.502 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -51.58 -65.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 73.53 110.86 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.71 HD12 ' CG ' ' A' ' 34' ' ' ASP . 26.4 mt -65.79 -18.78 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.25 111.12 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.743 HG21 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 57.11 26.29 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.33 111.138 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -51.49 109.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 75.41 110.842 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.0 m -68.7 123.67 21.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.54 110.874 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 pt -125.42 158.26 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.647 0.737 . . . . 63.14 111.12 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.6 Cg_endo -69.76 138.05 36.91 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 74.42 112.322 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -26.1 4.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.906 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.35 -27.43 15.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 72.03 110.818 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -109.59 39.91 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.865 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.09 122.66 45.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.877 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 m 49.3 35.88 8.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 54.42 110.868 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.69 -31.81 16.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.84 34.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 71.11 112.479 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.19 143.28 50.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 74.24 110.848 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.0 t -86.6 13.46 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.181 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 31' ' ' VAL . 28.1 m-20 -38.53 -41.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 64.2 110.803 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.88 173.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 73.21 110.836 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.71 ' CG ' HD12 ' A' ' 17' ' ' ILE . 9.4 m-20 -97.63 -24.05 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.57 -7.37 12.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.862 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 22.82 61.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 60.25 112.446 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -69.25 -13.47 62.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 65.43 110.824 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -80.11 -24.16 40.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.24 110.875 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -123.03 39.88 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.977 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -90.39 50.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 73.44 110.879 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.0 -5.93 72.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.515 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 119.288 -0.387 . . . . 52.54 110.892 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.518 -0.233 . . . . 31.12 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m 52.03 31.41 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 73.35 110.909 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.15 -68.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.967 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 106.49 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.27 -0.423 . . . . 75.31 110.836 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.484 HG11 ' HB ' ' A' ' 18' ' ' THR . 27.9 t -75.44 135.18 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 75.33 111.147 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.97 170.46 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 71.21 111.162 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.25 -169.87 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.873 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -169.59 1.71 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.792 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.5 -63.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 73.14 110.926 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.78 46.33 3.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 54.15 112.5 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -138.61 158.75 43.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.33 110.942 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -143.8 148.18 41.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 71.13 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 163.59 37.67 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.256 . . . . 74.02 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 m -103.75 -65.13 1.03 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.858 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.21 -127.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 53.5 112.462 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 3.3 m-80 -52.23 -52.43 52.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.42 110.875 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 mm -61.61 -18.13 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.22 111.101 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' HB ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 58.43 22.27 9.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.143 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -62.12 113.73 3.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.45 110.941 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.0 m -82.56 130.94 35.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 64.11 110.911 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.741 HG21 ' OD1' ' A' ' 32' ' ' ASP . 7.1 pt -131.59 159.39 72.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 71.13 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.5 Cg_endo -69.79 138.31 37.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 61.5 112.393 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -48.47 -27.6 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.17 -29.21 13.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.812 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.401 ' N ' ' CD1' ' A' ' 25' ' ' TRP . 4.9 m0 -109.5 52.91 0.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 70.45 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.31 122.78 45.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 75.23 110.897 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.2 m 49.02 32.32 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.0 -31.26 16.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 63.22 110.829 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 34.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.492 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.78 143.14 47.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 75.54 110.94 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.4 t -88.73 13.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 72.32 111.181 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.741 ' OD1' HG21 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -39.6 -37.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 72.33 110.893 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.1 m -70.91 125.05 25.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 75.52 110.871 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -31.93 63.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.814 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.96 7.15 46.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 75.32 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.82 27.25 19.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.734 . . . . 43.21 112.485 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t -66.57 -18.0 65.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 51.13 110.87 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -80.21 -21.21 43.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.916 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -119.19 39.31 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -112.44 69.25 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 73.33 110.923 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.88 -21.35 10.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.21 112.486 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 119.282 -0.389 . . . . 64.13 110.846 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.45 -0.26 . . . . 10.01 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 140.5 29.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 63.42 110.865 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -171.34 132.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.955 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.48 137.11 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 71.4 110.836 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 6' ' ' THR . 2.9 t 62.56 161.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 62.31 111.119 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.408 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 66.36 126.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 73.01 111.141 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.2 m -134.62 -169.25 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 73.43 110.928 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.2 -170.83 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 52.53 110.876 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -67.95 -64.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 71.33 110.957 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 46.63 3.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 53.22 112.458 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -139.77 156.6 46.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.386 . . . . 74.23 110.913 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -141.56 153.41 65.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.743 . . . . 74.32 110.873 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 165.76 29.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.709 2.273 . . . . 64.15 112.376 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 m -103.98 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 63.25 110.859 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.23 -121.96 0.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.715 -0.755 . . . . 70.14 112.48 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 2.0 p30 -57.61 -54.19 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 74.44 110.91 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.59 HD13 ' CB ' ' A' ' 34' ' ' ASP . 2.8 mp -63.55 -19.29 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 64.15 111.134 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.96 23.79 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.35 111.111 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.3 116.35 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 72.23 110.924 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.9 m -83.31 124.03 30.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 65.52 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -127.29 157.64 71.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.653 0.74 . . . . 71.41 111.054 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.4 Cg_endo -69.81 137.97 36.57 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.711 2.274 . . . . 55.34 112.29 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -49.28 -26.1 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.909 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -28.51 24.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 70.34 110.933 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -108.47 42.52 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 73.23 110.919 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -107.63 131.16 54.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.851 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 m 51.21 37.77 19.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 54.45 110.853 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -101.25 11.67 38.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 75.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.62 29.31 74.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 73.31 112.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -110.92 138.69 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 65.44 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -85.07 12.11 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 51.54 111.166 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -38.36 -42.03 0.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 74.32 110.848 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.28 136.14 57.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 73.34 110.852 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.59 ' CB ' HD13 ' A' ' 17' ' ' ILE . 32.9 m-20 -55.04 -26.38 36.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.879 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -10.57 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 40.22 110.911 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.26 16.12 70.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.692 -0.766 . . . . 64.33 112.483 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -18.65 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 72.32 110.79 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.26 -22.75 65.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.868 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -115.69 39.82 2.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 51.44 110.901 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -120.3 66.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.928 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.0 -13.54 9.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.716 -0.754 . . . . 30.41 112.454 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 119.345 -0.36 . . . . 63.12 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.461 -0.256 . . . . 54.41 112.461 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -61.66 124.1 19.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.805 0.336 . . . . 72.33 110.906 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.35 -73.81 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 72.41 110.892 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.91 -58.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 44.45 110.845 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 18' ' ' THR . 47.8 t -122.15 135.43 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 75.32 111.161 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.74 169.87 17.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 75.45 111.106 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.2 m -125.7 -169.78 2.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 71.11 110.892 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.0 -174.23 2.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 63.33 110.886 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -54.82 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 43.23 110.945 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.91 38.58 3.17 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.697 -0.763 . . . . 22.25 112.472 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -141.53 158.36 43.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 71.45 110.926 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -142.76 152.22 58.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.628 0.727 . . . . 73.24 110.842 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 164.15 35.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.277 . . . . 74.31 112.347 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.1 m -104.17 -69.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 65.22 110.877 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.46 -120.52 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 64.43 112.478 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 2.2 m-80 -59.23 -53.18 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 75.33 110.798 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.9 mm -61.17 -17.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 73.51 111.154 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 61.04 22.17 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.147 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.97 121.78 12.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 71.52 110.874 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.6 m -90.06 123.99 34.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.915 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 11.5 pt -124.31 157.59 64.08 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 72.43 111.192 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 52.9 Cg_endo -69.85 138.37 37.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.04 112.347 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -48.4 -27.08 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.54 110.904 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -29.73 18.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.969 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 3.6 m0 -110.41 58.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 63.14 110.904 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -125.58 126.53 44.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 72.45 110.883 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t 48.25 47.47 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 75.4 110.859 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -116.93 -25.15 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 75.23 110.823 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.87 42.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 54.24 112.498 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -125.93 134.9 51.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.863 0.363 . . . . 71.53 110.922 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.5 t -87.17 11.82 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 70.3 111.191 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.97 -38.77 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.815 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.1 131.68 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.417 . . . . 63.33 110.816 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.4 -35.99 68.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.852 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.33 2.52 39.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.913 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 50.89 33.72 28.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 62.03 112.469 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -77.12 -3.25 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.895 0.378 . . . . 62.33 110.858 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.14 -20.56 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.31 110.846 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -120.5 38.49 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.946 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -114.55 64.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 73.3 110.936 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.45 -16.85 7.03 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 44.55 112.47 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 119.353 -0.356 . . . . 54.41 110.903 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.447 -0.261 . . . . 30.5 112.447 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.3 m -153.37 34.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.372 . . . . 44.43 110.887 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.98 159.39 29.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 74.22 110.962 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.46 125.02 45.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.878 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG11 ' HB ' ' A' ' 18' ' ' THR . 35.5 t -96.85 126.34 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 51.1 111.072 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.17 176.01 8.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 61.44 111.094 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.3 m -126.62 -171.95 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.872 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.08 -169.59 2.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.855 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 9' ' ' LEU . 4.7 mt -65.42 -67.68 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 74.12 110.917 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.01 47.51 3.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.555 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -143.99 155.1 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.961 0.41 . . . . 53.41 110.903 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.16 153.39 69.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.632 0.729 . . . . 74.1 110.91 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 165.34 31.28 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.723 2.282 . . . . 71.53 112.321 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 m -107.52 -71.25 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 52.01 110.864 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.22 -128.58 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 54.23 112.507 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.31 -48.34 68.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.744 0.307 . . . . 73.1 110.895 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 mm -66.24 -14.97 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 53.02 111.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 ' HB ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER 55.99 24.59 7.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 73.43 111.164 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -60.86 120.01 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.903 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.4 m -86.63 124.42 32.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.309 -0.405 . . . . 62.3 110.908 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 12.4 pt -125.34 157.45 67.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.597 0.713 . . . . 75.31 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.0 Cg_endo -69.84 138.43 37.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 61.32 112.327 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -48.74 -27.03 2.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.84 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.14 110.9 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -109.78 57.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -126.14 127.74 46.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.882 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.3 t 51.84 29.76 6.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.15 110.895 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.71 -34.71 11.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.779 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.99 44.92 0.52 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 75.31 112.422 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -128.12 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 72.42 110.962 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.6 t -87.26 12.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.18 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -39.6 -39.14 0.69 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.875 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.11 123.96 19.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 72.43 110.883 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.49 -26.74 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 73.11 110.848 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -14.46 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.875 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.22 26.57 72.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 44.23 112.492 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.8 t -74.0 -7.13 51.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 74.15 110.887 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.89 -20.13 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.888 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -122.44 38.98 4.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 52.22 110.888 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -119.54 -30.9 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 70.34 110.878 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.09 15.46 8.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.783 -0.723 . . . . 52.44 112.513 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 119.371 -0.347 . . . . 64.11 110.886 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.504 -0.238 . . . . 41.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -130.7 142.81 50.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.781 0.324 . . . . 54.34 110.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -160.43 160.06 31.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.12 110.873 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.5 138.0 44.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 75.55 110.89 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 175.26 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.54 111.17 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 141.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.33 111.079 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 m -129.49 -169.68 2.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.888 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -169.48 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 63.45 110.822 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.52 -67.51 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 62.3 110.96 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.53 46.02 3.3 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 62.54 112.439 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -140.19 150.33 44.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 63.02 110.921 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -140.8 152.78 66.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.718 0.771 . . . . 73.33 110.82 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 164.48 34.32 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 33.31 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -98.69 -75.62 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.853 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.21 -132.52 2.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 73.43 112.475 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 16' ' ' ASN . 1.1 p30 -52.35 -49.69 63.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 71.02 110.874 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.547 HD12 ' OD1' ' A' ' 35' ' ' ASN . 11.8 mt -58.99 -21.69 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.25 111.154 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.59 21.09 11.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 71.34 111.127 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -58.8 117.07 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 63.33 110.888 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.9 m -81.96 138.79 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.12 110.853 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.455 HG23 ' HD3' ' A' ' 19' ' ' LYS . 1.8 pt -140.16 159.52 63.7 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.606 0.717 . . . . 74.43 111.118 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.74 136.17 32.38 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.752 2.302 . . . . 73.31 112.334 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -26.15 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.9 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.99 -26.96 11.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.904 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -110.15 40.21 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -109.24 131.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 74.14 110.823 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.0 m 48.8 32.99 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.845 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -92.66 -27.4 17.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 75.04 110.909 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.79 31.53 5.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 52.51 112.445 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -118.24 142.08 47.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 73.43 110.96 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 31' ' ' VAL . 4.9 t -85.66 12.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.45 . . . . 62.21 111.151 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -38.46 -42.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.915 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.5 m -52.98 173.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 53.03 110.916 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -106.4 -11.97 15.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.868 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.547 ' OD1' HD12 ' A' ' 17' ' ' ILE . 4.7 m-80 -121.09 9.15 10.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.868 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.29 37.46 38.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.747 . . . . 62.24 112.487 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -94.96 -6.79 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 74.11 110.842 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -83.24 -22.96 32.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 62.52 110.893 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.06 39.95 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.15 110.89 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -104.08 65.84 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.32 110.874 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.55 -15.75 10.58 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.735 -0.745 . . . . 44.44 112.461 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 119.369 -0.348 . . . . 72.33 110.918 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.432 -0.267 . . . . 74.5 112.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -54.76 -60.61 3.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 73.14 110.843 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -66.54 154.77 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 62.43 110.951 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -158.72 29.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 72.45 110.822 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 6' ' ' THR . 1.7 t -94.33 168.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.124 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.494 ' H ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -89.46 13.36 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 64.32 111.189 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 m -64.5 -175.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 51.23 110.895 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 -164.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.21 110.871 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -62.94 1.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 74.44 110.909 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.58 46.13 3.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 12.54 112.51 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.5 151.21 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 72.53 110.913 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -139.8 152.96 69.4 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.642 0.734 . . . . 71.33 110.9 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 18' ' ' THR . 53.7 Cg_endo -69.74 175.11 8.53 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.695 2.264 . . . . 55.22 112.392 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 m -108.03 -75.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.909 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.86 -105.73 0.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.508 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' ND2' HD22 ' A' ' 35' ' ' ASN . 6.8 p30 -74.25 -46.45 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.324 . . . . 74.32 110.861 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.596 HD12 ' CG ' ' A' ' 34' ' ' ASP . 19.9 mt -70.81 -12.0 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.097 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 55.84 26.16 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.12 111.159 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.12 116.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.02 110.916 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.0 m -80.53 120.68 24.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.44 110.918 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 10.7 pt -126.9 157.71 70.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 75.0 111.162 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.81 136.85 33.88 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.728 2.286 . . . . 63.31 112.29 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -26.36 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.24 110.943 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.53 -27.7 17.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.846 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -108.88 42.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.92 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -108.29 128.17 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 72.21 110.851 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.6 m 54.08 37.07 26.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.45 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.79 14.3 32.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.93 25.73 64.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 65.22 112.474 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -108.12 137.49 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 75.33 110.887 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -83.59 11.61 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 61.34 111.17 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -38.9 -41.16 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 71.3 110.811 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.56 141.76 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 50.43 110.894 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.596 ' CG ' HD12 ' A' ' 17' ' ' ILE . 1.1 p30 -54.57 -35.73 63.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 61.4 110.892 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.482 HD22 ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -111.95 8.45 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 61.23 110.907 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.2 31.8 27.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.772 . . . . 62.34 112.475 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -71.81 -16.14 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.349 . . . . 74.1 110.875 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.69 -16.2 61.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 72.12 110.849 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.51 38.89 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.03 110.873 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -28.47 7.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.973 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.72 11.76 18.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.775 -0.726 . . . . 53.11 112.541 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 119.281 -0.39 . . . . 70.43 110.892 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.494 -0.242 . . . . 52.33 112.494 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -128.39 63.19 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 74.41 110.86 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.82 26.46 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 62.21 110.921 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -154.47 26.04 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.812 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG11 ' CG2' ' A' ' 18' ' ' THR . 21.6 t 65.31 118.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 74.12 111.16 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.5 131.59 41.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 73.45 111.131 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 m -133.68 -169.5 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 24.34 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -167.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 73.21 110.883 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -86.84 -11.07 51.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 70.2 110.908 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -122.98 25.37 6.43 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.721 -0.752 . . . . 73.02 112.498 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.97 162.26 32.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.01 110.886 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.52 152.98 46.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.643 0.735 . . . . 75.2 110.843 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 162.45 42.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 63.01 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -102.48 -75.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 72.2 110.922 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.76 -115.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.765 -0.731 . . . . 55.54 112.466 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -52.6 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 74.25 110.915 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' CB ' ' A' ' 34' ' ' ASP . 46.5 mt -58.33 -21.96 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 74.24 111.139 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.431 ' CG2' HG11 ' A' ' 5' ' ' VAL . 1.6 m 59.42 22.18 10.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 64.32 111.194 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -54.09 121.36 7.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.02 110.929 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 m -75.47 116.51 16.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 73.02 110.914 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 pt -114.51 158.06 41.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 74.43 111.134 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 21' ' ' ILE . 54.1 Cg_endo -69.73 136.67 33.67 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.71 2.273 . . . . 74.41 112.339 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.3 -26.62 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.934 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -52.52 -27.7 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -106.31 44.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 73.05 110.903 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -116.28 128.49 55.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.04 110.878 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t 50.02 31.68 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.795 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -33.2 14.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.462 . . . . 61.45 110.914 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.69 47.44 0.79 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.742 . . . . 60.34 112.502 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -138.03 146.24 42.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.31 110.905 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 31' ' ' VAL . 5.1 t -89.2 13.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.13 111.123 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' VAL . 13.9 m-20 -36.98 -44.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 71.42 110.874 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.42 135.28 33.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 64.24 110.925 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.698 ' CB ' HD12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -55.43 -30.19 60.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.872 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 13.4 20.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.87 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.66 30.51 28.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.742 -0.742 . . . . 52.24 112.459 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 m -72.4 -31.06 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 74.22 110.809 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.95 -28.47 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 75.04 110.892 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -107.82 38.66 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 70.42 110.821 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.36 57.95 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 75.44 110.934 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.71 9.23 21.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 32.12 112.487 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.3 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 119.311 -0.376 . . . . 54.44 110.907 -179.903 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_